case_id,sample_id,diagnosis_age,sex,prior_diagnosis,genetic_ancestry_recoded,tissue_source_site,birth_from_initial_pathologic_diagnosis_date,last_communication_contact_from_initial_pathologic_diagnosis_date,days_last_followup,form_completion_date,buffa_hypoxia_score,ragnum_hypoxia_score,winter_hypoxia_score,fraction_genome_altered,mutation_count,aneuploidy_score,msi_score_mantis,msi_sensor_score,log_tmb_nonsynonymous,tumor_type,tumor_necrosis_percent,tumor_nuclei_percent,tumor_weight,neoplasm_disease_lymph_node_stage_american_joint_committee_on_cancer_code,clin_T_short,path_T_short,clinical_m,clinical_t,pathologic_n,pathologic_t,psa_value,gleason_primary_pattern,gleason_secondary_pattern,gleason_score,treatments_min_start_date,treatments_max_stop_date,has_radiation_therapy_any,has_hormone_therapy,has_chemo_therapy,primary_therapy_outcome_success,patient_current_status_has_neoplasm,has_new_tumor_event_after_initial_treatment,os_status,os_months,dss_status,dss_months,pfs_status,pfs_months,dfs_status,dfs_months,new_tumor_event_type,residual_tumor,has_PSM,has_SVI,has_ECE,has_T4,has_LNI,has_g43,gleason_capra_val,gleason_grade,PCBP1,PABPN1,PTPRF,DANCR,MYC
TCGA-2A-A8VL,TCGA-2A-A8VL-01,51,Male,0.0,EAS_OTHER_OR_MISSING,Memorial Sloan Kettering Cancer Center,-18658.0,621.0,621.0,2014-03-29,-27.0,-24.0,-34.0,0.03,22.0,0.0,0.3257,0.0,0.5306282510621704,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,150.0,N0,,t2,m0,,n0,t2b,0.05,3.0,3.0,6.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,20.41621462,0:ALIVE OR DEAD TUMOR FREE,20.41621462,0:CENSORED,20.41621462,,,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.5306575919211443,4.054761669628291,7.5233549458304925,4.297396872236424,5.115590963890906
TCGA-2A-A8VO,TCGA-2A-A8VO-01,57,Male,0.0,EUR,Memorial Sloan Kettering Cancer Center,-20958.0,1701.0,1701.0,2014-03-30,-29.0,-24.0,-26.0,0.0211,27.0,0.0,0.3286,0.0,0.6418538861723947,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,250.0,,t1,t3/t4,m0,t1c,,t3a,0.05,3.0,3.0,6.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,55.92267482,0:ALIVE OR DEAD TUMOR FREE,55.92267482,0:CENSORED,55.92267482,,,,R1,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,2.5722105933123083,3.819831652426537,6.693552469699709,4.374378769116874,5.527821022395033
TCGA-2A-A8VT,TCGA-2A-A8VT-01,47,Male,0.0,EAS_OTHER_OR_MISSING,Memorial Sloan Kettering Cancer Center,-17365.0,1373.0,1373.0,2014-03-29,-39.0,-22.0,-42.0,0.1418,39.0,14.0,0.3152,0.0,0.8329091229351039,"Prostate Adenocarcinoma, Acinar Type",0.0,95.0,250.0,N1,t2,t3/t4,m0,t2c,n1,t4,0.05,4.0,5.0,9.0,85.0,1086.0,True,True,False,No Treatment Indicated,False,False,0:LIVING,45.13923135,0:ALIVE OR DEAD TUMOR FREE,45.13923135,0:CENSORED,45.13923135,,,,R1,1.0,0.0,0.0,1.0,1.0,0.0,3.0,5.0,4.077986376505979,4.506392483858435,8.006108360327849,3.352433684381394,6.809907006540059
TCGA-2A-A8VV,TCGA-2A-A8VV-01,52,Male,0.0,EAS_OTHER_OR_MISSING,Memorial Sloan Kettering Cancer Center,-19065.0,671.0,671.0,2014-03-29,-25.0,-22.0,-36.0,0.0092,25.0,0.0,0.3136,0.0,0.5877866649021191,"Prostate Adenocarcinoma, Acinar Type",0.0,65.0,150.0,N0,t2,t2,m0,t2b,n0,t2b,0.05,3.0,3.0,6.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,22.06003222,0:ALIVE OR DEAD TUMOR FREE,22.06003222,0:CENSORED,22.06003222,,,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.24094012477072,3.96893860473764,7.592505624624856,4.814170986813631,6.062870761881253
TCGA-2A-A8VX,TCGA-2A-A8VX-01,70,Male,0.0,EUR,Memorial Sloan Kettering Cancer Center,-25904.0,1378.0,1378.0,2014-03-29,,,,0.0756,30.0,2.0,0.3361,0.03,0.6931471805599453,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,250.0,N0,t2,t3/t4,m0,t2c,n0,t3b,0.05,4.0,4.0,8.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,45.30361311,0:ALIVE OR DEAD TUMOR FREE,45.30361311,0:CENSORED,45.30361311,,,,R0,0.0,1.0,0.0,0.0,0.0,0.0,3.0,4.0,2.5137433845942603,3.371405524555692,6.433840784963111,5.317636915054838,5.282665903417674
TCGA-2A-A8W1,TCGA-2A-A8W1-01,54,Male,0.0,EAS_OTHER_OR_MISSING,Memorial Sloan Kettering Cancer Center,-19964.0,112.0,112.0,2014-03-29,-13.0,-14.0,-24.0,0.1079,24.0,2.0,0.3309,0.01,0.5877866649021191,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,250.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.05,4.0,3.0,7.0,,0.0,,False,False,No Treatment Indicated,,False,0:LIVING,3.682151429,0:ALIVE OR DEAD TUMOR FREE,3.682151429,0:CENSORED,3.682151429,,,,R1,1.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,3.6041425075232647,4.371398554256791,7.691892142250174,4.663059923747817,6.303824576221467
TCGA-2A-A8W3,TCGA-2A-A8W3-01,69,Male,0.0,EUR,Memorial Sloan Kettering Cancer Center,-25557.0,863.0,863.0,2014-03-29,-25.0,-22.0,-26.0,0.0776,34.0,1.0,0.335,0.0,0.7576857015412665,"Prostate Adenocarcinoma, Acinar Type",0.0,95.0,250.0,N0,t2,t3/t4,m0,t2b,n0,t3a,0.36,4.0,5.0,9.0,,0.0,False,False,False,No Treatment Indicated,False,True,0:LIVING,28.37229181,0:ALIVE OR DEAD TUMOR FREE,28.37229181,1:PROGRESSION,6.509517704,,,Biochemical evidence of disease,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,3.931011660045744,4.208860569137507,8.17491170476475,4.2420689225722406,6.375777971667346
TCGA-2A-AAYF,TCGA-2A-AAYF-01,57,Male,0.0,EUR,Memorial Sloan Kettering Cancer Center,-20866.0,1364.0,1364.0,2014-07-07,,,,0.0222,14.0,0.0,0.3205,0.0,0.3829922524833785,"Prostate Adenocarcinoma, Acinar Type",0.0,95.0,250.0,,t1,t3/t4,m0,t1c,,t3a,0.05,3.0,4.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,44.84334418,0:ALIVE OR DEAD TUMOR FREE,44.84334418,0:CENSORED,44.84334418,0:DiseaseFree,44.84334418,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.67064775223919,3.357580154490591,7.470367662247552,4.019586280736255,6.02933803102826
TCGA-2A-AAYO,TCGA-2A-AAYO-01,57,Male,0.0,EUR,Memorial Sloan Kettering Cancer Center,-21183.0,1272.0,1272.0,2014-07-07,,,,0.0208,20.0,1.0,0.3296,0.06,0.5108256239659906,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,300.0,,t1,t2,m0,t1c,,t2c,0.05,3.0,3.0,6.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,41.8187198,0:ALIVE OR DEAD TUMOR FREE,41.8187198,0:CENSORED,41.8187198,0:DiseaseFree,41.8187198,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.371001191541668,3.565182828931716,6.19256110613886,3.818421123463809,5.652721666591279
TCGA-2A-AAYU,TCGA-2A-AAYU-01,56,Male,0.0,EUR,Memorial Sloan Kettering Cancer Center,-20582.0,615.0,615.0,2014-07-07,,,,0.04,21.0,1.0,0.3309,0.04,0.5306282510621704,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,250.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.05,3.0,3.0,6.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,20.21895651,0:ALIVE OR DEAD TUMOR FREE,20.21895651,0:CENSORED,20.21895651,,,,R1,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,3.914487985917812,3.596589331059543,8.400031924183285,4.488720652895283,6.171403006510962
TCGA-4L-AA1F,TCGA-4L-AA1F-01,64,Male,0.0,EUR,"Proteogenex, Inc.",-23665.0,350.0,350.0,2014-11-14,,,,0.1387,25.0,14.0,0.3414,0.05,0.6061358033884974,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,400.0,N0,t2,t3/t4,m1a,t2c,n0,t3b,3.5,4.0,4.0,8.0,15.0,,False,True,False,No Treatment Indicated,False,False,0:LIVING,11.50672321,0:ALIVE OR DEAD TUMOR FREE,11.50672321,0:CENSORED,11.50672321,0:DiseaseFree,11.50672321,,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,4.0,3.1931882405328165,3.1666190478679828,6.995820279511225,2.8081996817832056,4.8620248182177646
TCGA-CH-5737,TCGA-CH-5737-01,73,Male,0.0,EUR,Indivumed,-26753.0,91.0,91.0,2012-03-16,-23.0,-18.0,-22.0,0.0572,46.0,1.0,0.2518,0.0,0.9295359584925968,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t2,m0,,n0,t2c,14.69,4.0,3.0,7.0,,0.0,,False,False,No Treatment Indicated,False,,0:LIVING,2.991748036,0:ALIVE OR DEAD TUMOR FREE,2.991748036,0:CENSORED,2.991748036,,,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,2.8545742055118097,2.259905175353353,8.487913171383491,4.210170635640168,6.176951022081523
TCGA-CH-5738,TCGA-CH-5738-01,72,Male,0.0,EUR,Indivumed,-26329.0,212.0,212.0,2012-03-16,-35.0,-20.0,-46.0,0.0011,15.0,0.0,0.2594,0.0,0.4054651081081644,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,,,,m0,,,,0.01,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,6.969786633,0:ALIVE OR DEAD TUMOR FREE,6.969786633,0:CENSORED,6.969786633,0:DiseaseFree,6.969786633,,R0,0.0,0.0,0.0,,0.0,0.0,0.0,1.0,3.302962380189662,3.172823507835735,8.05437911244179,4.434688269186704,7.0626387490707385
TCGA-CH-5739,TCGA-CH-5739-01,65,Male,0.0,EUR,Indivumed,-23953.0,671.0,671.0,2012-03-16,-33.0,-20.0,-40.0,0.0882,34.0,4.0,0.2588,0.01,0.7576857015412665,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t3/t4,m0,,n0,t3a,0.02,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,22.06003222,0:ALIVE OR DEAD TUMOR FREE,22.06003222,0:CENSORED,22.06003222,0:DiseaseFree,22.06003222,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,2.8072930909451754,2.485298009362139,7.989288901773568,4.326515776581538,7.520605324025728
TCGA-CH-5740,TCGA-CH-5740-01,57,Male,0.0,EUR,Indivumed,-20880.0,31.0,31.0,2012-03-21,-35.0,-14.0,-48.0,0.076,21.0,0.0,0.2611,0.02,0.5306282510621704,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t2,m0,,n0,t2c,1.6,3.0,4.0,7.0,,0.0,,False,False,No Treatment Indicated,False,,0:LIVING,1.019166913,0:ALIVE OR DEAD TUMOR FREE,1.019166913,0:CENSORED,1.019166913,,,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.343095086030594,3.534372923939101,7.86150259048132,5.707902973914376,7.933642269276497
TCGA-CH-5741,TCGA-CH-5741-01,56,Male,0.0,EUR,Indivumed,-20759.0,395.0,395.0,2012-03-16,-25.0,-18.0,-44.0,0.0576,21.0,0.0,0.2602,0.04,0.5306282510621704,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N1,,t3/t4,m0,,n1,t3b,0.02,4.0,5.0,9.0,61.0,334.0,True,True,False,Complete Remission/Response,False,False,0:LIVING,12.98615906,0:ALIVE OR DEAD TUMOR FREE,12.98615906,0:CENSORED,12.98615906,0:DiseaseFree,12.98615906,,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.2356811134044845,2.527846038565188,7.619659503744839,4.394973656860901,5.4596709550065
TCGA-CH-5743,TCGA-CH-5743-01,66,Male,0.0,EUR,Indivumed,-24321.0,425.0,425.0,2012-03-16,-35.0,-18.0,-36.0,0.0,,,0.2748,0.0,0.0,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t2,m0,,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,True,0:LIVING,13.97244962,0:ALIVE OR DEAD TUMOR FREE,13.97244962,1:PROGRESSION,13.97244962,0:DiseaseFree,13.97244962,New Primary Tumor,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.7643036872723528,3.2675657602714314,8.198981255998625,3.2132850617377056,6.72051378703711
TCGA-CH-5744,TCGA-CH-5744-01,64,Male,0.0,EUR,Indivumed,-23621.0,60.0,60.0,2012-03-16,-25.0,-18.0,-34.0,0.0505,21.0,1.0,0.2721,0.01,0.5306282510621704,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t2,m0,,n0,t2c,9.63,4.0,3.0,7.0,,0.0,,False,False,No Treatment Indicated,False,,0:LIVING,1.972581122,0:ALIVE OR DEAD TUMOR FREE,1.972581122,0:CENSORED,1.972581122,,,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,3.4746826367134056,3.184978459693331,8.123816193518364,3.539692354473906,5.782280121606313
TCGA-CH-5745,TCGA-CH-5745-01,68,Male,0.0,EUR,Indivumed,-24837.0,91.0,91.0,2012-03-16,,,,,24.0,,0.2674,0.0,0.5877866649021191,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t3/t4,m0,,n0,t3a,4.3,3.0,4.0,7.0,,0.0,,False,False,No Treatment Indicated,False,,0:LIVING,2.991748036,0:ALIVE OR DEAD TUMOR FREE,2.991748036,0:CENSORED,2.991748036,,,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,2.1335306471750117,2.9415383033718934,8.489887287890472,4.071582492755421,6.739578112048051
TCGA-CH-5746,TCGA-CH-5746-01,57,Male,0.0,EUR,Indivumed,-20941.0,731.0,731.0,2012-03-16,-35.0,-20.0,-42.0,0.0125,9.0,0.0,0.2718,0.01,0.262364264467491,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t2,m0,,n0,t2c,0.1,3.0,4.0,7.0,,0.0,True,False,False,Complete Remission/Response,False,False,0:LIVING,24.03261334,0:ALIVE OR DEAD TUMOR FREE,24.03261334,0:CENSORED,24.03261334,0:DiseaseFree,24.03261334,,R1,1.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.329841176530627,3.879744969419229,8.336471300939113,4.50467759063253,6.582057657292546
TCGA-CH-5748,TCGA-CH-5748-01,64,Male,0.0,EUR,Indivumed,-23649.0,31.0,31.0,2012-03-21,-31.0,-20.0,-28.0,0.0125,33.0,0.0,0.2656,0.0,0.7419373447293773,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t3/t4,,,n0,t3a,,4.0,3.0,7.0,,0.0,,False,False,No Treatment Indicated,True,,0:LIVING,1.019166913,0:ALIVE OR DEAD TUMOR FREE,1.019166913,0:CENSORED,1.019166913,,,,R1,1.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,2.861260639453137,3.3011778981458355,8.569582609414999,4.909360298003826,7.620679508195043
TCGA-CH-5750,TCGA-CH-5750-01,72,Male,0.0,EUR,Indivumed,-26389.0,396.0,396.0,2012-03-16,-29.0,-14.0,-24.0,0.0118,34.0,0.0,0.2643,0.03,0.7576857015412665,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t2,m0,,n0,t2c,0.02,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,13.01903541,0:ALIVE OR DEAD TUMOR FREE,13.01903541,0:CENSORED,13.01903541,0:DiseaseFree,13.01903541,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.05039721363622,3.639556327960424,8.389920817115602,5.017374114227268,7.50898001670472
TCGA-CH-5751,TCGA-CH-5751-01,68,Male,0.0,EUR,Indivumed,-24957.0,1065.0,1065.0,2012-03-16,-21.0,2.0,-38.0,0.2044,28.0,4.0,0.2715,0.04,0.6763400624130557,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N1,,t3/t4,m0,,n1,t4,0.01,5.0,5.0,10.0,122.0,,False,True,False,Complete Remission/Response,False,True,0:LIVING,35.01331492,0:ALIVE OR DEAD TUMOR FREE,35.01331492,1:PROGRESSION,11.9998685,1:Recurred/Progressed,11.9998685,Distant Metastasis,R1,1.0,0.0,0.0,1.0,1.0,0.0,3.0,5.0,2.8893567203891863,3.549570605785488,8.197029400949743,4.062104438156866,7.7596052741041746
TCGA-CH-5752,TCGA-CH-5752-01,66,Male,0.0,EUR,Indivumed,-24290.0,943.0,943.0,2012-03-16,-29.0,-10.0,-44.0,0.0319,39.0,0.0,0.2548,0.01,0.8329091229351039,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t3/t4,m0,,n0,t3a,0.02,4.0,4.0,8.0,578.0,,True,True,False,Complete Remission/Response,False,False,0:LIVING,31.00239997,0:ALIVE OR DEAD TUMOR FREE,31.00239997,0:CENSORED,31.00239997,0:DiseaseFree,31.00239997,,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,4.0,3.3573267858624627,4.139117455456879,7.305678743242288,5.6180888565990665,8.027536154922501
TCGA-CH-5753,TCGA-CH-5753-01,70,Male,1.0,EUR,Indivumed,-25780.0,31.0,31.0,2012-03-21,-33.0,-20.0,-24.0,0.1622,47.0,5.0,0.2613,0.1,0.9426080403213986,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N1,,t3/t4,m0,,n1,t3b,4.53,4.0,5.0,9.0,,0.0,,False,False,No Treatment Indicated,False,,0:LIVING,1.019166913,0:ALIVE OR DEAD TUMOR FREE,1.019166913,0:CENSORED,1.019166913,,,,R0,0.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.6210555032997394,4.08533966935737,8.702524223677205,3.71151693236044,5.834883099423406
TCGA-CH-5754,TCGA-CH-5754-01,65,Male,0.0,EUR,Indivumed,-23803.0,62.0,62.0,2012-03-21,-17.0,-2.0,-16.0,0.2071,78.0,3.0,0.2719,0.01,1.2809338454620642,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N1,,t3/t4,m0,,n1,t3b,37.36,4.0,5.0,9.0,,0.0,,False,False,No Treatment Indicated,True,,0:LIVING,2.038333827,0:ALIVE OR DEAD TUMOR FREE,2.038333827,0:CENSORED,2.038333827,,,,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.178045317612782,3.635661535833248,7.930393769682071,3.6379579534069393,6.967652806894037
TCGA-CH-5761,TCGA-CH-5761-01,61,Male,0.0,EUR,Indivumed,-22433.0,28.0,28.0,2012-03-16,-1.0,8.0,-6.0,0.3199,48.0,8.0,0.2696,0.09,0.9555114450274363,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t3/t4,m0,,n0,t3b,8.49,5.0,4.0,9.0,,0.0,,False,False,No Treatment Indicated,False,,0:LIVING,0.920537857,0:ALIVE OR DEAD TUMOR FREE,0.920537857,0:CENSORED,0.920537857,,,,R0,0.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,3.028745942227124,3.319719081148038,7.784527539078633,4.126436039492171,7.146351777888887
TCGA-CH-5762,TCGA-CH-5762-01,60,Male,0.0,EUR,Indivumed,-22068.0,1339.0,1339.0,2012-03-16,-33.0,-14.0,-34.0,0.1191,59.0,1.0,0.2841,0.0,1.0986122886681098,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t3/t4,m0,,n0,t3b,0.01,4.0,3.0,7.0,,0.0,True,False,False,Complete Remission/Response,False,False,0:LIVING,44.02143538,0:ALIVE OR DEAD TUMOR FREE,44.02143538,0:CENSORED,44.02143538,0:DiseaseFree,44.02143538,,R1,1.0,1.0,0.0,0.0,0.0,1.0,2.0,3.0,3.52854631527383,3.409418092494648,8.099998914672069,3.763836458890952,7.274830984740961
TCGA-CH-5763,TCGA-CH-5763-01,66,Male,1.0,EUR,Indivumed,-24380.0,365.0,365.0,2012-03-16,-31.0,-16.0,-36.0,0.0,16.0,,0.2624,0.0,0.4274440146095482,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t3/t4,m0,,n0,t3a,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,11.9998685,0:ALIVE OR DEAD TUMOR FREE,11.9998685,0:CENSORED,11.9998685,0:DiseaseFree,11.9998685,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.4151502054263867,3.0701316807720618,8.474513513830997,3.913703241562751,6.865498214569897
TCGA-CH-5764,TCGA-CH-5764-01,66,Male,1.0,EUR,Indivumed,-24257.0,31.0,31.0,2012-03-16,-39.0,-20.0,-38.0,0.0578,33.0,2.0,0.2607,0.01,0.7419373447293773,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t3/t4,m0,,n0,t3b,13.95,4.0,3.0,7.0,,0.0,,False,False,No Treatment Indicated,False,,0:LIVING,1.019166913,0:ALIVE OR DEAD TUMOR FREE,1.019166913,0:CENSORED,1.019166913,,,,R0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.0,2.997057510173684,3.143524032521613,8.462604515256382,4.9624518528904895,7.108303853931922
TCGA-CH-5765,TCGA-CH-5765-01,55,Male,0.0,EUR,Indivumed,-20364.0,700.0,700.0,2012-03-16,-35.0,-16.0,-46.0,0.0544,26.0,1.0,0.2822,0.05,0.6418538861723947,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t3/t4,m0,,n0,t3a,0.02,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,23.01344643,0:ALIVE OR DEAD TUMOR FREE,23.01344643,0:CENSORED,23.01344643,0:DiseaseFree,23.01344643,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.1189576791895526,3.76316720925484,8.151000804929136,4.105594275795191,6.719787175674185
TCGA-CH-5766,TCGA-CH-5766-01,55,Male,0.0,EUR,Indivumed,-20392.0,31.0,31.0,2012-03-16,-25.0,-16.0,-36.0,0.0616,29.0,3.0,0.2647,0.0,0.6763400624130557,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N1,,t3/t4,m0,,n1,t3a,13.9,4.0,3.0,7.0,,0.0,,False,False,No Treatment Indicated,False,,0:LIVING,1.019166913,0:ALIVE OR DEAD TUMOR FREE,1.019166913,0:CENSORED,1.019166913,,,,R0,0.0,0.0,1.0,0.0,1.0,1.0,2.0,3.0,3.4469840116779347,3.2723815780930465,8.800198113666362,3.9452612200121866,5.727416784422136
TCGA-CH-5767,TCGA-CH-5767-01,66,Male,0.0,EUR,Indivumed,-24287.0,458.0,458.0,2012-03-16,-23.0,-24.0,-28.0,0.0836,35.0,1.0,0.3007,0.0,0.773189888387328,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t2,m0,,n0,t2c,0.04,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,15.05736923,0:ALIVE OR DEAD TUMOR FREE,15.05736923,0:CENSORED,15.05736923,0:DiseaseFree,15.05736923,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,2.7908345810890016,2.9055819587663905,7.830556403611116,4.493339908813507,6.581851342973359
TCGA-CH-5769,TCGA-CH-5769-01,48,Male,0.0,EUR,Indivumed,-17807.0,62.0,62.0,2012-03-16,-13.0,6.0,-24.0,0.0284,108.0,0.0,0.3402,0.2,1.518783544238962,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t3/t4,m0,,n0,t3b,11.16,5.0,4.0,9.0,,0.0,,False,False,No Treatment Indicated,True,,0:LIVING,2.038333827,0:ALIVE OR DEAD TUMOR FREE,2.038333827,0:CENSORED,2.038333827,,,,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,2.353436217861783,2.856547537804078,8.338005826307228,4.6224618673827305,6.280360633891068
TCGA-CH-5771,TCGA-CH-5771-01,63,Male,0.0,EUR,Indivumed,-23101.0,396.0,396.0,2012-03-16,-31.0,-18.0,-42.0,0.0353,26.0,,0.2627,0.0,0.6241543092515653,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t2,m0,,n0,t2c,0.03,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,13.01903541,0:ALIVE OR DEAD TUMOR FREE,13.01903541,0:CENSORED,13.01903541,0:DiseaseFree,13.01903541,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,2.688650361086544,1.933119364431808,8.32191862717009,3.44534267503828,5.714866429896964
TCGA-CH-5772,TCGA-CH-5772-01,63,Male,1.0,EUR,Indivumed,-23194.0,486.0,486.0,2012-03-16,-35.0,-18.0,-32.0,0.0255,46.0,0.0,0.2662,0.0,0.9295359584925968,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t3/t4,m0,,n0,t3a,0.03,4.0,5.0,9.0,,0.0,True,False,False,Complete Remission/Response,False,False,0:LIVING,15.97790709,0:ALIVE OR DEAD TUMOR FREE,15.97790709,0:CENSORED,15.97790709,0:DiseaseFree,15.97790709,,R1,1.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,3.242495805044206,3.1758918148492703,7.476346851181485,4.375171527495756,6.602329190840131
TCGA-CH-5788,TCGA-CH-5788-01,69,Male,0.0,EUR,Indivumed,-25233.0,821.0,821.0,2012-03-16,-13.0,2.0,-14.0,0.2537,30.0,6.0,0.2555,0.15,0.6931471805599453,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N1,,t3/t4,m0,,n1,t3b,3.58,4.0,3.0,7.0,151.0,396.0,False,True,False,Progressive Disease,False,,0:LIVING,26.99148503,0:ALIVE OR DEAD TUMOR FREE,26.99148503,0:CENSORED,26.99148503,,,,R0,0.0,1.0,0.0,0.0,1.0,1.0,2.0,3.0,3.25173423893108,3.1586924861838,8.108687012169773,4.811897405154902,8.460076588648883
TCGA-CH-5789,TCGA-CH-5789-01,61,Male,0.0,EUR,Indivumed,-22494.0,304.0,304.0,2012-03-16,-27.0,-16.0,-30.0,0.0,3.0,0.0,0.2699,0.02,0.0953101798043249,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t3/t4,m0,,n0,t3a,0.02,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,9.99441102,0:ALIVE OR DEAD TUMOR FREE,9.99441102,0:CENSORED,9.99441102,0:DiseaseFree,9.99441102,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.385320587412354,2.963677566622854,8.572315961851105,2.987448210438548,6.56124364200286
TCGA-CH-5790,TCGA-CH-5790-01,64,Male,1.0,EUR,Indivumed,-23529.0,974.0,974.0,2012-03-16,-37.0,-16.0,-38.0,0.0336,20.0,1.0,0.2693,0.04,0.5108256239659906,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t2,m0,,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,32.02156689,0:ALIVE OR DEAD TUMOR FREE,32.02156689,0:CENSORED,32.02156689,0:DiseaseFree,32.02156689,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.24548045085612,3.678826868227333,8.647450871174325,4.446031204857843,7.049440181742719
TCGA-CH-5791,TCGA-CH-5791-01,72,Male,1.0,EUR,Indivumed,-26390.0,1004.0,1004.0,2012-03-16,-31.0,-16.0,-46.0,0.1138,36.0,1.0,0.2627,0.01,0.7884573603642703,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t3/t4,m0,,n0,t3a,0.18,3.0,4.0,7.0,,0.0,False,False,False,No Treatment Indicated,,True,0:LIVING,33.00785745,0:ALIVE OR DEAD TUMOR FREE,33.00785745,1:PROGRESSION,13.01903541,0:DiseaseFree,33.00785745,New Primary Tumor,R1,1.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.573798643589297,3.220856163960882,9.096911453061304,3.973519439685016,5.458864265634285
TCGA-CH-5792,TCGA-CH-5792-01,57,Male,0.0,EUR,Indivumed,-21002.0,91.0,91.0,2012-03-21,-37.0,-20.0,-40.0,0.0871,33.0,0.0,0.2789,0.0,0.7576857015412665,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t3/t4,m0,,n0,t3a,11.49,4.0,5.0,9.0,,0.0,,False,False,No Treatment Indicated,True,,0:LIVING,2.991748036,0:ALIVE OR DEAD TUMOR FREE,2.991748036,0:CENSORED,2.991748036,,,,R1,1.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,2.778397838842776,2.253444750262485,8.419806001322408,3.713695814843359,6.287747465466201
TCGA-CH-5794,TCGA-CH-5794-01,65,Male,0.0,EUR,Indivumed,-23924.0,882.0,882.0,2012-03-16,-33.0,-20.0,-28.0,0.044,24.0,0.0,0.2695,0.0,0.5877866649021191,"Prostate Adenocarcinoma, Acinar Type",20.0,60.0,100.0,N0,,t2,m0,,n0,t2b,0.01,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,28.9969425,0:ALIVE OR DEAD TUMOR FREE,28.9969425,0:CENSORED,28.9969425,0:DiseaseFree,28.9969425,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.110897723329813,2.64429470241661,8.373108317590507,5.14328728624977,6.53875076545611
TCGA-EJ-5494,TCGA-EJ-5494-01,50,Male,0.0,EUR,University of Pittsburgh,-18596.0,1477.0,1477.0,2012-03-29,-39.0,-20.0,-30.0,0.0008,27.0,0.0,0.2665,0.0,0.6418538861723947,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,150.0,N0,t2,t3/t4,m0,t2a,n0,t3a,,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,48.55837196,0:ALIVE OR DEAD TUMOR FREE,48.55837196,0:CENSORED,48.55837196,0:DiseaseFree,48.55837196,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,3.77306797704616,2.363171077119244,8.621073457729478,4.248550015930882,7.189342262395871
TCGA-EJ-5495,TCGA-EJ-5495-01,68,Male,0.0,EUR,University of Pittsburgh,-24904.0,1760.0,1760.0,2012-03-29,-43.0,-20.0,-46.0,0.0709,68.0,4.0,0.2615,0.0,1.1837700971104574,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,200.0,N1,t1,t3/t4,m0,t1c,n1,t3b,0.13,5.0,3.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,57.86237959,0:ALIVE OR DEAD TUMOR FREE,57.86237959,0:CENSORED,57.86237959,0:DiseaseFree,57.86237959,,R0,0.0,1.0,0.0,0.0,1.0,0.0,3.0,4.0,3.065813544775505,2.603786553123299,8.05656185309776,4.207721092007713,6.017579004539069
TCGA-EJ-5496,TCGA-EJ-5496-01,59,Male,0.0,EUR,University of Pittsburgh,-21897.0,595.0,595.0,2012-03-30,-33.0,-14.0,-36.0,0.0687,31.0,2.0,0.2588,0.01,0.7096764823472214,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,150.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,,0:LIVING,19.56142946,0:ALIVE OR DEAD TUMOR FREE,19.56142946,0:CENSORED,19.56142946,0:DiseaseFree,19.56142946,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.40540699672383,2.8707789725257764,8.160282395855209,4.663652027544782,5.838213091424025
TCGA-EJ-5497,TCGA-EJ-5497-01,47,Male,0.0,EUR,University of Pittsburgh,-17523.0,405.0,405.0,2012-03-30,-37.0,-16.0,-38.0,0.0283,17.0,0.0,0.26,0.0,0.4700036292457356,"Prostate Adenocarcinoma, Acinar Type",0.0,75.0,250.0,N0,t2,t2,m0,t2c,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,,0:LIVING,13.31492258,0:ALIVE OR DEAD TUMOR FREE,13.31492258,0:CENSORED,13.31492258,0:DiseaseFree,13.31492258,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.4658177832317136,2.808220279500857,8.270742434236936,4.326846505038488,6.236990013677002
TCGA-EJ-5498,TCGA-EJ-5498-01,56,Male,0.0,EUR,University of Pittsburgh,-20472.0,1720.0,1720.0,2012-03-30,-39.0,-16.0,-38.0,0.0012,28.0,2.0,0.2612,0.01,0.6592456287118501,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,220.0,N0,t2,t2,,t2c,n0,t2c,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,56.54732551,0:ALIVE OR DEAD TUMOR FREE,56.54732551,0:CENSORED,56.54732551,0:DiseaseFree,56.54732551,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,3.307035009244663,1.8435417249054504,8.238394229587826,4.119281467076696,6.742227234655243
TCGA-EJ-5499,TCGA-EJ-5499-01,61,Male,0.0,EUR,University of Pittsburgh,-22286.0,1415.0,1415.0,2012-03-30,-27.0,-14.0,-26.0,0.0438,30.0,1.0,0.2581,0.0,0.6931471805599453,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,250.0,N0,t2,t3/t4,m0,t2b,n0,t3a,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,46.52003814,0:ALIVE OR DEAD TUMOR FREE,46.52003814,0:CENSORED,46.52003814,0:DiseaseFree,46.52003814,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,2.969030732622681,1.5708514834229197,7.866694128982369,4.704562150049131,6.649420021000014
TCGA-EJ-5501,TCGA-EJ-5501-01,55,Male,0.0,EUR,University of Pittsburgh,-20409.0,1365.0,1365.0,2012-03-30,-23.0,-20.0,-24.0,0.0709,17.0,2.0,0.2751,0.02,0.4489502202606691,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,200.0,N0,t2,t3/t4,m0,t2b,n0,t3b,0.1,4.0,3.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,44.87622054,0:ALIVE OR DEAD TUMOR FREE,44.87622054,0:CENSORED,44.87622054,0:DiseaseFree,44.87622054,,R0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.0,3.525480092025449,2.620680241224301,8.659458303672276,4.801753619227391,6.485830918402587
TCGA-EJ-5502,TCGA-EJ-5502-01,50,Male,0.0,EUR,University of Pittsburgh,-18447.0,1171.0,1171.0,2012-03-30,-37.0,-22.0,-34.0,0.0,11.0,0.0,0.2697,0.0,0.3123746852860549,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,280.0,N0,t2,t2,m0,t2c,n0,t2c,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,38.49820824,0:ALIVE OR DEAD TUMOR FREE,38.49820824,0:CENSORED,38.49820824,0:DiseaseFree,38.49820824,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,3.722979619911584,3.3807017467199114,8.505587293657348,4.009678602868303,5.856151592881944
TCGA-EJ-5503,TCGA-EJ-5503-01,50,Male,0.0,EUR,University of Pittsburgh,-18395.0,1391.0,1391.0,2012-03-30,-37.0,-16.0,-44.0,0.0002,7.0,0.0,0.2653,0.0,0.2097205307117988,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,280.0,N0,t2,t3/t4,m0,t2b,n0,t3a,0.1,5.0,3.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,45.73100569,0:ALIVE OR DEAD TUMOR FREE,45.73100569,0:CENSORED,45.73100569,0:DiseaseFree,45.73100569,,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,4.0,3.281876258041914,2.9899927429616096,8.780154888103059,3.534945580061843,4.499947908318537
TCGA-EJ-5504,TCGA-EJ-5504-01,65,Male,0.0,EUR,University of Pittsburgh,-24072.0,1427.0,1427.0,2012-04-02,-29.0,-20.0,-30.0,0.119,40.0,2.0,0.2626,0.01,0.8472978602443463,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,320.0,N1,t2,t3/t4,m0,t2c,n1,t3a,1.0,4.0,3.0,7.0,,0.0,False,False,False,Progressive Disease,True,False,0:LIVING,46.91455436,0:ALIVE OR DEAD TUMOR FREE,46.91455436,0:CENSORED,46.91455436,,,,R1,1.0,0.0,1.0,0.0,1.0,1.0,2.0,3.0,2.8595521793719505,2.1478602227315893,8.186482234635553,4.858647465766828,6.901758709329389
TCGA-EJ-5505,TCGA-EJ-5505-01,57,Male,0.0,EUR,University of Pittsburgh,-21164.0,922.0,922.0,2012-04-02,-35.0,-18.0,-36.0,0.0415,27.0,0.0,0.2667,0.01,0.6418538861723947,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,170.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,30.31199658,0:ALIVE OR DEAD TUMOR FREE,30.31199658,0:CENSORED,30.31199658,0:DiseaseFree,30.31199658,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,2.891749685586821,2.363535560432942,8.5058468766945,4.335847656735904,5.989613619567997
TCGA-EJ-5506,TCGA-EJ-5506-01,67,Male,0.0,EUR,University of Pittsburgh,-24617.0,1381.0,1381.0,2012-04-02,-35.0,-16.0,-48.0,0.0,8.0,,0.2664,0.01,0.2363887783273882,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,200.0,N1,t3/t4,t3/t4,m0,t3b,n1,t3b,0.1,5.0,3.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,45.40224217,0:ALIVE OR DEAD TUMOR FREE,45.40224217,0:CENSORED,45.40224217,0:DiseaseFree,45.40224217,,RX,0.0,1.0,0.0,0.0,1.0,0.0,3.0,4.0,3.2207168919989164,3.0522941572734714,8.873265379521397,3.611325850076689,4.160299037498155
TCGA-EJ-5507,TCGA-EJ-5507-01,54,Male,0.0,EUR,University of Pittsburgh,-19759.0,1457.0,1457.0,2012-04-02,-27.0,-10.0,-40.0,0.1945,29.0,4.0,0.2557,0.05,0.6763400624130557,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,450.0,N1,t2,t3/t4,m0,t2c,n1,t3b,0.1,4.0,5.0,9.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,47.90084492,0:ALIVE OR DEAD TUMOR FREE,47.90084492,0:CENSORED,47.90084492,0:DiseaseFree,47.90084492,,R0,0.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.084421491735768,2.932363591434856,8.727053896824394,3.993121811522387,5.375824877929649
TCGA-EJ-5508,TCGA-EJ-5508-01,65,Male,0.0,EUR,University of Pittsburgh,-23758.0,1965.0,1965.0,2012-04-02,-35.0,-16.0,-38.0,0.0136,21.0,0.0,0.2577,0.0,0.5306282510621704,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,180.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,64.60203176,0:ALIVE OR DEAD TUMOR FREE,64.60203176,0:CENSORED,64.60203176,0:DiseaseFree,64.60203176,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.0197730690400277,3.0454604451592258,8.24338632493739,4.082004232222693,7.056884780881936
TCGA-EJ-5509,TCGA-EJ-5509-01,63,Male,0.0,EUR,University of Pittsburgh,-23368.0,1464.0,1464.0,2012-04-02,-29.0,-22.0,-36.0,0.1386,19.0,2.0,0.2652,0.0,0.4906229162443896,"Prostate Adenocarcinoma, Acinar Type",0.0,75.0,170.0,N0,t2,t2,m0,t2a,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,48.13097939,0:ALIVE OR DEAD TUMOR FREE,48.13097939,0:CENSORED,48.13097939,0:DiseaseFree,48.13097939,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.9772799234999163,1.8102785675873747,8.72360873001952,5.152418710081809,6.138466365265034
TCGA-EJ-5510,TCGA-EJ-5510-01,48,Male,0.0,EUR,University of Pittsburgh,-17895.0,1887.0,1887.0,2012-04-02,-35.0,-18.0,-48.0,0.1085,19.0,2.0,0.2695,0.0,0.4906229162443896,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,170.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,62.0376763,0:ALIVE OR DEAD TUMOR FREE,62.0376763,0:CENSORED,62.0376763,0:DiseaseFree,62.0376763,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,2.9449333890579075,1.7851738744226586,8.521960774053241,4.067432209485519,6.0301594831028655
TCGA-EJ-5511,TCGA-EJ-5511-01,55,Male,0.0,AFR,University of Pittsburgh,-20409.0,1476.0,1476.0,2012-04-03,-35.0,-18.0,-40.0,0.1235,36.0,3.0,0.2797,0.02,0.7884573603642703,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,230.0,N0,t2,t3/t4,m0,t2b,n0,t3a,0.04,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,48.52549561,0:ALIVE OR DEAD TUMOR FREE,48.52549561,0:CENSORED,48.52549561,0:DiseaseFree,48.52549561,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,2.981560432296056,3.157819839478863,8.828101884492204,4.73351704140616,7.502539059398577
TCGA-EJ-5512,TCGA-EJ-5512-01,46,Male,0.0,EUR,University of Pittsburgh,-17127.0,1733.0,1733.0,2012-04-03,-29.0,-20.0,-42.0,0.0309,13.0,0.0,0.262,0.0,0.3829922524833785,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,180.0,N0,t1,t2,m0,t1c,n0,t2c,0.0,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,56.97471809,0:ALIVE OR DEAD TUMOR FREE,56.97471809,0:CENSORED,56.97471809,0:DiseaseFree,56.97471809,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.6029556511589105,2.6102984702980896,7.892790504833608,4.687503061924391,5.831993746269447
TCGA-EJ-5514,TCGA-EJ-5514-01,66,Male,0.0,EUR,University of Pittsburgh,-24165.0,1829.0,1829.0,2012-04-03,-25.0,0.0,-36.0,0.1629,26.0,4.0,0.2647,0.0,0.6418538861723947,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,220.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,4.0,5.0,9.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,60.13084788,0:ALIVE OR DEAD TUMOR FREE,60.13084788,0:CENSORED,60.13084788,0:DiseaseFree,60.13084788,,R0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,5.0,2.706176880379602,3.0299122134063325,8.33180328074826,4.350758888634577,6.078385676984662
TCGA-EJ-5515,TCGA-EJ-5515-01,60,Male,0.0,EUR,University of Pittsburgh,-22097.0,1832.0,1832.0,2012-04-03,-29.0,-20.0,-36.0,0.0,12.0,,0.2903,0.01,0.3600027337988489,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,200.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,60.22947694,0:ALIVE OR DEAD TUMOR FREE,60.22947694,0:CENSORED,60.22947694,0:DiseaseFree,60.22947694,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,2.566181933698165,2.4643546035516404,8.37501770384836,3.1720233974282928,4.374608296607756
TCGA-EJ-5516,TCGA-EJ-5516-01,49,Male,0.0,EUR,University of Pittsburgh,-17980.0,1889.0,1889.0,2012-04-03,-33.0,-12.0,-30.0,0.0454,23.0,1.0,0.258,0.0,0.5500463367269643,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,280.0,N0,t2,t3/t4,m0,t2b,n0,t3a,0.12,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,62.103429,0:ALIVE OR DEAD TUMOR FREE,62.103429,0:CENSORED,62.103429,0:DiseaseFree,62.103429,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,2.838266046622673,1.6140030448649043,8.01333495756895,3.601815349728493,6.423193244094039
TCGA-EJ-5517,TCGA-EJ-5517-01,55,Male,0.0,EUR,University of Pittsburgh,-20422.0,1889.0,1889.0,2012-04-03,-25.0,-16.0,-40.0,0.0327,19.0,0.0,0.2528,0.0,0.4906229162443896,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,180.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,62.103429,0:ALIVE OR DEAD TUMOR FREE,62.103429,0:CENSORED,62.103429,0:DiseaseFree,62.103429,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.2425720207671525,1.452858964713811,7.246272210595845,4.073880201554134,6.265525036382456
TCGA-EJ-5518,TCGA-EJ-5518-01,66,Male,0.0,EUR,University of Pittsburgh,-24313.0,2118.0,2118.0,2012-04-03,-33.0,-20.0,-26.0,0.179,31.0,1.0,0.2726,0.0,0.7096764823472214,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,280.0,N0,t3/t4,t3/t4,m0,t3b,n0,t4,0.1,4.0,5.0,9.0,,0.0,False,False,False,Progressive Disease,True,True,0:LIVING,69.63211362,0:ALIVE OR DEAD TUMOR FREE,69.63211362,1:PROGRESSION,69.17184469,,,Distant Metastasis,R1,1.0,0.0,0.0,1.0,0.0,0.0,3.0,5.0,3.3321350377566192,1.8138940376156336,8.798444907265687,3.803185697875894,7.870465828000461
TCGA-EJ-5519,TCGA-EJ-5519-01,64,Male,0.0,EUR,University of Pittsburgh,-23669.0,1962.0,1962.0,2012-04-03,-33.0,-20.0,-34.0,0.1289,71.0,4.0,0.2689,0.04,1.203972804225936,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,300.0,N1,t2,t3/t4,m0,t2c,n1,t3b,0.2,4.0,4.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,64.5034027,0:ALIVE OR DEAD TUMOR FREE,64.5034027,0:CENSORED,64.5034027,0:DiseaseFree,64.5034027,,R0,0.0,1.0,0.0,0.0,1.0,0.0,3.0,4.0,3.366070376404919,3.030442025156869,8.62892739089105,3.854903281724658,6.934919814814199
TCGA-EJ-5521,TCGA-EJ-5521-01,63,Male,0.0,EUR,University of Pittsburgh,-23304.0,2279.0,2279.0,2012-04-04,-13.0,-20.0,-16.0,0.0736,40.0,0.0,0.2677,0.0,0.8472978602443463,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,170.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,74.9252063,0:ALIVE OR DEAD TUMOR FREE,74.9252063,0:CENSORED,74.9252063,0:DiseaseFree,74.9252063,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.2798575474468747,1.6115973339938936,8.110152841952651,4.26088378918649,5.382985357518483
TCGA-EJ-5522,TCGA-EJ-5522-01,51,Male,0.0,EUR,University of Pittsburgh,-18802.0,2079.0,2079.0,2012-04-03,-35.0,-14.0,-34.0,0.0245,14.0,0.0,0.2546,0.0,0.3829922524833785,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,200.0,N0,t2,t2,m0,t2a,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,68.34993589,0:ALIVE OR DEAD TUMOR FREE,68.34993589,0:CENSORED,68.34993589,0:DiseaseFree,68.34993589,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.7494913616025247,3.4303254216317693,8.76922923839902,4.339372587763497,6.40526912961498
TCGA-EJ-5524,TCGA-EJ-5524-01,57,Male,0.0,EUR,University of Pittsburgh,-20854.0,1882.0,1882.0,2012-04-04,-31.0,-12.0,-40.0,0.0951,37.0,0.0,0.2541,0.0,0.803495237579557,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,180.0,N0,t2,t3/t4,m0,t2b,n0,t3a,0.1,4.0,5.0,9.0,477.0,477.0,True,False,False,Progressive Disease,True,False,0:LIVING,61.87329454,0:ALIVE OR DEAD TUMOR FREE,61.87329454,1:PROGRESSION,8.712233291,,,Locoregional Recurrence,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,3.1066330779274427,2.902999694863484,8.144049939629713,3.7753245116041705,6.042427654254469
TCGA-EJ-5525,TCGA-EJ-5525-01,67,Male,0.0,EUR,University of Pittsburgh,-24535.0,1115.0,1115.0,2012-04-04,-29.0,-8.0,-32.0,0.2169,58.0,5.0,0.2706,0.31,1.0761394327024147,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,220.0,N0,t3/t4,t2,m0,t3a,n0,t2c,3.0,4.0,5.0,9.0,,0.0,False,False,False,Progressive Disease,True,True,0:LIVING,36.65713253,0:ALIVE OR DEAD TUMOR FREE,36.65713253,1:PROGRESSION,17.95048821,,,Distant Metastasis,R0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,5.0,2.6911321195738105,3.1714150166092434,8.625271220074994,5.262591009540705,8.322346866507043
TCGA-EJ-5526,TCGA-EJ-5526-01,56,Male,0.0,EAS_OTHER_OR_MISSING,University of Pittsburgh,-20558.0,1909.0,1909.0,2012-04-04,-31.0,-12.0,-36.0,0.1147,30.0,4.0,0.2691,0.0,0.7096764823472214,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,210.0,N1,t1,t3/t4,m0,t1c,n1,t3a,0.1,4.0,4.0,8.0,,0.0,False,False,False,Progressive Disease,True,True,0:LIVING,62.76095604,0:ALIVE OR DEAD TUMOR FREE,62.76095604,1:PROGRESSION,17.65460105,,,Locoregional Recurrence,R0,0.0,0.0,1.0,0.0,1.0,0.0,3.0,4.0,2.561497221019815,3.396858193780159,7.881712333173957,3.366615969509166,6.06782798935239
TCGA-EJ-5527,TCGA-EJ-5527-01,69,Male,0.0,EUR,University of Pittsburgh,-25234.0,1778.0,1778.0,2012-04-04,-33.0,-16.0,-30.0,0.0694,29.0,2.0,0.2574,0.0,0.6763400624130557,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,230.0,N0,t2,t3/t4,m0,t2a,n0,t3a,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,58.45415393,0:ALIVE OR DEAD TUMOR FREE,58.45415393,0:CENSORED,58.45415393,0:DiseaseFree,58.45415393,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,2.720103317115971,2.117595313759208,8.60231322887793,4.484337954477265,7.342631187516049
TCGA-EJ-5530,TCGA-EJ-5530-01,61,Male,0.0,EUR,University of Pittsburgh,-22316.0,1832.0,1832.0,2012-04-04,-41.0,-16.0,-46.0,0.015,45.0,1.0,0.2709,0.0,0.9426080403213986,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,220.0,N0,t2,t2,m0,t2c,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,60.22947694,0:ALIVE OR DEAD TUMOR FREE,60.22947694,0:CENSORED,60.22947694,0:DiseaseFree,60.22947694,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.471486635730024,3.275066661765736,9.074895000479108,4.256180376981417,7.3107727188267635
TCGA-EJ-5531,TCGA-EJ-5531-01,62,Male,0.0,EUR,University of Pittsburgh,-22760.0,1273.0,1273.0,2012-04-04,-37.0,-20.0,-30.0,0.0111,29.0,2.0,0.3296,0.29,0.6763400624130557,"Prostate Adenocarcinoma, Acinar Type",0.0,75.0,250.0,N0,t2,t3/t4,m0,t2b,n0,t3a,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,41.85159615,0:ALIVE OR DEAD TUMOR FREE,41.85159615,0:CENSORED,41.85159615,0:DiseaseFree,41.85159615,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,2.916438426844345,1.4723317960000384,8.355311008769021,4.004896843214848,6.003532528720798
TCGA-EJ-5532,TCGA-EJ-5532-01,57,Male,0.0,EUR,University of Pittsburgh,-21110.0,1828.0,1828.0,2012-04-04,-29.0,-22.0,-26.0,0.0722,19.0,3.0,0.2755,0.01,0.4906229162443896,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,280.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,60.09797153,0:ALIVE OR DEAD TUMOR FREE,60.09797153,0:CENSORED,60.09797153,0:DiseaseFree,60.09797153,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,2.476148348745653,2.137306779193289,8.33904694634717,4.054857157445082,7.364024314172414
TCGA-EJ-5542,TCGA-EJ-5542-01,60,Male,1.0,EUR,University of Pittsburgh,-21942.0,1513.0,1513.0,2012-04-04,-33.0,-16.0,-38.0,0.0794,23.0,2.0,0.2605,0.0,0.5690945320786457,"Prostate Adenocarcinoma, Acinar Type",0.0,75.0,150.0,N0,t2,t3/t4,m0,t2b,n0,t3a,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,49.74192064,0:ALIVE OR DEAD TUMOR FREE,49.74192064,0:CENSORED,49.74192064,0:DiseaseFree,49.74192064,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,2.745603069744317,2.157334807577724,8.709165855956952,4.475966836900233,6.569646022670523
TCGA-EJ-7115,TCGA-EJ-7115-01,65,Male,0.0,EUR,University of Pittsburgh,-23986.0,2687.0,2687.0,2012-04-05,-33.0,-22.0,-44.0,0.0616,40.0,1.0,0.3155,0.0,1.1096621247448044,"Prostate Adenocarcinoma, Acinar Type",0.0,20.0,100.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,88.33875793,0:ALIVE OR DEAD TUMOR FREE,88.33875793,0:CENSORED,88.33875793,0:DiseaseFree,88.33875793,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,2.4475791965488827,2.1104300641862976,8.384835975355982,4.356341040205686,5.73044432298668
TCGA-EJ-7123,TCGA-EJ-7123-01,59,Male,1.0,EUR,University of Pittsburgh,-21741.0,2572.0,2572.0,2012-04-05,-21.0,-22.0,-34.0,0.076,55.0,4.0,0.2867,0.0,1.4966424183633829,"Prostate Adenocarcinoma, Acinar Type",0.0,65.0,100.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,84.55797745,0:ALIVE OR DEAD TUMOR FREE,84.55797745,0:CENSORED,84.55797745,0:DiseaseFree,84.55797745,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0624498738852437,2.287738232412941,8.572464525996082,5.446196667855624,6.868654667765717
TCGA-EJ-7125,TCGA-EJ-7125-01,44,Male,0.0,EUR,University of Pittsburgh,-16425.0,2850.0,2850.0,2012-04-05,-25.0,-20.0,-40.0,0.0036,89.0,0.0,0.3004,0.0,1.8510760464368303,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,140.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,93.69760331,0:ALIVE OR DEAD TUMOR FREE,93.69760331,0:CENSORED,93.69760331,0:DiseaseFree,93.69760331,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.426855132324212,1.6943899274073104,6.329295848102515,3.760827709018613,4.17229548475702
TCGA-EJ-7218,TCGA-EJ-7218-01,71,Male,0.0,EUR,University of Pittsburgh,-26181.0,2542.0,2542.0,2014-03-03,-25.0,-22.0,-26.0,0.0499,24.0,0.0,0.3217,0.0,0.5877866649021191,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,360.0,N0,t2,t2,m0,t2a,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,83.57168689,0:ALIVE OR DEAD TUMOR FREE,83.57168689,0:CENSORED,83.57168689,0:DiseaseFree,83.57168689,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.680774425492461,3.435441911636402,8.161955684904962,5.164834538767026,6.287692066260268
TCGA-EJ-7314,TCGA-EJ-7314-01,62,Male,0.0,EUR,University of Pittsburgh,-22766.0,1150.0,1150.0,2012-04-05,-33.0,-18.0,-42.0,0.0268,33.0,1.0,0.3115,0.0,1.0761394327024147,"Prostate Adenocarcinoma, Acinar Type",0.0,40.0,350.0,N0,t2,t3/t4,m0,t2c,n0,t3b,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,37.80780485,0:ALIVE OR DEAD TUMOR FREE,37.80780485,0:CENSORED,37.80780485,0:DiseaseFree,37.80780485,,R0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.0,3.172087422592933,1.911193023032455,8.312541295534116,3.0959750399890984,7.111521728641585
TCGA-EJ-7315,TCGA-EJ-7315-01,68,Male,0.0,EUR,University of Pittsburgh,-25154.0,1008.0,1008.0,2012-04-05,-23.0,-16.0,-32.0,0.091,23.0,1.0,0.3382,0.0,0.8892620593492495,"Prostate Adenocarcinoma, Acinar Type",0.0,50.0,250.0,N0,t2,t3/t4,m0,t2a,n0,t3a,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,33.13936286,0:ALIVE OR DEAD TUMOR FREE,33.13936286,0:CENSORED,33.13936286,0:DiseaseFree,33.13936286,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,3.4910192982967496,2.15156661217406,8.006225079323226,2.776967240653652,5.504000599524464
TCGA-EJ-7317,TCGA-EJ-7317-01,71,Male,0.0,EUR,University of Pittsburgh,-26064.0,771.0,771.0,2012-04-05,-27.0,-22.0,-28.0,0.0281,32.0,0.0,0.314,0.04,1.1314021114911006,"Prostate Adenocarcinoma, Acinar Type",0.0,35.0,300.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,25.34766742,0:ALIVE OR DEAD TUMOR FREE,25.34766742,0:CENSORED,25.34766742,0:DiseaseFree,25.34766742,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.188812341045768,1.610652821838066,8.085237678474051,4.541892685878068,4.921907567224313
TCGA-EJ-7318,TCGA-EJ-7318-01,51,Male,0.0,EUR,University of Pittsburgh,-18686.0,1029.0,1029.0,2014-03-03,-15.0,-22.0,-12.0,0.0309,31.0,1.0,0.3304,0.0,0.7259370035442264,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,200.0,,t3/t4,t3/t4,m0,t3a,,t3a,0.08,4.0,3.0,7.0,,0.0,False,False,False,Partial Remission/Response,True,False,0:LIVING,33.82976625,0:ALIVE OR DEAD TUMOR FREE,33.82976625,1:PROGRESSION,12.49301378,,,Locoregional Recurrence,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,3.3722417160265974,3.077619007877731,7.444098018937164,5.005876016529004,5.845073491026246
TCGA-EJ-7321,TCGA-EJ-7321-01,57,Male,0.0,AFR,University of Pittsburgh,-21108.0,824.0,824.0,2012-04-05,-37.0,-16.0,-50.0,0.0318,30.0,0.0,0.3395,0.0,0.6931471805599453,"Prostate Adenocarcinoma, Acinar Type",0.0,40.0,250.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.1,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,27.09011408,0:ALIVE OR DEAD TUMOR FREE,27.09011408,0:CENSORED,27.09011408,0:DiseaseFree,27.09011408,,R0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,3.467135986475536,3.021586326553947,8.638370384822885,3.1784756326914403,5.693983103514425
TCGA-EJ-7325,TCGA-EJ-7325-01,63,Male,1.0,EUR,University of Pittsburgh,-23029.0,1070.0,1070.0,2014-03-03,,,,0.0457,18.0,1.0,0.3188,0.05,0.4700036292457356,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,200.0,N0,t3/t4,t3/t4,m0,t3b,n0,t3b,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,35.17769668,0:ALIVE OR DEAD TUMOR FREE,35.17769668,0:CENSORED,35.17769668,0:DiseaseFree,35.17769668,,R0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,2.0,1.587268968104325,3.0151228596297743,6.292216705710761,4.760960736871102,5.12715863091722
TCGA-EJ-7327,TCGA-EJ-7327-01,61,Male,0.0,EUR,University of Pittsburgh,-22475.0,923.0,923.0,2012-04-05,-41.0,-16.0,-46.0,0.0189,27.0,0.0,0.2991,0.0,1.0531499147076315,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,300.0,N0,t2,t3/t4,m0,t2a,n0,t3b,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,30.34487293,0:ALIVE OR DEAD TUMOR FREE,30.34487293,0:CENSORED,30.34487293,0:DiseaseFree,30.34487293,,R0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,2.0,2.615086662176285,1.7357387819123469,8.68336696857139,3.3846577110944294,3.7537221889962513
TCGA-EJ-7328,TCGA-EJ-7328-01,70,Male,0.0,EUR,University of Pittsburgh,-25756.0,842.0,842.0,2012-04-05,-35.0,-20.0,-50.0,0.036,24.0,0.0,0.3458,0.0,1.0055218654801463,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,350.0,N0,t1,t3/t4,m0,t1c,n0,t3a,,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,27.68188842,0:ALIVE OR DEAD TUMOR FREE,27.68188842,0:CENSORED,27.68188842,0:DiseaseFree,27.68188842,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,2.7668071513029213,3.8506794268648914,7.354771258796561,4.770871322190817,5.959002708099815
TCGA-EJ-7330,TCGA-EJ-7330-01,68,Male,0.0,EUR,University of Pittsburgh,-25050.0,191.0,191.0,2012-04-05,-31.0,-20.0,-32.0,0.1741,37.0,4.0,0.3671,0.0,1.262241712355572,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,250.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.1,4.0,3.0,7.0,,0.0,,False,False,No Treatment Indicated,False,,0:LIVING,6.27938324,0:ALIVE OR DEAD TUMOR FREE,6.27938324,0:CENSORED,6.27938324,,,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,3.0021444143602527,1.9741621677966,7.627326675969163,2.949665656742062,6.249422585464092
TCGA-EJ-7331,TCGA-EJ-7331-01,64,Male,0.0,EUR,University of Pittsburgh,-23458.0,742.0,742.0,2012-04-05,-33.0,-22.0,-28.0,0.0322,24.0,0.0,0.348,0.0,0.9555114450274363,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,250.0,N0,t1,t2,m0,t1c,n0,t2c,0.8,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,24.39425321,0:ALIVE OR DEAD TUMOR FREE,24.39425321,0:CENSORED,24.39425321,0:DiseaseFree,24.39425321,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0074287541334286,2.694791066028243,8.507806134151862,4.549515160046773,5.913511775730899
TCGA-EJ-7781,TCGA-EJ-7781-01,65,Male,0.0,EUR,University of Pittsburgh,-23937.0,1073.0,1073.0,2012-04-06,-33.0,-20.0,-34.0,0.064,54.0,1.0,0.3098,0.0,1.5260563034950492,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,200.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,35.27632574,0:ALIVE OR DEAD TUMOR FREE,35.27632574,0:CENSORED,35.27632574,0:DiseaseFree,35.27632574,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.287620044112067,2.707038804416892,8.812366015014927,4.113375456158886,6.772406956237962
TCGA-EJ-7782,TCGA-EJ-7782-01,71,Male,0.0,AFR,University of Pittsburgh,-25965.0,1167.0,1167.0,2012-04-06,-31.0,-16.0,-30.0,0.1234,357.0,2.0,0.4712,4.18,3.110547947833984,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,N0,t2,t2,m0,t2c,n0,t2c,0.1,4.0,4.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,38.36670283,0:ALIVE OR DEAD TUMOR FREE,38.36670283,0:CENSORED,38.36670283,0:DiseaseFree,38.36670283,,R0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,4.0,2.234715900126094,3.5233110307514166,9.12046729038753,4.301829051031621,5.681676952527004
TCGA-EJ-7783,TCGA-EJ-7783-01,70,Male,0.0,EUR,University of Pittsburgh,-25600.0,787.0,787.0,2012-04-06,-35.0,-14.0,-38.0,0.0357,37.0,2.0,0.3263,0.06,1.203972804225936,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,250.0,N0,t2,t3/t4,m0,t2c,n0,t3a,0.7,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,25.87368906,0:ALIVE OR DEAD TUMOR FREE,25.87368906,0:CENSORED,25.87368906,0:DiseaseFree,25.87368906,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,3.1935825250816485,2.229187973160184,6.236802554048058,2.858160077189853,5.302805229639588
TCGA-EJ-7784,TCGA-EJ-7784-01,63,Male,0.0,EUR,University of Pittsburgh,-23183.0,781.0,781.0,2012-04-06,-37.0,-18.0,-52.0,0.2403,36.0,7.0,0.3355,0.07,1.2237754316221157,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,N0,t2,t2,m0,t2c,n0,t2c,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,25.67643094,0:ALIVE OR DEAD TUMOR FREE,25.67643094,0:CENSORED,25.67643094,0:DiseaseFree,25.67643094,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,2.6569768075328826,3.161307263720935,8.691206813554565,4.721542185324691,7.65297113609515
TCGA-EJ-7785,TCGA-EJ-7785-01,54,Male,0.0,EUR,University of Pittsburgh,-19939.0,1177.0,1177.0,2012-04-06,-37.0,-20.0,-32.0,0.0206,18.0,0.0,0.3321,0.0,0.7884573603642703,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,150.0,N0,t2,t3/t4,m0,t2b,n0,t3a,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,38.69546635,0:ALIVE OR DEAD TUMOR FREE,38.69546635,0:CENSORED,38.69546635,0:DiseaseFree,38.69546635,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.114700172405481,2.876683921179048,8.525849244201178,3.5086695041816807,6.68789912316383
TCGA-EJ-7786,TCGA-EJ-7786-01,62,Male,0.0,EUR,University of Pittsburgh,-22793.0,1096.0,1096.0,2012-04-06,-33.0,-24.0,-44.0,0.0839,30.0,1.0,0.3371,0.04,1.0986122886681098,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,150.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,36.03248184,0:ALIVE OR DEAD TUMOR FREE,36.03248184,0:CENSORED,36.03248184,0:DiseaseFree,36.03248184,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0803336174311786,2.690528841401457,8.114877646123407,2.9113080903653263,6.35575983882189
TCGA-EJ-7788,TCGA-EJ-7788-01,53,Male,0.0,EUR,University of Pittsburgh,-19623.0,859.0,859.0,2012-04-06,-37.0,-16.0,-46.0,0.0647,27.0,0.0,0.3475,0.0,0.6418538861723947,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,300.0,N0,t3/t4,t3/t4,m0,t3b,n0,t3b,0.2,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,28.2407864,0:ALIVE OR DEAD TUMOR FREE,28.2407864,0:CENSORED,28.2407864,0:DiseaseFree,28.2407864,,R0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,2.0,2.445461867178357,3.5971735846720305,8.51159691334888,4.333967504365674,6.103713734032352
TCGA-EJ-7789,TCGA-EJ-7789-01,66,Male,0.0,AFR,University of Pittsburgh,-24107.0,1105.0,1105.0,2012-04-06,-13.0,-16.0,-20.0,0.3433,30.0,7.0,0.3603,0.06,1.0531499147076315,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,300.0,N0,t1,t3/t4,m0,t1c,n0,t3a,,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,36.328369,0:ALIVE OR DEAD TUMOR FREE,36.328369,0:CENSORED,36.328369,0:DiseaseFree,36.328369,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,2.533264313071792,3.809795133779879,8.256061462420954,4.610924432422211,6.102868054251107
TCGA-EJ-7791,TCGA-EJ-7791-01,67,Male,0.0,EUR,University of Pittsburgh,-24621.0,1118.0,1118.0,2012-04-09,-31.0,-20.0,-38.0,0.0001,19.0,,0.3074,0.0,0.4906229162443896,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,200.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,36.75576158,0:ALIVE OR DEAD TUMOR FREE,36.75576158,0:CENSORED,36.75576158,0:DiseaseFree,36.75576158,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.9134160332853054,2.480213411628074,8.820348437209885,3.619096028942013,6.271692720285375
TCGA-EJ-7792,TCGA-EJ-7792-01,53,Male,0.0,EUR,University of Pittsburgh,-19454.0,1396.0,1396.0,2012-04-09,-37.0,-24.0,-46.0,0.0252,17.0,0.0,0.3138,0.01,0.7576857015412665,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,200.0,N0,t1,t2,m0,t1c,n0,t2c,0.13,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,45.89538745,0:ALIVE OR DEAD TUMOR FREE,45.89538745,0:CENSORED,45.89538745,0:DiseaseFree,45.89538745,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.6417772116921188,2.661111097901239,8.070342096030606,3.404657930325598,5.0966202892299695
TCGA-EJ-7793,TCGA-EJ-7793-01,49,Male,0.0,EUR,University of Pittsburgh,-17982.0,114.0,114.0,2012-04-09,-29.0,-16.0,-42.0,0.0031,11.0,0.0,0.3176,0.0,0.3123746852860549,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,250.0,,t2,t2,m0,t2c,,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,,0:LIVING,3.747904133,0:ALIVE OR DEAD TUMOR FREE,3.747904133,0:CENSORED,3.747904133,0:DiseaseFree,3.747904133,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.667710499945521,1.738076041880165,8.435686927353391,4.5245840256345335,5.171859319973454
TCGA-EJ-7794,TCGA-EJ-7794-01,67,Male,0.0,EUR,University of Pittsburgh,-24478.0,1306.0,1306.0,2012-04-09,-35.0,-22.0,-36.0,0.0372,13.0,0.0,0.3006,0.0,0.6061358033884974,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,120.0,N0,t2,t2,m0,t2c,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,42.93651576,0:ALIVE OR DEAD TUMOR FREE,42.93651576,0:CENSORED,42.93651576,0:DiseaseFree,42.93651576,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.459916807192095,3.038383501956221,8.332671239317458,3.228818690495881,5.967712744082457
TCGA-EJ-7797,TCGA-EJ-7797-01,53,Male,0.0,EUR,University of Pittsburgh,-19616.0,983.0,983.0,2012-04-09,-33.0,-18.0,-44.0,0.015,24.0,1.0,0.3237,0.0,0.6061358033884974,"Prostate Adenocarcinoma, Acinar Type",0.0,50.0,150.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,32.31745406,0:ALIVE OR DEAD TUMOR FREE,32.31745406,0:CENSORED,32.31745406,0:DiseaseFree,32.31745406,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.622086970988523,3.238817424836234,8.121871746939332,4.351698992293887,6.617067753096115
TCGA-EJ-8468,TCGA-EJ-8468-01,63,Male,0.0,EUR,University of Pittsburgh,-23371.0,2347.0,2347.0,2012-10-12,-33.0,-18.0,-36.0,0.0819,21.0,0.0,0.312,0.0,0.9028677116771496,"Prostate Adenocarcinoma, Acinar Type",2.0,80.0,650.0,N0,t3/t4,t3/t4,,t3a,n0,t3a,0.1,4.0,4.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,77.16079824,0:ALIVE OR DEAD TUMOR FREE,77.16079824,0:CENSORED,77.16079824,0:DiseaseFree,77.16079824,,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,4.0,3.2980864023568013,3.5292712437059315,8.010761939200009,3.9005383914807816,5.208068493754354
TCGA-EJ-8469,TCGA-EJ-8469-01,46,Male,0.0,AFR,University of Pittsburgh,-17014.0,2324.0,2324.0,2012-10-14,-25.0,-4.0,-38.0,0.1805,25.0,5.0,0.3399,0.07,0.6241543092515653,"Prostate Adenocarcinoma, Acinar Type",5.0,80.0,750.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3a,3.1,4.0,5.0,9.0,,0.0,False,False,False,Partial Remission/Response,True,True,0:LIVING,76.40464214,0:ALIVE OR DEAD TUMOR FREE,76.40464214,1:PROGRESSION,63.28697768,,,Locoregional Recurrence,RX,0.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,3.723897080014385,4.290468639543647,8.4649520573226,5.069195175416816,8.262010724868167
TCGA-EJ-8470,TCGA-EJ-8470-01,58,Male,0.0,AFR,University of Pittsburgh,-21209.0,1159.0,1159.0,2012-10-15,-25.0,-14.0,-36.0,0.0984,20.0,1.0,0.2922,0.01,0.5306282510621704,"Prostate Adenocarcinoma, Acinar Type",0.0,15.0,200.0,N0,t2,t2,m0,t2c,n0,t2c,,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,38.10369201,0:ALIVE OR DEAD TUMOR FREE,38.10369201,0:CENSORED,38.10369201,0:DiseaseFree,38.10369201,,,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,2.906986772072065,4.388058627655434,7.881141498599694,3.2994498212912173,6.438014999557448
TCGA-EJ-8472,TCGA-EJ-8472-01,63,Male,0.0,EUR,University of Pittsburgh,-23104.0,756.0,756.0,2012-10-19,-29.0,-8.0,-36.0,0.2158,43.0,11.0,0.3318,0.01,1.33500106673234,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,180.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3a,0.4,4.0,4.0,8.0,,0.0,False,False,False,Partial Remission/Response,False,False,0:LIVING,24.85452214,0:ALIVE OR DEAD TUMOR FREE,24.85452214,1:PROGRESSION,6.443765,,,Biochemical evidence of disease,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,4.0,3.012407769172808,4.469378079061725,7.34982878498297,3.4932886649169737,4.6241886471320734
TCGA-EJ-8474,TCGA-EJ-8474-01,69,Male,0.0,EUR,University of Pittsburgh,-25561.0,766.0,766.0,2013-01-22,-31.0,-14.0,-48.0,0.0311,42.0,0.0,0.3154,0.0,1.3261904371386808,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,200.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3a,0.01,4.0,4.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,25.18328566,0:ALIVE OR DEAD TUMOR FREE,25.18328566,0:CENSORED,25.18328566,0:DiseaseFree,25.18328566,,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,4.0,2.6938771990259904,3.810823522085265,7.809184181199692,5.302560333033506,6.27932270971912
TCGA-EJ-A46B,TCGA-EJ-A46B-01,66,Male,1.0,EUR,University of Pittsburgh,-24305.0,657.0,657.0,2013-01-22,,,,0.0,1.0,0.0,0.3247,0.0,0.0327898225004103,"Prostate Adenocarcinoma, Acinar Type",5.0,5.0,200.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.1,4.0,4.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,21.59976329,0:ALIVE OR DEAD TUMOR FREE,21.59976329,0:CENSORED,21.59976329,0:DiseaseFree,21.59976329,,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,4.0,2.5201204768282497,3.3788722519372447,8.0659206867566,3.739545709774225,4.823790113829861
TCGA-EJ-A46D,TCGA-EJ-A46D-01,53,Male,0.0,EUR,University of Pittsburgh,-19466.0,626.0,626.0,2013-01-22,-29.0,-20.0,-38.0,0.0004,11.0,0.0,0.2985,0.0,0.3123746852860549,"Prostate Adenocarcinoma, Acinar Type",2.0,50.0,200.0,N0,t2,t2,m0,t2c,n0,t2c,0.03,3.0,5.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,20.58059638,0:ALIVE OR DEAD TUMOR FREE,20.58059638,0:CENSORED,20.58059638,0:DiseaseFree,20.58059638,,,1.0,0.0,0.0,0.0,0.0,0.0,3.0,4.0,3.4589593866180968,4.061871222274233,7.747141647903456,4.440447299270984,6.148018914689975
TCGA-EJ-A46E,TCGA-EJ-A46E-01,57,Male,0.0,EUR,University of Pittsburgh,-21054.0,524.0,524.0,2013-01-23,,,,0.0,5.0,,0.3085,0.0,0.1541506801129724,"Prostate Adenocarcinoma, Acinar Type",2.0,5.0,400.0,N0,t1,,m0,t1c,n0,,0.1,4.0,4.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,,0:LIVING,17.22720847,0:ALIVE OR DEAD TUMOR FREE,17.22720847,0:CENSORED,17.22720847,0:DiseaseFree,17.22720847,,R0,0.0,0.0,0.0,,0.0,0.0,3.0,4.0,2.336540478923692,3.888860120724549,8.048024701616049,3.4114669226447694,6.984741996373493
TCGA-EJ-A46F,TCGA-EJ-A46F-01,57,Male,0.0,EUR,University of Pittsburgh,-21160.0,783.0,783.0,2013-01-24,,,,0.1446,32.0,4.0,0.3086,0.01,0.7259370035442264,"Prostate Adenocarcinoma, Acinar Type",5.0,5.0,400.0,N1,t2,t3/t4,m0,t2c,n1,t3b,19.8,4.0,4.0,8.0,,0.0,False,False,False,Partial Remission/Response,False,False,0:LIVING,25.74218365,0:ALIVE OR DEAD TUMOR FREE,25.74218365,1:PROGRESSION,7.068415689,,,Biochemical evidence of disease,R0,0.0,1.0,0.0,0.0,1.0,0.0,3.0,4.0,0.7837499830071748,3.052120229626917,7.347335237050115,4.119530485242549,5.190919010835896
TCGA-EJ-A46G,TCGA-EJ-A46G-01,71,Male,1.0,EUR,University of Pittsburgh,-26219.0,668.0,668.0,2013-01-24,-35.0,-20.0,-42.0,0.2006,48.0,2.0,0.2991,0.03,0.9426080403213986,"Prostate Adenocarcinoma, Other Subtype",5.0,20.0,350.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3a,0.1,4.0,4.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,21.96140316,0:ALIVE OR DEAD TUMOR FREE,21.96140316,0:CENSORED,21.96140316,0:DiseaseFree,21.96140316,,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,4.0,2.3748725557636625,4.459982360699751,7.399393292768584,3.678263500324918,6.093984758863178
TCGA-EJ-A46H,TCGA-EJ-A46H-01,60,Male,0.0,AFR,University of Pittsburgh,-22059.0,724.0,724.0,2013-01-24,,,,0.0,2.0,0.0,0.315,0.0,0.0645385214500711,"Prostate Adenocarcinoma, Acinar Type",5.0,50.0,200.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,23.80247888,0:ALIVE OR DEAD TUMOR FREE,23.80247888,0:CENSORED,23.80247888,0:DiseaseFree,23.80247888,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.1319515941850247,3.994796926691387,8.317688011076495,2.782010091214417,6.897405018975322
TCGA-EJ-A46I,TCGA-EJ-A46I-01,57,Male,0.0,AFR,University of Pittsburgh,-21046.0,668.0,668.0,2013-01-24,-39.0,-24.0,-42.0,0.0,8.0,,0.3214,0.0,0.2097205307117988,"Prostate Adenocarcinoma, Acinar Type",0.0,75.0,200.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,21.96140316,0:ALIVE OR DEAD TUMOR FREE,21.96140316,0:CENSORED,21.96140316,0:DiseaseFree,21.96140316,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,2.240100580901452,3.783718557790366,8.251395301874812,4.047756486549213,6.06035223755082
TCGA-EJ-A65B,TCGA-EJ-A65B-01,55,Male,0.0,EUR,University of Pittsburgh,-20204.0,710.0,710.0,2014-03-03,,,,0.0,34.0,3.0,0.301,0.0,0.7576857015412665,"Prostate Adenocarcinoma, Other Subtype",0.0,75.0,200.0,N0,t3/t4,t3/t4,m0,t3b,n0,t3b,0.01,4.0,5.0,9.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,23.34220995,0:ALIVE OR DEAD TUMOR FREE,23.34220995,0:CENSORED,23.34220995,0:DiseaseFree,23.34220995,,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,2.3803969919884493,2.5454000724994623,7.199793055085652,3.985409348197409,6.1304387709053065
TCGA-EJ-A65D,TCGA-EJ-A65D-01,66,Male,0.0,EUR,University of Pittsburgh,-24297.0,393.0,393.0,2014-03-05,,,,0.1029,35.0,2.0,0.314,0.01,0.773189888387328,"Prostate Adenocarcinoma, Other Subtype",2.0,80.0,200.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3a,0.1,4.0,4.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,12.92040635,0:ALIVE OR DEAD TUMOR FREE,12.92040635,0:CENSORED,12.92040635,0:DiseaseFree,12.92040635,,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,4.0,2.243973671919306,3.969859618954699,6.754868800439872,5.5171622891423935,6.354393974843811
TCGA-EJ-A65E,TCGA-EJ-A65E-01,67,Male,0.0,AFR,University of Pittsburgh,-24558.0,417.0,417.0,2014-03-05,-21.0,-16.0,-30.0,0.0394,33.0,1.0,0.3002,0.01,0.7259370035442264,"Prostate Adenocarcinoma, Other Subtype",0.0,85.0,300.0,N0,t3/t4,t3/t4,m0,t3b,n0,t3b,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,13.7094388,0:ALIVE OR DEAD TUMOR FREE,13.7094388,0:CENSORED,13.7094388,0:DiseaseFree,13.7094388,,R0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.0,2.8261721935235125,4.423295789239359,7.966987567464403,4.110613805500896,4.586014082512518
TCGA-EJ-A65F,TCGA-EJ-A65F-01,59,Male,0.0,EUR,University of Pittsburgh,-21681.0,560.0,560.0,2014-03-04,-25.0,-20.0,-40.0,0.1558,67.0,2.0,0.3247,0.0,1.1837700971104574,"Prostate Adenocarcinoma, Other Subtype",0.0,80.0,250.0,N0,t3/t4,t3/t4,m0,t3b,n0,t3b,0.8,4.0,5.0,9.0,215.0,270.0,True,False,False,Complete Remission/Response,True,False,0:LIVING,18.41075714,0:ALIVE OR DEAD TUMOR FREE,18.41075714,1:PROGRESSION,2.465726403,,,Biochemical evidence of disease,R0,0.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,2.734980523435889,4.099715999160909,7.936662670705572,4.630422945880381,7.081437633296947
TCGA-EJ-A65G,TCGA-EJ-A65G-01,57,Male,0.0,EUR,University of Pittsburgh,-20821.0,666.0,666.0,2014-03-05,-29.0,-24.0,-36.0,0.0,19.0,0.0,0.3127,0.0,0.4906229162443896,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,200.0,N0,t2,t2,m0,t2c,n0,t2c,0.1,3.0,5.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,21.89565046,0:ALIVE OR DEAD TUMOR FREE,21.89565046,0:CENSORED,21.89565046,0:DiseaseFree,21.89565046,,R0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,4.0,2.0182424712784144,3.5828329546092115,7.015597921559055,4.573471478500071,5.260244001422084
TCGA-EJ-A65J,TCGA-EJ-A65J-01,62,Male,1.0,EUR,University of Pittsburgh,-22904.0,451.0,451.0,2014-03-04,-15.0,-22.0,-32.0,0.078,31.0,0.0,0.3196,0.0,0.7096764823472214,"Prostate Adenocarcinoma, Acinar Type",0.0,75.0,200.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3a,0.1,4.0,5.0,9.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,14.82723477,0:ALIVE OR DEAD TUMOR FREE,14.82723477,0:CENSORED,14.82723477,0:DiseaseFree,14.82723477,,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,2.949460228427057,3.017262748591207,8.662399569537707,3.870946612525112,4.724715748085598
TCGA-EJ-A65M,TCGA-EJ-A65M-01,65,Male,0.0,AFR,University of Pittsburgh,-23767.0,230.0,230.0,2014-03-04,,,,0.075,31.0,0.0,0.311,0.0,0.7259370035442264,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,160.0,N0,t2,t2,m0,t2c,n0,t2c,0.1,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,7.561560969,0:ALIVE OR DEAD TUMOR FREE,7.561560969,0:CENSORED,7.561560969,0:DiseaseFree,7.561560969,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.5265696604977834,2.853177289298122,6.8117908233115765,5.336411939120827,6.098255314848628
TCGA-EJ-A6RA,TCGA-EJ-A6RA-01,70,Male,0.0,EUR,University of Pittsburgh,-25679.0,353.0,353.0,2014-03-04,-21.0,-22.0,-24.0,0.0,10.0,0.0,0.3317,0.0,0.287682072201781,"Prostate Adenocarcinoma, Acinar Type",0.0,75.0,200.0,N1,t3/t4,t3/t4,m0,t3b,n1,t3b,0.652,4.0,4.0,8.0,,0.0,False,False,False,Complete Remission/Response,True,False,0:LIVING,11.60535227,0:ALIVE OR DEAD TUMOR FREE,11.60535227,1:PROGRESSION,11.60535227,,,Locoregional Recurrence,R0,0.0,1.0,0.0,0.0,1.0,0.0,3.0,4.0,3.486109369591841,3.550999138763864,7.741915904819442,4.19269917799206,5.300156679155493
TCGA-EJ-A6RC,TCGA-EJ-A6RC-01,64,Male,1.0,EUR,University of Pittsburgh,-23598.0,873.0,873.0,2014-03-04,-31.0,-22.0,-38.0,0.0002,21.0,0.0,0.331,0.0,0.5306282510621704,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,280.0,N0,t1,,m0,t1c,n0,,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,28.70105533,0:ALIVE OR DEAD TUMOR FREE,28.70105533,0:CENSORED,28.70105533,0:DiseaseFree,28.70105533,,R0,0.0,0.0,0.0,,0.0,1.0,2.0,3.0,3.357411247016051,3.0015680783688112,7.380925942762794,4.007644030878014,6.167630896299684
TCGA-EJ-A7NF,TCGA-EJ-A7NF-01,56,Male,0.0,EUR,University of Pittsburgh,-20587.0,250.0,250.0,2014-03-04,-23.0,-22.0,-26.0,0.0162,13.0,0.0,0.3275,0.0,0.3829922524833785,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,150.0,N0,t2,t2,m0,t2c,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,8.21908801,0:ALIVE OR DEAD TUMOR FREE,8.21908801,0:CENSORED,8.21908801,0:DiseaseFree,8.21908801,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.2320006495546783,3.8956516182404366,7.194568750178456,4.729552770453971,5.631232360985956
TCGA-EJ-A7NG,TCGA-EJ-A7NG-01,64,Male,0.0,EUR,University of Pittsburgh,-23458.0,432.0,432.0,2014-03-04,-35.0,-24.0,-30.0,0.0,2.0,0.0,0.3218,0.0,0.0645385214500711,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,180.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3a,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,14.20258408,0:ALIVE OR DEAD TUMOR FREE,14.20258408,0:CENSORED,14.20258408,0:DiseaseFree,14.20258408,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.557091443998696,4.017351841787775,7.936973547381602,3.8530974246460463,5.523587046187376
TCGA-EJ-A7NH,TCGA-EJ-A7NH-01,56,Male,0.0,EUR,University of Pittsburgh,-20734.0,474.0,474.0,2014-03-05,-31.0,-18.0,-34.0,0.0822,19.0,4.0,0.3335,0.05,0.4906229162443896,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,250.0,N0,t2,t2,m0,t2c,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,15.58339087,0:ALIVE OR DEAD TUMOR FREE,15.58339087,0:CENSORED,15.58339087,0:DiseaseFree,15.58339087,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.623703016318038,4.45000368926292,7.805084756546922,3.771103818919882,6.277449214705383
TCGA-EJ-A7NJ,TCGA-EJ-A7NJ-01,59,Male,0.0,EUR,University of Pittsburgh,-21748.0,197.0,197.0,2014-03-04,-31.0,-22.0,-40.0,0.0,8.0,0.0,0.3221,0.0,0.2363887783273882,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,200.0,N0,t2,t2,m0,t2c,n0,t2c,0.1,4.0,4.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,6.476641352,0:ALIVE OR DEAD TUMOR FREE,6.476641352,0:CENSORED,6.476641352,0:DiseaseFree,6.476641352,,R0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,4.0,3.9144497156070224,4.398815504304024,8.528814690621815,3.063779029770571,4.074882159382702
TCGA-EJ-A7NK,TCGA-EJ-A7NK-01,58,Male,0.0,EUR,University of Pittsburgh,-21530.0,476.0,476.0,2014-03-04,-35.0,-22.0,-36.0,0.0001,4.0,0.0,0.3182,0.04,0.1251631426598883,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,150.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3a,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,15.64914357,0:ALIVE OR DEAD TUMOR FREE,15.64914357,0:CENSORED,15.64914357,0:DiseaseFree,15.64914357,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.472071799416068,4.2890229053898254,8.095534164614303,3.496551828158504,5.494185170426325
TCGA-EJ-A7NM,TCGA-EJ-A7NM-01,64,Male,0.0,EUR,University of Pittsburgh,-23603.0,128.0,128.0,2014-03-04,-31.0,-18.0,-30.0,0.0738,45.0,1.0,0.3229,0.0,0.9162907318741552,"Prostate Adenocarcinoma, Other Subtype",0.0,70.0,360.0,N1,t3/t4,t3/t4,m0,t3b,n1,t3b,0.1,4.0,5.0,9.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,4.208173061,0:ALIVE OR DEAD TUMOR FREE,4.208173061,0:CENSORED,4.208173061,0:DiseaseFree,4.208173061,,R0,0.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,4.004375544188077,4.655071277300119,8.106119006247177,4.233542986612922,6.014674418246612
TCGA-EJ-A7NN,TCGA-EJ-A7NN-01,61,Male,0.0,EUR,University of Pittsburgh,-22499.0,197.0,197.0,2014-03-04,,,,,32.0,,0.3318,0.0,0.7259370035442264,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,400.0,N1,t3/t4,t3/t4,m0,t3b,n1,t3b,0.3,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,6.476641352,0:ALIVE OR DEAD TUMOR FREE,6.476641352,1:PROGRESSION,6.476641352,1:Recurred/Progressed,6.476641352,Biochemical evidence of disease,R1,1.0,1.0,0.0,0.0,1.0,1.0,2.0,3.0,3.405107416833946,3.979330298747703,7.660470887106212,2.9172980779160524,3.984689597324541
TCGA-EJ-A8FN,TCGA-EJ-A8FN-01,58,Male,0.0,EUR,University of Pittsburgh,-21506.0,329.0,329.0,2014-03-24,-27.0,-24.0,-36.0,0.0836,32.0,2.0,0.3157,0.0,0.7419373447293773,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,390.0,N0,t2,t2,m0,t2c,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,10.81631982,0:ALIVE OR DEAD TUMOR FREE,10.81631982,0:CENSORED,10.81631982,0:DiseaseFree,10.81631982,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.7129808879020296,3.693196995445636,7.533019743471145,3.840956636796739,5.806254447479654
TCGA-EJ-A8FO,TCGA-EJ-A8FO-01,51,Male,0.0,EUR,University of Pittsburgh,-18875.0,282.0,282.0,2014-03-24,,,,0.0,15.0,0.0,0.3206,0.0,0.4054651081081644,"Prostate Adenocarcinoma, Other Subtype",0.0,75.0,250.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3a,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,9.271131275,0:ALIVE OR DEAD TUMOR FREE,9.271131275,0:CENSORED,9.271131275,0:DiseaseFree,9.271131275,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,4.004096841582884,3.5115818918104003,7.782428878895125,3.2759456861740834,6.885654891447991
TCGA-EJ-A8FP,TCGA-EJ-A8FP-01,59,Male,0.0,EUR,University of Pittsburgh,-21769.0,299.0,299.0,2014-03-24,,,,0.0001,8.0,0.0,0.3209,0.0,0.2363887783273882,"Prostate Adenocarcinoma, Other Subtype",0.0,80.0,350.0,N0,t2,t2,m0,t2c,n0,t2c,0.2,3.0,5.0,8.0,,0.0,False,False,False,Complete Remission/Response,True,False,0:LIVING,9.83002926,0:ALIVE OR DEAD TUMOR FREE,9.83002926,1:PROGRESSION,3.846533189,1:Recurred/Progressed,3.846533189,Biochemical evidence of disease,R0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,4.0,3.3907502172401847,3.766404344476301,7.950869625412192,3.342568967558648,4.96067387445808
TCGA-EJ-A8FS,TCGA-EJ-A8FS-01,66,Male,0.0,EUR,University of Pittsburgh,-24380.0,266.0,266.0,2014-03-24,-27.0,-20.0,-38.0,0.0934,28.0,2.0,0.3282,0.0,0.6592456287118501,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,280.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3a,0.3,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,True,False,0:LIVING,8.745109643,0:ALIVE OR DEAD TUMOR FREE,8.745109643,1:PROGRESSION,7.101292041,1:Recurred/Progressed,7.101292041,Biochemical evidence of disease,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,2.8826039248980253,3.666268037622853,7.883558503416367,5.125584982133523,6.636172166835885
TCGA-EJ-A8FU,TCGA-EJ-A8FU-01,64,Male,0.0,EUR,University of Pittsburgh,-23472.0,138.0,138.0,2014-03-24,-31.0,-24.0,-40.0,0.0,8.0,0.0,0.3166,0.0,0.2363887783273882,"Prostate Adenocarcinoma, Acinar Type",0.0,65.0,200.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3a,,5.0,3.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,4.536936582,0:ALIVE OR DEAD TUMOR FREE,4.536936582,0:CENSORED,4.536936582,0:DiseaseFree,4.536936582,,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,4.0,3.6307316253515314,3.8117689923239135,7.873119238847378,3.60293190406964,5.307053229945392
TCGA-EJ-AB20,TCGA-EJ-AB20-01,61,Male,0.0,EUR,University of Pittsburgh,-22626.0,131.0,131.0,2014-06-23,,,,0.0543,13.0,2.0,0.3281,0.06,0.3600027337988489,"Prostate Adenocarcinoma, Acinar Type",0.0,75.0,260.0,N0,t2,t2,m0,t2c,n0,t2c,0.1,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,4.306802117,0:ALIVE OR DEAD TUMOR FREE,4.306802117,0:CENSORED,4.306802117,0:DiseaseFree,4.306802117,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.585106763012251,2.6302889700859757,5.85594984330384,3.3197335301331496,4.671950022960008
TCGA-EJ-AB27,TCGA-EJ-AB27-01,51,Male,0.0,AFR,University of Pittsburgh,-18648.0,145.0,145.0,2014-06-24,,,,0.0001,15.0,1.0,0.3237,0.0,0.4054651081081644,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,520.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,4.767071046,0:ALIVE OR DEAD TUMOR FREE,4.767071046,0:CENSORED,4.767071046,0:DiseaseFree,4.767071046,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,4.2983063958064855,3.378164779871632,8.161074426037676,4.148226408608377,5.839901656881733
TCGA-FC-7708,TCGA-FC-7708-01,52,Male,0.0,EAS_OTHER_OR_MISSING,Asterand,-19144.0,864.0,864.0,2012-02-17,-27.0,-20.0,-36.0,0.0483,26.0,1.0,0.3334,0.0,0.6241543092515653,"Prostate Adenocarcinoma, Acinar Type",0.0,95.0,337.0,N0,t1,t3/t4,m0,t1c,n0,t3a,,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,28.40516816,0:ALIVE OR DEAD TUMOR FREE,28.40516816,0:CENSORED,28.40516816,0:DiseaseFree,28.40516816,,RX,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,3.202856497442581,3.7310311422101017,8.325712455823224,4.248102144905266,6.2874686012003655
TCGA-FC-7961,TCGA-FC-7961-01,62,Male,0.0,EUR,Asterand,-22888.0,469.0,469.0,2012-03-16,-15.0,-12.0,-18.0,0.2165,44.0,11.0,0.3182,0.95,0.9028677116771496,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,400.0,N0,t1,t3/t4,m0,t1c,n0,t3a,,4.0,5.0,9.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,15.41900911,0:ALIVE OR DEAD TUMOR FREE,15.41900911,0:CENSORED,15.41900911,0:DiseaseFree,15.41900911,,,1.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,1.9759969576164431,3.784483043807499,7.773483433906718,4.528758832036226,5.050149034254956
TCGA-FC-A4JI,TCGA-FC-A4JI-01,70,Male,0.0,EAS_OTHER_OR_MISSING,Asterand,-25931.0,877.0,877.0,2013-02-11,11.0,12.0,2.0,0.4645,26.0,16.0,0.3483,0.02,0.6241543092515653,"Prostate Adenocarcinoma, Acinar Type",0.0,97.0,572.0,,t3/t4,t3/t4,m0,t4,,t3a,,5.0,3.0,8.0,51.0,147.0,True,True,False,Complete Remission/Response,False,False,0:LIVING,28.83256074,0:ALIVE OR DEAD TUMOR FREE,28.83256074,0:CENSORED,28.83256074,0:DiseaseFree,28.83256074,,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,4.0,3.5297335078159264,3.8805288085305696,7.484293641219791,3.333251974091572,6.995391803521141
TCGA-FC-A5OB,TCGA-FC-A5OB-01,53,Male,0.0,EUR,Asterand,-19413.0,680.0,680.0,2013-07-12,-21.0,-18.0,-34.0,0.0326,24.0,0.0,0.3086,0.02,0.5877866649021191,"Prostate Adenocarcinoma, Acinar Type",0.0,100.0,329.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3b,5.22,4.0,5.0,9.0,118.0,344.0,True,True,False,No Treatment Indicated,True,False,0:LIVING,22.35591939,0:ALIVE OR DEAD TUMOR FREE,22.35591939,0:CENSORED,22.35591939,,,,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,2.4663399879794747,3.4900181041465523,7.743632773282046,4.537886196288338,4.986192466465464
TCGA-FC-A66V,TCGA-FC-A66V-01,74,Male,0.0,EUR,Asterand,-27282.0,524.0,524.0,2013-07-12,,,,0.0,,0.0,0.3117,0.0,0.0,"Prostate Adenocarcinoma, Acinar Type",0.0,40.0,308.0,N0,t3/t4,t3/t4,m0,t3b,n0,t3b,10.8,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,17.22720847,0:ALIVE OR DEAD TUMOR FREE,17.22720847,0:CENSORED,17.22720847,0:DiseaseFree,17.22720847,,R0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.0,2.5842169156572985,3.366923648978518,7.210343078102148,3.6540459422521305,2.9538798135350466
TCGA-FC-A6HD,TCGA-FC-A6HD-01,77,Male,0.0,EUR,Asterand,-28197.0,789.0,789.0,2013-10-17,,,,0.0101,25.0,0.0,0.3288,0.0,0.6241543092515653,"Prostate Adenocarcinoma, Acinar Type",0.0,92.0,365.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3a,,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,,False,0:LIVING,25.93944176,0:ALIVE OR DEAD TUMOR FREE,25.93944176,0:CENSORED,25.93944176,0:DiseaseFree,25.93944176,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,1.6138145065686496,2.84647325749991,6.8739915560076765,5.408341630478852,6.232265496295444
TCGA-FC-A8O0,TCGA-FC-A8O0-01,68,Male,0.0,EUR,Asterand,-25115.0,616.0,616.0,2014-02-27,-37.0,-24.0,-34.0,0.0001,14.0,0.0,0.3192,0.0,0.3829922524833785,"Prostate Adenocarcinoma, Acinar Type",0.0,50.0,1469.0,N0,t2,t3/t4,m0,t2c,n0,t3a,7.82,3.0,3.0,6.0,,0.0,,False,False,Complete Remission/Response,False,False,0:LIVING,20.25183286,0:ALIVE OR DEAD TUMOR FREE,20.25183286,0:CENSORED,20.25183286,0:DiseaseFree,20.25183286,,R0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,3.0685332408127115,4.034488660380349,7.978971807735625,3.2414436166865657,2.8855548419789754
TCGA-G9-6329,TCGA-G9-6329-01,67,Male,0.0,EUR,Roswell Park,-24797.0,1266.0,1266.0,2012-03-20,-23.0,-20.0,-18.0,0.0115,24.0,4.0,0.2856,0.0,0.6061358033884974,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,,t1,t2,m0,t1c,,t2c,0.03,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,41.62146168,0:ALIVE OR DEAD TUMOR FREE,41.62146168,0:CENSORED,41.62146168,0:DiseaseFree,41.62146168,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.65289945387296,2.447658535982697,6.8148515943469015,4.784430694672692,4.5474991849552255
TCGA-G9-6332,TCGA-G9-6332-01,55,Male,0.0,EUR,Roswell Park,-20166.0,2657.0,2657.0,2012-03-20,,,,0.0657,19.0,0.0,0.344,0.04,0.8472978602443463,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,N0,t2,t3/t4,m0,t2b,n0,t3a,0.73,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,True,0:LIVING,87.35246737,0:ALIVE OR DEAD TUMOR FREE,87.35246737,1:PROGRESSION,38.79409541,1:Recurred/Progressed,38.79409541,Biochemical evidence of disease,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,2.788456030313607,2.6392784769534234,7.463500668738657,5.099227865774861,6.207996287918577
TCGA-G9-6333,TCGA-G9-6333-01,66,Male,0.0,EUR,Roswell Park,-24249.0,2465.0,2465.0,2012-03-19,-21.0,-22.0,-22.0,0.0463,30.0,1.0,0.2902,0.0,1.0531499147076315,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,N0,t1,t2,m0,t1c,n0,t2c,0.03,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,81.04020778,0:ALIVE OR DEAD TUMOR FREE,81.04020778,0:CENSORED,81.04020778,0:DiseaseFree,81.04020778,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,1.80277224712483,2.823260228233444,7.862698721155602,4.0613614711443295,5.564847608318648
TCGA-G9-6336,TCGA-G9-6336-01,57,Male,0.0,EUR,Roswell Park,-20851.0,2068.0,2068.0,2012-03-19,-23.0,-22.0,-24.0,0.0001,15.0,,0.2877,0.0,0.4054651081081644,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,200.0,N0,t2,,m0,t2c,n0,,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,67.98829602,0:ALIVE OR DEAD TUMOR FREE,67.98829602,0:CENSORED,67.98829602,0:DiseaseFree,67.98829602,,R1,1.0,0.0,1.0,,0.0,0.0,1.0,2.0,2.7066631572479958,2.131721171155929,7.719218357222826,3.8711339518281753,5.030349322144695
TCGA-G9-6338,TCGA-G9-6338-01,61,Male,0.0,EUR,Roswell Park,-22360.0,2028.0,2028.0,2012-03-16,,,,0.1109,39.0,0.0,0.2993,0.0,0.8329091229351039,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,200.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.05,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,True,False,0:LIVING,66.67324194,0:ALIVE OR DEAD TUMOR FREE,66.67324194,0:CENSORED,66.67324194,0:DiseaseFree,66.67324194,,R1,1.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,1.91169158187234,2.0743341661027426,5.393117553107237,3.5105315776320998,5.191306018918691
TCGA-G9-6339,TCGA-G9-6339-01,58,Male,0.0,EUR,Roswell Park,-21305.0,2551.0,2551.0,2013-10-29,,,,0.0368,38.0,2.0,0.318,0.0,0.8183103236610101,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,200.0,N0,t3/t4,t3/t4,m0,t3b,n0,t3b,0.03,3.0,4.0,7.0,1811.0,1865.0,True,False,False,Complete Remission/Response,False,False,0:LIVING,83.86757405,0:ALIVE OR DEAD TUMOR FREE,83.86757405,1:PROGRESSION,53.71995923,1:Recurred/Progressed,53.71995923,Biochemical evidence of disease,R0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,2.0,1.8830733484512632,2.9185961351212693,7.3589799177109105,4.383676647753319,5.346644921588527
TCGA-G9-6342,TCGA-G9-6342-01,61,Male,0.0,EUR,Roswell Park,-22472.0,1696.0,1696.0,2012-03-16,-27.0,-20.0,-44.0,0.0524,52.0,1.0,0.2949,0.0,1.410986973710262,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,200.0,,t2,t3/t4,m0,t2c,,t3a,0.05,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,55.75829306,0:ALIVE OR DEAD TUMOR FREE,55.75829306,0:CENSORED,55.75829306,0:DiseaseFree,55.75829306,,R0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,2.0823960351538884,3.2153990376536994,8.375851370607574,3.230848576408882,6.184881292153918
TCGA-G9-6343,TCGA-G9-6343-01,62,Male,0.0,EUR,Roswell Park,-22843.0,2450.0,2450.0,2012-03-16,,,,0.0142,26.0,1.0,0.2931,0.0,0.6061358033884974,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,,t2,t2,m0,t2a,,t2c,0.03,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,,0:LIVING,80.5470625,0:ALIVE OR DEAD TUMOR FREE,80.5470625,0:CENSORED,80.5470625,0:DiseaseFree,80.5470625,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,2.2813718451477816,2.5195419045784364,6.56439798566853,4.764770764387076,3.942992978488472
TCGA-G9-6347,TCGA-G9-6347-01,59,Male,0.0,EUR,Roswell Park,-21721.0,2089.0,2089.0,2013-10-29,,,,0.0001,14.0,0.0,0.3085,0.03,0.4054651081081644,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,,t1,t2,m0,t1c,,t2c,0.03,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,68.67869941,0:ALIVE OR DEAD TUMOR FREE,68.67869941,0:CENSORED,68.67869941,0:DiseaseFree,68.67869941,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.1536108022844322,1.3769571144777275,5.719051981641579,3.401029673623332,3.738303073656354
TCGA-G9-6348,TCGA-G9-6348-01,68,Male,0.0,EUR,Roswell Park,-24936.0,1515.0,1515.0,2012-03-15,-9.0,-22.0,-4.0,0.082,34.0,1.0,0.2995,0.0,1.1837700971104574,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,200.0,N0,t3/t4,t2,m0,t3a,n0,t2c,0.02,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,49.80767334,0:ALIVE OR DEAD TUMOR FREE,49.80767334,0:CENSORED,49.80767334,0:DiseaseFree,49.80767334,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,1.495592840198345,2.266666623396169,6.111840931347768,2.7101286554591417,4.0973411087967015
TCGA-G9-6351,TCGA-G9-6351-01,51,Male,0.0,EUR,Roswell Park,-18723.0,2048.0,2048.0,2012-03-14,-31.0,-18.0,-36.0,0.0335,75.0,0.0,0.2905,0.01,1.6550484236224583,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,,t1,t2,m0,t1c,,t2c,0.03,3.0,4.0,7.0,774.0,826.0,True,False,False,Complete Remission/Response,False,False,0:LIVING,67.33076898,0:ALIVE OR DEAD TUMOR FREE,67.33076898,0:CENSORED,67.33076898,0:DiseaseFree,67.33076898,,R1,1.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,1.766383141001298,2.361291124547263,8.097091918786933,4.481466867264216,5.294602370493792
TCGA-G9-6353,TCGA-G9-6353-01,58,Male,0.0,EUR,Roswell Park,-21221.0,1542.0,1542.0,2012-03-14,-27.0,-20.0,-30.0,0.0,5.0,0.0,0.2785,0.0,0.287682072201781,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,,t1,t3/t4,m0,t1c,,t3a,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,50.69533485,0:ALIVE OR DEAD TUMOR FREE,50.69533485,0:CENSORED,50.69533485,0:DiseaseFree,50.69533485,,R1,1.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.319805772888128,2.724104519866845,7.727394319360264,3.922407195283831,5.1574358693387055
TCGA-G9-6354,TCGA-G9-6354-01,55,Male,0.0,EAS_OTHER_OR_MISSING,Roswell Park,-20403.0,2066.0,2066.0,2013-10-29,,,,0.0579,22.0,3.0,0.3244,0.0,0.5500463367269643,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,,t1,t2,m0,t1c,,t2b,0.03,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,67.92254332,0:ALIVE OR DEAD TUMOR FREE,67.92254332,0:CENSORED,67.92254332,0:DiseaseFree,67.92254332,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.085084678628649,2.955015156437071,6.775611597537069,4.83603015087226,4.344920792448315
TCGA-G9-6356,TCGA-G9-6356-01,60,Male,0.0,EUR,Roswell Park,-22010.0,1434.0,1434.0,2012-03-14,-37.0,-22.0,-42.0,0.0021,23.0,2.0,0.2889,0.0,0.9426080403213986,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,N0,t1,t3/t4,m0,t1c,n0,t3b,0.13,4.0,5.0,9.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,47.14468883,0:ALIVE OR DEAD TUMOR FREE,47.14468883,0:CENSORED,47.14468883,0:DiseaseFree,47.14468883,,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,2.7743970180844166,2.183168880147036,7.867177407677101,3.37873355926538,6.569431849348127
TCGA-G9-6361,TCGA-G9-6361-01,61,Male,0.0,EUR,Roswell Park,-22565.0,1415.0,1415.0,2012-03-13,-33.0,-22.0,-28.0,0.0515,32.0,1.0,0.2999,0.0,0.7259370035442264,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,N0,t2,t3/t4,m0,t2c,n0,t3a,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,46.52003814,0:ALIVE OR DEAD TUMOR FREE,46.52003814,0:CENSORED,46.52003814,0:DiseaseFree,46.52003814,,R1,1.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.306466407756864,3.053945424962785,7.155865580888062,5.077106244105979,6.6176261438387485
TCGA-G9-6362,TCGA-G9-6362-01,57,Male,0.0,EUR,Roswell Park,-21149.0,1443.0,1443.0,2012-03-13,,,,0.0786,25.0,2.0,0.2891,0.03,0.8614824955200051,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.07,4.0,3.0,7.0,,0.0,False,False,False,Progressive Disease,False,True,0:LIVING,47.44057599,0:ALIVE OR DEAD TUMOR FREE,47.44057599,0:CENSORED,47.44057599,,,,R1,1.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,1.9182717302960528,2.944221270948316,4.739064990567236,5.305642266874995,2.3855414785195244
TCGA-G9-6363,TCGA-G9-6363-01,64,Male,0.0,EUR,Roswell Park,-23480.0,1378.0,1378.0,2012-03-09,-13.0,-12.0,-12.0,0.0845,44.0,1.0,0.2953,0.0,1.0986122886681098,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,N0,t2,t3/t4,m0,t2b,n0,t4,0.03,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,45.30361311,0:ALIVE OR DEAD TUMOR FREE,45.30361311,0:CENSORED,45.30361311,0:DiseaseFree,45.30361311,,R0,0.0,0.0,0.0,1.0,0.0,1.0,2.0,3.0,2.8547138227695306,2.3181722030030274,7.451288603084778,5.005148437412878,4.878190729319606
TCGA-G9-6364,TCGA-G9-6364-01,72,Male,1.0,EUR,Roswell Park,-26603.0,1198.0,1198.0,2012-03-09,-27.0,-20.0,-46.0,0.0368,21.0,2.0,0.2914,0.0,0.8754687373538999,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,N0,,t3/t4,m0,,n0,t3a,0.03,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,39.38586974,0:ALIVE OR DEAD TUMOR FREE,39.38586974,0:CENSORED,39.38586974,0:DiseaseFree,39.38586974,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,2.8345696492112653,2.5716768099709317,7.937095995560627,4.601007090555786,4.528902575626386
TCGA-G9-6365,TCGA-G9-6365-01,71,Male,0.0,EUR,Roswell Park,-26207.0,1363.0,1363.0,2012-03-09,-29.0,-22.0,-24.0,0.0142,24.0,0.0,0.2934,0.0,0.9682504706782838,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,N0,t2,t3/t4,,t2a,n0,t4,0.01,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,44.81046783,0:ALIVE OR DEAD TUMOR FREE,44.81046783,0:CENSORED,44.81046783,0:DiseaseFree,44.81046783,,R1,1.0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,2.269601731612347,3.648695519583242,7.531450864175881,3.9024112944722567,5.96921957639691
TCGA-G9-6366,TCGA-G9-6366-01,61,Male,0.0,EUR,Roswell Park,-22428.0,1947.0,1947.0,2012-03-08,-21.0,-24.0,-26.0,0.1159,28.0,1.0,0.3314,0.12,0.6592456287118501,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,,t1,t3/t4,,t1c,,t3b,0.1,4.0,3.0,7.0,,0.0,,False,False,Complete Remission/Response,,,0:LIVING,64.01025742,0:ALIVE OR DEAD TUMOR FREE,64.01025742,0:CENSORED,64.01025742,0:DiseaseFree,64.01025742,,R0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.0,2.3567917503656384,2.0375579354240254,7.6745206778600785,3.8442048528217607,6.341345355840922
TCGA-G9-6367,TCGA-G9-6367-01,60,Male,0.0,EUR,Roswell Park,-22176.0,1222.0,1222.0,2012-03-08,-29.0,-20.0,-40.0,0.0,2.0,0.0,0.2971,0.0,0.0953101798043249,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,N0,t2,t3/t4,m0,t2b,n0,t3a,0.42,4.0,5.0,9.0,,0.0,False,False,False,Progressive Disease,True,False,0:LIVING,40.17490219,0:ALIVE OR DEAD TUMOR FREE,40.17490219,0:CENSORED,40.17490219,,,,R1,1.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,2.85606940201505,1.5575816397293087,7.7757933013103875,3.0184383360025278,3.992451220481144
TCGA-G9-6369,TCGA-G9-6369-01,55,Male,0.0,EUR,Roswell Park,-20238.0,1215.0,1215.0,2012-03-07,,,,0.0878,31.0,1.0,0.2823,0.0,0.7096764823472214,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,N0,t1,t2,m0,t1c,n0,t2c,0.03,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,39.94476773,0:ALIVE OR DEAD TUMOR FREE,39.94476773,0:CENSORED,39.94476773,0:DiseaseFree,39.94476773,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,1.2094533656289497,1.6317562006060204,6.586138719252441,4.546153634825757,4.03786538242378
TCGA-G9-6370,TCGA-G9-6370-01,52,Male,0.0,EUR,Roswell Park,-19149.0,1156.0,1156.0,2012-03-07,-35.0,-18.0,-48.0,0.0,1.0,0.0,0.2935,0.0,0.0327898225004103,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,N0,t1,t3/t4,m0,t1c,n0,t3b,0.03,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,38.00506296,0:ALIVE OR DEAD TUMOR FREE,38.00506296,0:CENSORED,38.00506296,0:DiseaseFree,38.00506296,,R0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,2.0,3.1413510402540568,1.6831574480892595,8.259714550714193,3.238450599100797,5.669573910452127
TCGA-G9-6371,TCGA-G9-6371-01,58,Male,0.0,EUR,Roswell Park,-21365.0,1226.0,1226.0,2012-03-06,-27.0,-20.0,-26.0,0.0138,27.0,3.0,0.3089,0.0,0.6592456287118501,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,,t1,t2,m0,t1c,,t2c,0.03,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,40.3064076,0:ALIVE OR DEAD TUMOR FREE,40.3064076,0:CENSORED,40.3064076,0:DiseaseFree,40.3064076,,R1,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.8215673668697088,1.39391037754418,8.421960871564579,4.927038354293544,6.4595021122408856
TCGA-G9-6373,TCGA-G9-6373-01,68,Male,0.0,EUR,Roswell Park,-24887.0,811.0,811.0,2012-03-06,,,,0.1457,21.0,7.0,0.3311,0.06,0.8754687373538999,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,,t2,t3/t4,m0,t2b,,t3a,,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,26.6627215,0:ALIVE OR DEAD TUMOR FREE,26.6627215,0:CENSORED,26.6627215,0:DiseaseFree,26.6627215,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,2.4867143730307024,1.9429460763717084,6.955331404343887,4.073151846817357,5.19180344824173
TCGA-G9-6377,TCGA-G9-6377-01,61,Male,0.0,EUR,Roswell Park,-22419.0,958.0,958.0,2012-03-05,-11.0,-24.0,-10.0,0.1123,47.0,3.0,0.2984,0.0,0.9555114450274363,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,N0,t2,t2,m0,t2b,n0,t2c,0.03,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,31.49554525,0:ALIVE OR DEAD TUMOR FREE,31.49554525,0:CENSORED,31.49554525,0:DiseaseFree,31.49554525,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.2234225499349374,2.3666439430816597,7.969564958371911,4.2812382945619945,6.1056257021528975
TCGA-G9-6378,TCGA-G9-6378-01,54,Male,0.0,AFR,Roswell Park,-19879.0,1155.0,1155.0,2012-03-05,-25.0,-22.0,-38.0,0.0009,22.0,2.0,0.2901,0.0,0.5500463367269643,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,,t1,t2,m0,t1c,,t2c,0.03,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,37.97218661,0:ALIVE OR DEAD TUMOR FREE,37.97218661,0:CENSORED,37.97218661,0:DiseaseFree,37.97218661,,R1,1.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.318663914179837,2.133662156943876,6.413055814516768,3.952044625639722,4.667239302768296
TCGA-G9-6379,TCGA-G9-6379-01,68,Male,0.0,EUR,Roswell Park,-25126.0,1778.0,1778.0,2013-10-29,,,,0.0722,23.0,2.0,0.2984,0.01,0.5690945320786457,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,N0,t1,t3/t4,m0,t1b,n0,t3b,0.03,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,58.45415393,0:ALIVE OR DEAD TUMOR FREE,58.45415393,0:CENSORED,58.45415393,0:DiseaseFree,58.45415393,,R1,1.0,1.0,0.0,0.0,0.0,1.0,2.0,3.0,1.3904475779933103,2.89305150273685,6.437875221424193,4.480142306765311,4.468016292906912
TCGA-G9-6384,TCGA-G9-6384-01,53,Male,0.0,EUR,Roswell Park,-19620.0,765.0,765.0,2012-03-02,-33.0,-18.0,-50.0,0.0537,23.0,1.0,0.3033,0.0,0.9162907318741552,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,200.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.03,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,25.15040931,0:ALIVE OR DEAD TUMOR FREE,25.15040931,0:CENSORED,25.15040931,0:DiseaseFree,25.15040931,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.372687486718199,2.031077542536241,8.150445946132272,3.994661178976256,6.379239723048294
TCGA-G9-6385,TCGA-G9-6385-01,66,Male,0.0,EUR,Roswell Park,-24399.0,830.0,830.0,2012-03-02,-37.0,-18.0,-34.0,0.0,9.0,0.0,0.2929,0.0,0.4700036292457356,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,,t1,t2,m0,t1c,,t2c,0.064,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,27.28737219,0:ALIVE OR DEAD TUMOR FREE,27.28737219,0:CENSORED,27.28737219,0:DiseaseFree,27.28737219,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.279144386406188,2.2402837957822244,7.741619337739391,3.50286521136663,4.37867807846314
TCGA-G9-6494,TCGA-G9-6494-01,66,Male,0.0,EUR,Roswell Park,-24381.0,1771.0,1771.0,2012-04-06,-27.0,-22.0,-40.0,0.1102,29.0,5.0,0.2844,0.0,1.0761394327024147,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,N0,t1,t3/t4,m0,t1c,n0,t4,1.13,4.0,3.0,7.0,,0.0,False,False,False,Progressive Disease,True,False,0:LIVING,58.22401946,0:ALIVE OR DEAD TUMOR FREE,58.22401946,0:CENSORED,58.22401946,,,,R1,1.0,0.0,0.0,1.0,0.0,1.0,2.0,3.0,3.208688924683429,1.7279204545631992,8.33966297473835,3.9949779037781794,5.996555966444497
TCGA-G9-6496,TCGA-G9-6496-01,61,Male,0.0,EUR,Roswell Park,-22602.0,1726.0,1726.0,2012-03-21,,,,0.0874,33.0,1.0,0.2946,0.04,1.1735135967381347,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,N0,t1,t2,m0,t1c,n0,t2c,0.03,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,56.74458362,0:ALIVE OR DEAD TUMOR FREE,56.74458362,0:CENSORED,56.74458362,0:DiseaseFree,56.74458362,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,2.534534784582584,2.243303486918138,7.253665039287634,3.839032418508365,4.21607454575133
TCGA-G9-6498,TCGA-G9-6498-01,53,Male,0.0,EUR,Roswell Park,-19568.0,1952.0,1952.0,2013-10-29,,,,0.0109,19.0,0.0,0.3274,0.0,0.4906229162443896,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,,t1,t3/t4,m0,t1c,,t3a,0.03,3.0,4.0,7.0,1424.0,1483.0,True,False,False,Complete Remission/Response,False,False,0:LIVING,64.17463918,0:ALIVE OR DEAD TUMOR FREE,64.17463918,1:PROGRESSION,44.12006444,1:Recurred/Progressed,44.12006444,Biochemical evidence of disease,R1,1.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,0.9407305601848625,2.335111615166046,4.407794602309823,3.574610177361349,4.61594591019758
TCGA-G9-6499,TCGA-G9-6499-01,66,Male,0.0,EUR,Roswell Park,-24388.0,1543.0,1543.0,2012-03-20,-13.0,-24.0,-8.0,0.2884,32.0,20.0,0.2846,0.04,1.1420974005014657,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3a,0.11,4.0,5.0,9.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,50.7282112,0:ALIVE OR DEAD TUMOR FREE,50.7282112,0:CENSORED,50.7282112,0:DiseaseFree,50.7282112,,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,2.035623909730721,2.370108469207648,7.231229822452603,5.2420841705500125,6.360332668954369
TCGA-G9-7509,TCGA-G9-7509-01,48,Male,0.0,AFR,Roswell Park,-17538.0,1610.0,1610.0,2014-05-14,,,,0.0096,20.0,0.0,0.3225,0.0,0.5108256239659906,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,200.0,,t1,t2,m0,t1c,,t2c,0.03,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,52.93092678,0:ALIVE OR DEAD TUMOR FREE,52.93092678,0:CENSORED,52.93092678,0:DiseaseFree,52.93092678,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,4.119264864337288,3.5297584908460564,7.904959699416459,4.221204285056354,5.657488525708133
TCGA-G9-7510,TCGA-G9-7510-01,66,Male,0.0,EUR,Roswell Park,-24187.0,1185.0,1185.0,2012-05-31,-17.0,-18.0,-26.0,0.0311,34.0,4.0,0.3182,0.0,0.7576857015412665,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,200.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.03,4.0,4.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,38.95847717,0:ALIVE OR DEAD TUMOR FREE,38.95847717,0:CENSORED,38.95847717,0:DiseaseFree,38.95847717,,R1,1.0,0.0,1.0,0.0,0.0,0.0,3.0,4.0,2.402340172217714,2.1571407491492973,7.832030468745961,4.507648777942061,6.170684220277238
TCGA-G9-7519,TCGA-G9-7519-01,58,Male,0.0,EUR,Roswell Park,-21276.0,849.0,849.0,2012-05-31,-15.0,-20.0,-18.0,0.0001,33.0,1.0,0.3314,0.0,0.7419373447293773,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,200.0,,t1,t2,m0,t1c,,t2c,0.03,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,27.91202288,0:ALIVE OR DEAD TUMOR FREE,27.91202288,0:CENSORED,27.91202288,0:DiseaseFree,27.91202288,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.3013827869214003,1.7309659518600808,6.869918278203183,3.832707767491124,5.110137700221142
TCGA-G9-7521,TCGA-G9-7521-01,52,Male,0.0,EUR,Roswell Park,-19216.0,942.0,942.0,2012-05-31,-21.0,-18.0,-28.0,0.189,20.0,14.0,0.3153,0.02,0.5108256239659906,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,200.0,N1,t3/t4,t3/t4,m0,t3a,n1,t3a,0.06,4.0,4.0,8.0,207.0,,False,True,False,No Treatment Indicated,False,False,0:LIVING,30.96952362,0:ALIVE OR DEAD TUMOR FREE,30.96952362,0:CENSORED,30.96952362,,,,R0,0.0,0.0,1.0,0.0,1.0,0.0,3.0,4.0,2.570365776573606,1.832484990287604,8.826823018110689,3.137224794375264,3.8219550647013536
TCGA-G9-7522,TCGA-G9-7522-01,49,Male,0.0,EUR,Roswell Park,-18033.0,1078.0,1078.0,2012-05-31,-21.0,-20.0,-42.0,0.0051,8.0,0.0,0.3325,0.0,0.2363887783273882,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,200.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,35.4407075,0:ALIVE OR DEAD TUMOR FREE,35.4407075,0:CENSORED,35.4407075,0:DiseaseFree,35.4407075,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.660198461837854,1.9255057805467075,8.151181988888904,3.7677395355455774,5.069190878119678
TCGA-G9-7523,TCGA-G9-7523-01,44,Male,0.0,AFR,Roswell Park,-16269.0,857.0,857.0,2012-05-31,-19.0,-20.0,-28.0,0.0001,12.0,7.0,0.3357,0.0,0.3364722366212129,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,200.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.03,5.0,5.0,10.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,28.1750337,0:ALIVE OR DEAD TUMOR FREE,28.1750337,0:CENSORED,28.1750337,0:DiseaseFree,28.1750337,,R1,1.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,1.8532371848859368,1.864770534484847,6.715727297347863,3.519252531419708,4.763655898301345
TCGA-G9-7525,TCGA-G9-7525-01,64,Male,0.0,EUR,Roswell Park,-23481.0,994.0,994.0,2012-05-31,,,,0.0583,33.0,1.0,0.3311,0.0,0.7259370035442264,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,200.0,N0,t1,t2,m0,t1c,n0,t2c,0.03,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,32.67909393,0:ALIVE OR DEAD TUMOR FREE,32.67909393,0:CENSORED,32.67909393,0:DiseaseFree,32.67909393,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,2.27357556561538,1.0125686735030557,7.526378732389205,4.48370616051588,5.170245564723465
TCGA-G9-A9S0,TCGA-G9-A9S0-01,53,Male,0.0,EUR,Roswell Park,-19530.0,,,2014-06-17,,,,0.1906,24.0,4.0,0.3267,0.03,0.5877866649021191,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,160.0,N1,t2,t3/t4,m0,t2a,n1,t3b,10.87,4.0,4.0,8.0,115.0,762.0,True,True,True,No Treatment Indicated,True,True,1:DECEASED,26.00519446,1:DEAD WITH TUMOR,26.00519446,1:PROGRESSION,13.90669691,,,Distant Metastasis,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,4.0,3.0570516347006254,3.0429419501035686,8.020652205791968,4.894667424227057,6.597538623064136
TCGA-G9-A9S7,TCGA-G9-A9S7-01,55,Male,0.0,EUR,Roswell Park,-20213.0,728.0,728.0,2014-07-14,,,,0.0549,22.0,2.0,0.32,0.02,0.5690945320786457,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,210.0,N0,t2,t3/t4,m0,t2a,n0,t3a,0.13,4.0,4.0,8.0,493.0,543.0,True,False,False,Partial Remission/Response,True,False,0:LIVING,23.93398429,0:ALIVE OR DEAD TUMOR FREE,23.93398429,0:CENSORED,23.93398429,,,,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,4.0,3.94057083647184,4.679305558035339,7.92893816878253,4.381456430146994,5.072088645859513
TCGA-H9-7775,TCGA-H9-7775-01,68,Male,0.0,EUR,ABS - IUPUI,-24898.0,185.0,185.0,2012-02-08,-35.0,-20.0,-44.0,0.0311,26.0,1.0,0.3632,0.07,0.6241543092515653,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,220.0,,,t2,,,,t2c,0.04,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,,False,0:LIVING,6.082125127,0:ALIVE OR DEAD TUMOR FREE,6.082125127,0:CENSORED,6.082125127,0:DiseaseFree,6.082125127,,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.7629228026418207,3.1446663993885613,7.871278137224237,4.211728689099397,6.687091490894311
TCGA-H9-A6BX,TCGA-H9-A6BX-01,60,Male,0.0,EUR,ABS - IUPUI,-22039.0,941.0,941.0,2013-11-26,,,,0.0,5.0,0.0,0.3129,0.0,0.1541506801129724,"Prostate Adenocarcinoma, Acinar Type",0.0,30.0,210.0,,,t2,,,,t2c,0.04,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,30.93664727,0:ALIVE OR DEAD TUMOR FREE,30.93664727,0:CENSORED,30.93664727,0:DiseaseFree,30.93664727,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.621969795883816,3.259905175353353,7.362555802644392,2.9657473511962897,4.698201805997407
TCGA-H9-A6BY,TCGA-H9-A6BY-01,63,Male,0.0,EUR,ABS - IUPUI,-23297.0,112.0,112.0,2013-12-02,,,,0.019,26.0,0.0,0.3027,0.04,0.6241543092515653,"Prostate Adenocarcinoma, Acinar Type",0.0,65.0,150.0,N0,t1,t3/t4,,t1c,n0,t3a,,3.0,4.0,7.0,,0.0,,False,False,No Treatment Indicated,,,0:LIVING,3.682151429,0:ALIVE OR DEAD TUMOR FREE,3.682151429,0:CENSORED,3.682151429,,,,RX,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,2.2756626689794053,3.204813692245835,6.901198770736494,5.227074861401527,6.287594189130554
TCGA-HC-7075,TCGA-HC-7075-01,63,Male,0.0,EUR,International Genomics Consortium,,601.0,601.0,2012-03-29,-33.0,-18.0,-36.0,0.0058,30.0,0.0,0.2898,0.0,0.6931471805599453,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,30.0,,t1,t2,m0,t1c,,t2a,0.01,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,19.75868758,0:ALIVE OR DEAD TUMOR FREE,19.75868758,0:CENSORED,19.75868758,0:DiseaseFree,19.75868758,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.8833471083373152,2.908832117931768,8.48460863864312,3.741089409322132,5.769687121223036
TCGA-HC-7077,TCGA-HC-7077-01,64,Male,0.0,AFR,International Genomics Consortium,-23636.0,2115.0,2115.0,2012-04-09,-27.0,-18.0,-34.0,0.0626,48.0,2.0,0.2945,0.01,0.9682504706782838,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,124.0,,t1,t3/t4,m0,t1c,,t3a,0.83,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,69.53348457,0:ALIVE OR DEAD TUMOR FREE,69.53348457,0:CENSORED,69.53348457,0:DiseaseFree,69.53348457,,R0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,2.694835630101976,2.5438670265159864,8.799083095616277,4.325148920370505,7.2999772506320495
TCGA-HC-7078,TCGA-HC-7078-01,69,Male,0.0,EUR,International Genomics Consortium,-25402.0,1985.0,1985.0,2012-04-10,-27.0,-18.0,-24.0,0.2282,30.0,6.0,0.3139,0.0,0.6931471805599453,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,25.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.01,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,65.2595588,0:ALIVE OR DEAD TUMOR FREE,65.2595588,0:CENSORED,65.2595588,0:DiseaseFree,65.2595588,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,2.349506822361645,3.385099662479357,7.622998414776639,4.887715343039784,5.471024839066756
TCGA-HC-7079,TCGA-HC-7079-01,51,Male,0.0,EUR,International Genomics Consortium,-18734.0,1184.0,1184.0,2012-04-10,-39.0,-18.0,-60.0,0.0,,0.0,0.2961,0.0,0.0,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,106.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3a,0.1,3.0,4.0,7.0,441.0,471.0,True,False,False,Partial Remission/Response,True,True,0:LIVING,38.92560082,0:ALIVE OR DEAD TUMOR FREE,38.92560082,1:PROGRESSION,12.49301378,,,Biochemical evidence of disease,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,2.205517632892706,3.335840512506147,7.2541036262814,2.5774409133886134,5.814470955128407
TCGA-HC-7080,TCGA-HC-7080-01,66,Male,0.0,EUR,International Genomics Consortium,-24243.0,1106.0,1106.0,2012-04-09,-27.0,-20.0,-30.0,0.1135,32.0,0.0,0.2875,0.05,0.7259370035442264,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,46.0,N0,t2,t2,m0,t2a,n0,t2a,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,True,0:LIVING,36.36124536,0:ALIVE OR DEAD TUMOR FREE,36.36124536,1:PROGRESSION,29.39145872,0:DiseaseFree,36.36124536,New Primary Tumor,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,4.016318022294673,4.882696843767206,8.241931206972495,4.836615957414016,5.18168301135244
TCGA-HC-7081,TCGA-HC-7081-01,62,Male,0.0,EUR,International Genomics Consortium,,1136.0,1136.0,2012-04-11,-33.0,-16.0,-32.0,0.0265,82.0,0.0,0.2953,0.0,1.3261904371386808,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,120.0,,,t3/t4,,,,t3b,,4.0,5.0,9.0,189.0,234.0,True,False,False,Partial Remission/Response,True,False,0:LIVING,37.34753592,0:ALIVE OR DEAD TUMOR FREE,37.34753592,0:CENSORED,37.34753592,,,,R2,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,3.3510063437338515,3.364320288799802,8.601217742156713,4.261846699280917,5.664849725217215
TCGA-HC-7209,TCGA-HC-7209-01,60,Male,0.0,EUR,International Genomics Consortium,-22129.0,440.0,440.0,2012-04-10,-33.0,-14.0,-36.0,0.0422,15.0,0.0,0.3354,0.0,0.4274440146095482,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,25.0,N0,t2,t2,,t2b,n0,t2c,0.05,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,14.4655949,0:ALIVE OR DEAD TUMOR FREE,14.4655949,0:CENSORED,14.4655949,0:DiseaseFree,14.4655949,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.8088071908646888,2.95352599957396,8.989458082051915,3.982947955157527,6.921078040537501
TCGA-HC-7210,TCGA-HC-7210-01,74,Male,0.0,EUR,International Genomics Consortium,-27343.0,868.0,868.0,2012-04-10,-21.0,-20.0,-26.0,0.0743,28.0,0.0,0.3196,0.0,0.6592456287118501,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,154.0,N0,,t2,,,n0,t2a,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,28.53667357,0:ALIVE OR DEAD TUMOR FREE,28.53667357,0:CENSORED,28.53667357,0:DiseaseFree,28.53667357,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.265481904551701,2.2463168707669574,8.992084075793862,3.217835590547223,6.526663550299274
TCGA-HC-7211,TCGA-HC-7211-01,62,Male,0.0,EUR,International Genomics Consortium,-22768.0,1221.0,1221.0,2012-04-11,-33.0,-22.0,-28.0,0.0483,21.0,2.0,0.3293,0.6,0.5306282510621704,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,143.0,N0,t2,t2,m0,t2a,n0,t2c,10.9,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,40.14202584,0:ALIVE OR DEAD TUMOR FREE,40.14202584,0:CENSORED,40.14202584,0:DiseaseFree,40.14202584,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.233121117919817,3.1166309120363063,7.107511078130303,3.918529351855412,3.498761465671852
TCGA-HC-7212,TCGA-HC-7212-01,56,Male,0.0,EUR,International Genomics Consortium,-20576.0,870.0,870.0,2012-04-11,-33.0,-22.0,-42.0,0.0854,31.0,0.0,0.3495,0.0,0.7096764823472214,"Prostate Adenocarcinoma, Acinar Type",2.0,75.0,153.0,N0,,t2,m0,,n0,t2a,0.28,3.0,4.0,7.0,446.0,501.0,True,False,False,Complete Remission/Response,,True,0:LIVING,28.60242628,0:ALIVE OR DEAD TUMOR FREE,28.60242628,0:CENSORED,28.60242628,0:DiseaseFree,28.60242628,,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.1513068250995717,2.8847541963487235,8.951213015613607,4.638519902825322,7.504501222142525
TCGA-HC-7213,TCGA-HC-7213-01,53,Male,0.0,EUR,International Genomics Consortium,-19699.0,1219.0,1219.0,2012-04-10,-19.0,-4.0,-20.0,0.1697,35.0,13.0,0.3531,0.0,0.773189888387328,"Prostate Adenocarcinoma, Acinar Type",2.0,90.0,151.0,N0,t3/t4,t3/t4,m0,t3b,n0,t3b,4.09,4.0,5.0,9.0,,0.0,False,False,False,Partial Remission/Response,False,True,0:LIVING,40.07627314,0:ALIVE OR DEAD TUMOR FREE,40.07627314,1:PROGRESSION,5.588979847,,,Biochemical evidence of disease,R0,0.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,3.628621970132027,3.069564695093359,8.766614705821588,3.887301050710928,5.223773913056853
TCGA-HC-7230,TCGA-HC-7230-01,50,Male,0.0,EUR,International Genomics Consortium,-18577.0,1001.0,1001.0,2011-10-06,-29.0,-16.0,-20.0,0.0527,23.0,2.0,0.3156,0.07,0.5690945320786457,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,19.0,N0,,t2,,,n0,t2c,3.0,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,32.90922839,0:ALIVE OR DEAD TUMOR FREE,32.90922839,0:CENSORED,32.90922839,0:DiseaseFree,32.90922839,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.21816118709516,3.075857757112748,8.95303499715711,3.892459030137466,6.669600837099423
TCGA-HC-7231,TCGA-HC-7231-01,66,Male,0.0,EUR,International Genomics Consortium,-24278.0,939.0,939.0,2011-10-06,-37.0,-14.0,-46.0,0.047,33.0,0.0,0.3442,0.0,0.7419373447293773,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,12.0,,t1,t2,m0,t1c,,t2c,,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,30.87089457,0:ALIVE OR DEAD TUMOR FREE,30.87089457,0:CENSORED,30.87089457,0:DiseaseFree,30.87089457,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.486225240955873,3.1175620692569788,8.705847652500827,4.450373281077607,5.971743563143376
TCGA-HC-7232,TCGA-HC-7232-01,66,Male,0.0,EUR,International Genomics Consortium,-24324.0,1161.0,1161.0,2012-04-11,-31.0,-20.0,-38.0,0.1165,23.0,2.0,0.3381,0.0,0.5690945320786457,"Prostate Adenocarcinoma, Acinar Type",0.0,65.0,160.0,,,t3/t4,,,,t3b,,4.0,5.0,9.0,794.0,851.0,True,False,False,Complete Remission/Response,False,True,0:LIVING,38.16944472,0:ALIVE OR DEAD TUMOR FREE,38.16944472,1:PROGRESSION,25.18328566,1:Recurred/Progressed,25.18328566,Biochemical evidence of disease,R0,0.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,2.9275551714371293,2.4183788759916496,8.722095398241757,3.679333711313673,5.185878435606079
TCGA-HC-7233,TCGA-HC-7233-01,73,Male,1.0,EUR,International Genomics Consortium,,1355.0,1355.0,2012-04-11,-31.0,-20.0,-34.0,0.0009,29.0,0.0,0.3436,0.05,0.6763400624130557,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,138.0,N0,,t2,,,n0,t2a,,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,True,False,0:LIVING,44.54745701,0:ALIVE OR DEAD TUMOR FREE,44.54745701,0:CENSORED,44.54745701,0:DiseaseFree,44.54745701,,R1,1.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,3.4733713140339084,2.5803384741957087,7.955245373174701,4.425768113726302,7.024770672550007
TCGA-HC-7736,TCGA-HC-7736-01,59,Male,0.0,EUR,International Genomics Consortium,-21703.0,1103.0,1103.0,2012-04-11,-31.0,-18.0,-34.0,0.1245,19.0,1.0,0.3035,0.0,0.5108256239659906,"Prostate Adenocarcinoma, Acinar Type",0.0,65.0,178.0,N0,t2,t2,m0,t2b,n0,t2c,0.02,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,36.2626163,0:ALIVE OR DEAD TUMOR FREE,36.2626163,0:CENSORED,36.2626163,0:DiseaseFree,36.2626163,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.38125568135433,3.310878122266393,8.806995813758101,4.188313879165493,6.9577207872949565
TCGA-HC-7737,TCGA-HC-7737-01,55,Male,0.0,AFR,International Genomics Consortium,-20122.0,1090.0,1090.0,2012-04-11,-25.0,-22.0,-38.0,0.0001,18.0,1.0,0.326,0.09,0.4700036292457356,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,43.0,N1,t1,t2,m0,t1c,n1,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,35.83522372,0:ALIVE OR DEAD TUMOR FREE,35.83522372,0:CENSORED,35.83522372,0:DiseaseFree,35.83522372,,R0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,2.0,1.9336104046525888,2.5421094383319427,8.151420487700841,3.83102596211392,6.129425218447753
TCGA-HC-7738,TCGA-HC-7738-01,58,Male,0.0,EUR,International Genomics Consortium,-21195.0,964.0,964.0,2012-03-29,,,,0.0275,35.0,0.0,0.3261,0.0,1.1735135967381347,"Prostate Adenocarcinoma, Acinar Type",0.0,75.0,27.0,,,t2,m0,,,t2c,,3.0,4.0,7.0,,0.0,False,False,False,Partial Remission/Response,False,True,0:LIVING,31.69280337,0:ALIVE OR DEAD TUMOR FREE,31.69280337,1:PROGRESSION,13.80806786,,,Biochemical evidence of disease,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.298423711931038,2.590314577496656,6.870454731081352,3.365874472131364,4.005256250067778
TCGA-HC-7740,TCGA-HC-7740-01,59,Male,0.0,EUR,International Genomics Consortium,-21883.0,717.0,717.0,2012-04-11,-35.0,-22.0,-44.0,0.0002,17.0,0.0,0.3044,0.98,0.7576857015412665,"Prostate Adenocarcinoma, Acinar Type",0.0,65.0,98.0,N0,t2,t2,m0,t2a,n0,t2c,0.0,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,23.57234441,0:ALIVE OR DEAD TUMOR FREE,23.57234441,0:CENSORED,23.57234441,0:DiseaseFree,23.57234441,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,1.89650436654306,3.035254391731169,6.916962636149538,3.716090986470233,3.6065725149040486
TCGA-HC-7742,TCGA-HC-7742-01,58,Male,0.0,EUR,International Genomics Consortium,-21323.0,938.0,938.0,2012-04-11,-19.0,-18.0,-38.0,0.1224,30.0,5.0,0.3372,0.0,1.041453874710514,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,30.0,N0,,t3/t4,m0,,n0,t3a,0.1,3.0,4.0,7.0,211.0,,False,True,False,Partial Remission/Response,True,True,0:LIVING,30.83801821,0:ALIVE OR DEAD TUMOR FREE,30.83801821,0:CENSORED,30.83801821,,,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.173847002082567,1.8085086166739743,8.414239992639262,3.74069014893122,4.790959659409534
TCGA-HC-7744,TCGA-HC-7744-01,46,Male,0.0,EUR,International Genomics Consortium,-17065.0,531.0,531.0,2012-04-11,-31.0,-12.0,-30.0,0.0174,32.0,0.0,0.3455,0.13,0.7259370035442264,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,111.0,N0,,t3/t4,m0,,n0,t3b,0.04,4.0,3.0,7.0,189.0,246.0,True,False,False,Complete Remission/Response,True,False,0:LIVING,17.45734293,0:ALIVE OR DEAD TUMOR FREE,17.45734293,0:CENSORED,17.45734293,0:DiseaseFree,17.45734293,,R1,1.0,1.0,0.0,0.0,0.0,1.0,2.0,3.0,3.145612247166476,2.855252219946513,8.915095391160353,5.400650635731272,7.374218773813384
TCGA-HC-7745,TCGA-HC-7745-01,65,Male,0.0,EUR,International Genomics Consortium,-24078.0,721.0,721.0,2012-04-11,,,,0.1515,25.0,3.0,0.3504,0.0,0.9555114450274363,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,34.0,N0,,t3/t4,,,n0,t3b,,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,23.70384982,0:ALIVE OR DEAD TUMOR FREE,23.70384982,0:CENSORED,23.70384982,0:DiseaseFree,23.70384982,,R0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.0,2.719577745146265,3.453780940852025,7.5377542146617635,4.036116453217653,6.257851693580831
TCGA-HC-7747,TCGA-HC-7747-01,52,Male,0.0,EUR,International Genomics Consortium,-19188.0,748.0,748.0,2012-04-12,-31.0,-18.0,-48.0,0.0652,31.0,0.0,0.3271,0.0,1.1096621247448044,"Prostate Adenocarcinoma, Acinar Type",0.0,65.0,25.0,N0,t2,t2,m0,t2b,n0,t2c,0.19,3.0,4.0,7.0,322.0,358.0,True,False,False,Complete Remission/Response,False,False,0:LIVING,24.59151133,0:ALIVE OR DEAD TUMOR FREE,24.59151133,0:CENSORED,24.59151133,0:DiseaseFree,24.59151133,,,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0943881022958126,2.022900402110079,7.940270719465347,4.569509319964868,7.296148094171552
TCGA-HC-7748,TCGA-HC-7748-01,60,Male,1.0,EUR,International Genomics Consortium,-22072.0,792.0,792.0,2012-04-12,-41.0,-20.0,-44.0,0.0414,22.0,1.0,0.3133,0.0,0.5690945320786457,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,217.0,N0,,t2,,,n0,t2a,0.1,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,26.03807082,0:ALIVE OR DEAD TUMOR FREE,26.03807082,0:CENSORED,26.03807082,0:DiseaseFree,26.03807082,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.05371957360449,2.849759123802511,9.024134032864628,3.719008159366136,6.861000031420337
TCGA-HC-7749,TCGA-HC-7749-01,70,Male,0.0,EUR,International Genomics Consortium,-25688.0,724.0,724.0,2012-04-20,-35.0,-18.0,-36.0,0.0318,49.0,0.0,0.3303,0.0,0.9555114450274363,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,40.0,N0,,t3/t4,m0,,n0,t3a,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,23.80247888,0:ALIVE OR DEAD TUMOR FREE,23.80247888,0:CENSORED,23.80247888,0:DiseaseFree,23.80247888,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,2.6584857115861675,3.100775858083134,8.344871539360698,4.9721182183841375,6.143564846918052
TCGA-HC-7750,TCGA-HC-7750-01,50,Male,0.0,EUR,International Genomics Consortium,-18580.0,522.0,522.0,2012-04-20,-35.0,-22.0,-38.0,0.0066,17.0,0.0,0.3058,0.08,0.4489502202606691,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,53.0,,t2,t2,m0,t2b,,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,17.16145577,0:ALIVE OR DEAD TUMOR FREE,17.16145577,0:CENSORED,17.16145577,0:DiseaseFree,17.16145577,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.678883192919827,2.5554726153431715,7.816696975100334,4.456628757787224,5.792589897036358
TCGA-HC-7752,TCGA-HC-7752-01,61,Male,0.0,EUR,International Genomics Consortium,-22366.0,782.0,782.0,2012-04-20,,,,0.0251,36.0,0.0,0.3542,0.06,1.1735135967381347,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,16.0,N0,,t2,m0,,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,25.7093073,0:ALIVE OR DEAD TUMOR FREE,25.7093073,0:CENSORED,25.7093073,0:DiseaseFree,25.7093073,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.51116438858385,2.642470537315822,4.868528739686303,3.1155493503686715,3.430030972219849
TCGA-HC-7817,TCGA-HC-7817-01,52,Male,0.0,EUR,International Genomics Consortium,-19207.0,928.0,928.0,2012-06-20,,,,0.0016,17.0,0.0,0.3051,0.0,0.4489502202606691,"Prostate Adenocarcinoma, Acinar Type",,,,,,t3/t4,m0,,,t3b,0.1,4.0,3.0,7.0,206.0,253.0,True,False,False,Complete Remission/Response,False,False,0:LIVING,30.50925469,0:ALIVE OR DEAD TUMOR FREE,30.50925469,0:CENSORED,30.50925469,0:DiseaseFree,30.50925469,,,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.0,2.366867712137269,3.294326666428011,7.597757601772923,4.224773478437933,5.506148077362313
TCGA-HC-7818,TCGA-HC-7818-01,66,Male,0.0,EUR,International Genomics Consortium,-24391.0,938.0,938.0,2012-04-20,-31.0,-22.0,-40.0,0.0,24.0,,0.3309,0.0,0.5877866649021191,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,37.0,N0,t2,t2,m0,t2b,n0,t2c,0.01,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,30.83801821,0:ALIVE OR DEAD TUMOR FREE,30.83801821,0:CENSORED,30.83801821,0:DiseaseFree,30.83801821,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.5028143046961624,3.109527721798356,8.418030520660404,4.429776626628965,6.188446423537372
TCGA-HC-7819,TCGA-HC-7819-01,53,Male,0.0,EUR,International Genomics Consortium,-19663.0,543.0,543.0,2012-04-20,,,,0.0674,24.0,1.0,0.3362,0.0,0.9426080403213986,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,36.0,N0,t2,t2,m0,t2c,n0,t2c,0.01,4.0,4.0,8.0,,0.0,False,False,False,Complete Remission/Response,True,False,0:LIVING,17.85185916,0:ALIVE OR DEAD TUMOR FREE,17.85185916,0:CENSORED,17.85185916,0:DiseaseFree,17.85185916,,R2,1.0,0.0,0.0,0.0,0.0,0.0,3.0,4.0,2.9260373837156544,2.080145978629491,8.539510134377942,3.108641540320191,4.188282224976879
TCGA-HC-7820,TCGA-HC-7820-01,72,Male,0.0,EUR,International Genomics Consortium,-26576.0,747.0,747.0,2012-04-20,-31.0,-20.0,-30.0,0.0386,30.0,2.0,0.3476,0.0,1.0986122886681098,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,23.0,,,t2,,,,t2c,,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,24.55863497,0:ALIVE OR DEAD TUMOR FREE,24.55863497,0:CENSORED,24.55863497,0:DiseaseFree,24.55863497,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.002432496039723,3.3636617062825813,8.301143594725984,3.997590491657374,6.118515466809646
TCGA-HC-7821,TCGA-HC-7821-01,54,Male,1.0,EUR,International Genomics Consortium,-19894.0,956.0,956.0,2012-04-20,-31.0,-22.0,-34.0,0.1347,21.0,4.0,0.3378,0.03,0.5690945320786457,"Prostate Adenocarcinoma, Acinar Type",0.0,65.0,97.0,N1,,t3/t4,m0,,n1,t3b,0.01,4.0,4.0,8.0,,0.0,True,False,False,Complete Remission/Response,True,True,0:LIVING,31.42979255,0:ALIVE OR DEAD TUMOR FREE,31.42979255,0:CENSORED,31.42979255,0:DiseaseFree,31.42979255,,,0.0,1.0,0.0,0.0,1.0,0.0,3.0,4.0,3.010117407333491,3.471694721122693,7.427608686769673,4.119098826433689,5.304803055785424
TCGA-HC-8213,TCGA-HC-8213-01,48,Male,0.0,EUR,International Genomics Consortium,-17673.0,589.0,589.0,2012-07-08,-29.0,-18.0,-36.0,0.0083,17.0,0.0,0.3019,0.0,0.4489502202606691,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,51.0,,,t2,,,,t2c,,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,19.36417135,0:ALIVE OR DEAD TUMOR FREE,19.36417135,0:CENSORED,19.36417135,0:DiseaseFree,19.36417135,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.3432941078624365,2.9256576871556965,7.161556187124443,5.133575855010217,6.599418969258098
TCGA-HC-8216,TCGA-HC-8216-01,58,Male,0.0,EUR,International Genomics Consortium,-21428.0,682.0,682.0,2012-06-17,-21.0,-18.0,-30.0,0.0667,98.0,5.0,0.31,0.01,1.4508328823355867,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,30.0,N0,t2,t3/t4,m0,t2a,n0,t3a,0.19,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,22.42167209,0:ALIVE OR DEAD TUMOR FREE,22.42167209,0:CENSORED,22.42167209,0:DiseaseFree,22.42167209,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,2.448821680009039,3.453491240407459,7.658716337671648,4.682562061361138,6.16154510238052
TCGA-HC-8256,TCGA-HC-8256-01,53,Male,0.0,EUR,International Genomics Consortium,-19598.0,860.0,860.0,2012-06-13,-35.0,-20.0,-40.0,0.0635,21.0,2.0,0.3097,0.0,0.5500463367269643,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,18.0,,,t2,m0,,,t2c,,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,28.27366275,0:ALIVE OR DEAD TUMOR FREE,28.27366275,0:CENSORED,28.27366275,0:DiseaseFree,28.27366275,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.66443732876226,3.609849500034336,8.257202071959407,4.485497672062233,5.837443761000192
TCGA-HC-8257,TCGA-HC-8257-01,70,Male,0.0,AFR,International Genomics Consortium,-25629.0,726.0,726.0,2012-10-01,-31.0,-18.0,-28.0,0.0697,39.0,0.0,0.3115,0.0,0.8329091229351039,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,63.0,N1,,t3/t4,,,n1,t3b,0.1,3.0,4.0,7.0,91.0,,False,True,False,Complete Remission/Response,True,False,0:LIVING,23.86823158,0:ALIVE OR DEAD TUMOR FREE,23.86823158,0:CENSORED,23.86823158,0:DiseaseFree,23.86823158,,R1,1.0,1.0,0.0,0.0,1.0,0.0,1.0,2.0,1.866235420696214,4.418338393493131,7.502111768309177,5.08821369588965,6.757147289472408
TCGA-HC-8258,TCGA-HC-8258-01,56,Male,0.0,AFR,International Genomics Consortium,-20703.0,847.0,847.0,2012-06-20,-29.0,-16.0,-30.0,0.0,18.0,,0.2544,1.57,0.4906229162443896,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,31.0,N0,,t2,,,n0,t2c,0.01,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,27.84627018,0:ALIVE OR DEAD TUMOR FREE,27.84627018,0:CENSORED,27.84627018,0:DiseaseFree,27.84627018,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.8834253159071768,2.219462838957155,7.067262248938619,3.800361538374856,3.4352952156471668
TCGA-HC-8259,TCGA-HC-8259-01,50,Male,0.0,AFR,International Genomics Consortium,-18309.0,924.0,924.0,2012-06-20,,,,0.0034,45.0,0.0,0.2961,0.0,0.9162907318741552,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,25.0,,t1,t2,m0,t1c,,t2a,0.01,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,30.37774929,0:ALIVE OR DEAD TUMOR FREE,30.37774929,0:CENSORED,30.37774929,0:DiseaseFree,30.37774929,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.6380274847881977,3.21868818766389,7.34346289950542,3.1261634252834427,4.245115315597531
TCGA-HC-8260,TCGA-HC-8260-01,43,Male,0.0,AFR,International Genomics Consortium,-15884.0,686.0,686.0,2012-06-20,-33.0,-16.0,-42.0,0.0003,9.0,0.0,0.3018,0.1,0.262364264467491,"Prostate Adenocarcinoma, Acinar Type",0.0,65.0,69.0,N0,,t2,m0,,n0,t2c,0.01,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,True,False,0:LIVING,22.5531775,0:ALIVE OR DEAD TUMOR FREE,22.5531775,0:CENSORED,22.5531775,0:DiseaseFree,22.5531775,,R1,1.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.1062813093543697,4.618673278367403,8.13766130989126,3.937325557888378,5.432672175505522
TCGA-HC-8261,TCGA-HC-8261-01,48,Male,0.0,AFR,International Genomics Consortium,-17874.0,546.0,546.0,2012-06-13,-27.0,-18.0,-26.0,0.0679,20.0,0.0,0.3571,1.06,0.5108256239659906,"Prostate Adenocarcinoma, Acinar Type",15.0,85.0,19.0,,,t2,,,,t2c,,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,17.95048821,0:ALIVE OR DEAD TUMOR FREE,17.95048821,0:CENSORED,17.95048821,0:DiseaseFree,17.95048821,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.1980854893259023,3.379828868150588,7.889376191403106,4.322036292958052,6.164756114433703
TCGA-HC-8262,TCGA-HC-8262-01,57,Male,0.0,EUR,International Genomics Consortium,-20946.0,679.0,679.0,2012-06-20,-23.0,-14.0,-26.0,0.0447,29.0,1.0,0.3024,0.0,0.6763400624130557,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,14.0,N0,,t2,,,n0,t2c,0.1,4.0,4.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,22.32304304,0:ALIVE OR DEAD TUMOR FREE,22.32304304,0:CENSORED,22.32304304,0:DiseaseFree,22.32304304,,R0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,4.0,2.11613183047984,3.73033562656157,7.776833707144894,4.141040345433593,6.309287165349671
TCGA-HC-8264,TCGA-HC-8264-01,60,Male,0.0,EUR,International Genomics Consortium,-22177.0,48.0,48.0,2013-01-25,-33.0,-22.0,-42.0,0.0698,35.0,1.0,0.3298,0.0,0.773189888387328,"Prostate Adenocarcinoma, Acinar Type",0.0,65.0,11.0,N1,,t3/t4,,,n1,t3b,,4.0,5.0,9.0,,0.0,,False,False,No Treatment Indicated,True,False,0:LIVING,1.578064898,0:ALIVE OR DEAD TUMOR FREE,1.578064898,0:CENSORED,1.578064898,,,,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.069066250934289,3.823912367487802,7.782405943749409,3.3296402900382303,5.207779648725614
TCGA-HC-8265,TCGA-HC-8265-01,66,Male,0.0,EUR,International Genomics Consortium,-24382.0,483.0,483.0,2012-06-20,-19.0,-24.0,-22.0,0.1478,52.0,1.0,0.3432,2.05,1.0176432262549244,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,60.0,N0,,t3/t4,,,n0,t3a,0.1,3.0,5.0,8.0,122.0,152.0,True,False,False,Complete Remission/Response,True,False,0:LIVING,15.87927804,0:ALIVE OR DEAD TUMOR FREE,15.87927804,0:CENSORED,15.87927804,0:DiseaseFree,15.87927804,,R1,1.0,0.0,1.0,0.0,0.0,0.0,3.0,4.0,1.7176928717521909,3.543669095416448,7.59930961007072,5.266632894859909,5.834981670494417
TCGA-HC-8266,TCGA-HC-8266-01,55,Male,0.0,EAS_OTHER_OR_MISSING,International Genomics Consortium,-20280.0,473.0,473.0,2012-10-01,-33.0,-22.0,-50.0,0.0385,22.0,8.0,0.3504,0.0,0.5500463367269643,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,56.0,N0,,t3/t4,m0,,n0,t3b,,4.0,4.0,8.0,,0.0,False,False,False,No Treatment Indicated,True,,0:LIVING,15.55051452,0:ALIVE OR DEAD TUMOR FREE,15.55051452,0:CENSORED,15.55051452,,,,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,4.0,1.8175414001514336,3.7719067012749488,7.643083419652656,3.858349084142439,5.508602957088031
TCGA-HC-A48F,TCGA-HC-A48F-01,47,Male,0.0,EUR,International Genomics Consortium,-17434.0,680.0,680.0,2013-02-21,-29.0,-12.0,-36.0,0.3399,19.0,5.0,0.3415,0.11,0.4906229162443896,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,80.0,N1,t1,t2,m0,t1c,n1,t2c,,4.0,4.0,8.0,57.0,168.0,True,True,False,Complete Remission/Response,True,False,0:LIVING,22.35591939,0:ALIVE OR DEAD TUMOR FREE,22.35591939,0:CENSORED,22.35591939,0:DiseaseFree,22.35591939,,R1,1.0,0.0,0.0,0.0,1.0,0.0,3.0,4.0,2.987775616142913,3.8611712934307794,7.345732560527464,4.5760141424448255,5.8114273585446
TCGA-HC-A4ZV,TCGA-HC-A4ZV-01,56,Male,0.0,AFR,International Genomics Consortium,-20634.0,23.0,23.0,2013-03-15,-21.0,-4.0,-28.0,0.3551,106.0,5.0,0.2828,0.1,1.5114575040003673,"Prostate Adenocarcinoma, Acinar Type",0.0,95.0,78.0,N0,t2,t3/t4,,t2c,n0,t3b,,5.0,4.0,9.0,,0.0,,False,False,No Treatment Indicated,True,False,0:LIVING,0.756156097,0:ALIVE OR DEAD TUMOR FREE,0.756156097,0:CENSORED,0.756156097,,,,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,2.1557816087742845,4.2322386300014365,7.911892275071412,5.363237672292051,6.670719974117741
TCGA-HC-A631,TCGA-HC-A631-01,67,Male,0.0,EUR,International Genomics Consortium,-24749.0,54.0,54.0,2014-04-22,-17.0,-16.0,-12.0,0.1911,29.0,3.0,0.3115,0.03,0.7096764823472214,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,65.0,N0,t2,t2,m0,t2,n0,t2c,,4.0,5.0,9.0,,0.0,,False,False,No Treatment Indicated,True,False,0:LIVING,1.77532301,0:ALIVE OR DEAD TUMOR FREE,1.77532301,0:CENSORED,1.77532301,,,,R1,1.0,0.0,0.0,0.0,0.0,0.0,3.0,5.0,1.914028675171847,3.7092354857762615,8.203027858027086,3.419484957980782,6.12797162961589
TCGA-HC-A632,TCGA-HC-A632-01,68,Male,0.0,EUR,International Genomics Consortium,-24916.0,61.0,61.0,2013-10-15,-33.0,-22.0,-62.0,0.1546,31.0,3.0,0.3221,0.01,0.7096764823472214,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,53.0,N0,t1,t3/t4,m0,t1c,n0,t3a,,4.0,5.0,9.0,,0.0,,False,False,No Treatment Indicated,False,False,0:LIVING,2.005457474,0:ALIVE OR DEAD TUMOR FREE,2.005457474,0:CENSORED,2.005457474,,,,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,2.606371157659863,3.757343335635176,6.640367867404275,4.411012631942079,6.007018293835683
TCGA-HC-A6AL,TCGA-HC-A6AL-01,64,Male,0.0,EUR,International Genomics Consortium,-23618.0,67.0,67.0,2013-09-19,,,,0.0662,38.0,1.0,0.305,0.04,0.803495237579557,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,63.0,N0,t1,t2,m0,t1c,n0,t2c,,3.0,4.0,7.0,,0.0,,False,False,No Treatment Indicated,False,False,0:LIVING,2.202715587,0:ALIVE OR DEAD TUMOR FREE,2.202715587,0:CENSORED,2.202715587,,,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.8933622107638715,3.730303016037025,7.401253293416346,5.106988946934561,5.907695875553277
TCGA-HC-A6AN,TCGA-HC-A6AN-01,67,Male,0.0,EUR,International Genomics Consortium,-24697.0,49.0,49.0,2014-04-22,,,,0.0831,30.0,3.0,0.3035,0.05,0.6931471805599453,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,70.0,N0,t1,t3/t4,m0,t1c,n0,t3a,,4.0,3.0,7.0,,0.0,,False,False,No Treatment Indicated,True,False,0:LIVING,1.61094125,0:ALIVE OR DEAD TUMOR FREE,1.61094125,0:CENSORED,1.61094125,,,,R1,1.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,2.563524250196903,2.838911439482908,7.497983529242846,4.520981616580342,5.50216190398449
TCGA-HC-A6AO,TCGA-HC-A6AO-01,52,Male,0.0,EUR,International Genomics Consortium,-19298.0,530.0,530.0,2013-09-19,,,,0.1062,25.0,2.0,0.303,0.1,0.6061358033884974,"Prostate Adenocarcinoma, Acinar Type",0.0,95.0,59.0,,t1,t2,m0,t1c,,t2c,,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,17.42446658,0:ALIVE OR DEAD TUMOR FREE,17.42446658,0:CENSORED,17.42446658,0:DiseaseFree,17.42446658,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,2.4906984783881825,3.070148858678259,7.047155547424026,6.174606157560221,5.453701937408949
TCGA-HC-A6AP,TCGA-HC-A6AP-01,61,Male,0.0,EUR,International Genomics Consortium,-22318.0,71.0,71.0,2013-09-19,,,,0.0485,29.0,0.0,0.3014,0.0,0.6763400624130557,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,62.0,,t1,t2,m0,t1c,,t2c,,3.0,4.0,7.0,,0.0,,False,False,No Treatment Indicated,,False,0:LIVING,2.334220995,0:ALIVE OR DEAD TUMOR FREE,2.334220995,0:CENSORED,2.334220995,,,,RX,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.165783336431569,2.9078905175706304,6.687866938500154,5.104533758754276,5.358223932883063
TCGA-HC-A6AQ,TCGA-HC-A6AQ-01,60,Male,1.0,EUR,International Genomics Consortium,-22208.0,106.0,106.0,2013-09-19,,,,0.0048,21.0,0.0,0.2968,0.0,0.5306282510621704,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,78.0,,t1,t2,m0,t1c,,t2c,,3.0,4.0,7.0,,0.0,,False,False,No Treatment Indicated,False,False,0:LIVING,3.484893316,0:ALIVE OR DEAD TUMOR FREE,3.484893316,0:CENSORED,3.484893316,,,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.126279086087681,3.2080177548958924,7.216739069026198,4.804760892773894,5.600537379067427
TCGA-HC-A6AS,TCGA-HC-A6AS-01,70,Male,0.0,EUR,International Genomics Consortium,-25661.0,44.0,44.0,2013-09-19,,,,0.0021,24.0,,0.2947,0.04,0.5877866649021191,"Prostate Adenocarcinoma, Acinar Type",0.0,75.0,60.0,N0,t1,t2,m0,t1c,n0,t2a,,3.0,4.0,7.0,,0.0,,False,False,No Treatment Indicated,False,False,0:LIVING,1.44655949,0:ALIVE OR DEAD TUMOR FREE,1.44655949,0:CENSORED,1.44655949,,,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.6280269793860938,3.489761275740863,6.8920363805158535,4.4053797647588455,5.690755100279676
TCGA-HC-A6HX,TCGA-HC-A6HX-01,55,Male,0.0,EUR,International Genomics Consortium,-20263.0,38.0,38.0,2013-09-19,,,,0.004,21.0,0.0,0.3096,0.0,0.5306282510621704,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,55.0,N0,t1,t2,m0,t1c,n0,t2c,,4.0,3.0,7.0,,0.0,,False,False,No Treatment Indicated,False,False,0:LIVING,1.249301378,0:ALIVE OR DEAD TUMOR FREE,1.249301378,0:CENSORED,1.249301378,,,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,1.5222566676267006,2.867817410043711,6.90569386475719,4.288033660812403,5.005620058307383
TCGA-HC-A6HY,TCGA-HC-A6HY-01,51,Male,0.0,EUR,International Genomics Consortium,-18779.0,134.0,134.0,2013-09-19,,,,0.0408,23.0,1.0,0.3298,0.0,0.5690945320786457,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,55.0,,t1,t2,m0,t1c,,t2c,,3.0,4.0,7.0,,0.0,,False,False,No Treatment Indicated,False,False,0:LIVING,4.405431173,0:ALIVE OR DEAD TUMOR FREE,4.405431173,0:CENSORED,4.405431173,,,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.5631093074094906,3.521817122134536,7.570598025562053,4.767458824147348,5.538510228214404
TCGA-HC-A76W,TCGA-HC-A76W-01,73,Male,1.0,EUR,International Genomics Consortium,-26755.0,213.0,213.0,2014-03-28,-35.0,-20.0,-36.0,0.0177,30.0,0.0,0.3226,0.0,0.6931471805599453,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,60.0,N0,t2,t3/t4,m0,t2,n0,t3b,0.01,3.0,4.0,7.0,,0.0,,False,False,No Treatment Indicated,True,False,0:LIVING,7.002662985,0:ALIVE OR DEAD TUMOR FREE,7.002662985,0:CENSORED,7.002662985,,,,R1,1.0,1.0,0.0,0.0,0.0,0.0,1.0,2.0,3.5980793061171954,3.907515628045654,7.42226580412692,4.390688318922428,6.332081317101966
TCGA-HC-A76X,TCGA-HC-A76X-01,62,Male,0.0,EUR,International Genomics Consortium,-22756.0,150.0,150.0,2014-03-28,-31.0,-18.0,-26.0,0.0041,29.0,0.0,0.3337,0.0,0.6931471805599453,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,73.0,N0,t1,t2,m0,t1c,n0,t2c,0.01,3.0,4.0,7.0,,0.0,,False,False,No Treatment Indicated,False,False,0:LIVING,4.931452806,0:ALIVE OR DEAD TUMOR FREE,4.931452806,0:CENSORED,4.931452806,,,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.838830781162876,4.046718045913751,8.152982947917954,4.9505104066029135,6.702737875555619
TCGA-HC-A8CY,TCGA-HC-A8CY-01,63,Male,0.0,EUR,International Genomics Consortium,-23154.0,290.0,290.0,2014-03-28,-25.0,-22.0,-38.0,0.1393,25.0,4.0,0.3203,0.0,0.6061358033884974,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,67.0,N1,t1,t3/t4,m0,t1c,n1,t3a,0.9,5.0,4.0,9.0,,0.0,,False,False,No Treatment Indicated,True,,0:LIVING,9.534142092,0:ALIVE OR DEAD TUMOR FREE,9.534142092,0:CENSORED,9.534142092,,,,R1,1.0,0.0,1.0,0.0,1.0,0.0,3.0,5.0,3.443699468942789,3.9744558910206793,8.437220247054826,3.5659383133998963,5.794499046368919
TCGA-HC-A8D0,TCGA-HC-A8D0-01,61,Male,0.0,EUR,International Genomics Consortium,-22465.0,775.0,775.0,2014-03-28,-29.0,-24.0,-24.0,0.0414,26.0,2.0,0.314,0.0,0.6241543092515653,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,66.0,N0,t1,t2,m0,t1c,n0,t2a,0.01,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,25.47917283,0:ALIVE OR DEAD TUMOR FREE,25.47917283,0:CENSORED,25.47917283,0:DiseaseFree,25.47917283,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.949665656742062,4.163699987084195,7.043352161080536,4.30919801986539,6.865181446583469
TCGA-HC-A8D1,TCGA-HC-A8D1-01,68,Male,0.0,EUR,International Genomics Consortium,-25137.0,573.0,573.0,2014-03-28,-33.0,-22.0,-42.0,0.0108,21.0,0.0,0.3278,0.0,0.5306282510621704,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,65.0,N0,t2,t2,m0,t2,n0,t2c,0.01,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,18.83814972,0:ALIVE OR DEAD TUMOR FREE,18.83814972,0:CENSORED,18.83814972,0:DiseaseFree,18.83814972,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.050310138013414,3.5549571523325474,8.030209152706917,4.167229454071668,6.7589480451792605
TCGA-HC-A9TE,TCGA-HC-A9TE-01,64,Male,0.0,EUR,International Genomics Consortium,-23543.0,587.0,587.0,2015-06-10,,,,0.5782,45.0,18.0,0.3271,0.0,0.9162907318741552,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,79.0,N0,t2,t3/t4,m0,t2c,n0,t3b,0.064,5.0,4.0,9.0,216.0,417.0,True,True,False,Partial Remission/Response,True,True,0:LIVING,19.29841865,0:ALIVE OR DEAD TUMOR FREE,19.29841865,1:PROGRESSION,7.101292041,,,Biochemical evidence of disease,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,2.780184093974001,3.011245149204265,7.287463060304581,2.6893438945722945,3.739200040230892
TCGA-HC-A9TH,TCGA-HC-A9TH-01,58,Male,0.0,EUR,International Genomics Consortium,-21460.0,844.0,844.0,2015-06-10,,,,0.0868,47.0,0.0,0.3178,0.0,0.9426080403213986,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,63.0,N0,t1,t3/t4,m0,t1b,n0,t3b,0.38,5.0,4.0,9.0,455.0,,False,True,False,Partial Remission/Response,True,True,0:LIVING,27.74764112,0:ALIVE OR DEAD TUMOR FREE,27.74764112,1:PROGRESSION,11.53959957,,,Biochemical evidence of disease,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,4.088099183997209,4.793302872316144,8.585607436593294,4.783346640739992,5.420199413714201
TCGA-HI-7168,TCGA-HI-7168-01,62,Male,0.0,EUR,Fox Chase,-22881.0,3323.0,3323.0,2012-02-20,-25.0,-18.0,-18.0,0.3786,38.0,26.0,0.3111,0.0,0.803495237579557,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,300.0,N0,t1,t3/t4,m0,t1c,n0,t3b,0.3,4.0,5.0,9.0,341.0,2014.0,True,True,False,Progressive Disease,,True,0:LIVING,109.2481178,0:ALIVE OR DEAD TUMOR FREE,109.2481178,1:PROGRESSION,82.35526186,,,Biochemical evidence of disease,R0,0.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,1.735652143968477,2.881840785706171,6.805661337962804,4.158619785782227,6.324542412874193
TCGA-HI-7169,TCGA-HI-7169-01,55,Male,0.0,EUR,Fox Chase,-20133.0,2684.0,2684.0,2012-02-21,,,,0.0009,27.0,0.0,0.352,0.0,0.6592456287118501,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,300.0,N0,t2,t3/t4,m0,t2b,n0,t3a,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,88.24012888,0:ALIVE OR DEAD TUMOR FREE,88.24012888,0:CENSORED,88.24012888,0:DiseaseFree,88.24012888,,R1,1.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,1.1282934010098176,1.64929354696714,4.233274538990934,2.639672083421792,2.528446296552478
TCGA-HI-7170,TCGA-HI-7170-01,58,Male,0.0,EUR,Fox Chase,-21199.0,2522.0,2522.0,2012-02-21,-23.0,-20.0,-22.0,0.0428,25.0,3.0,0.3233,0.0,0.6241543092515653,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,300.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,82.91415985,0:ALIVE OR DEAD TUMOR FREE,82.91415985,0:CENSORED,82.91415985,0:DiseaseFree,82.91415985,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.5740772812689974,1.655351828612554,6.696476578758067,3.72402809812818,6.028701746750505
TCGA-HI-7171,TCGA-HI-7171-01,56,Male,0.0,EUR,Fox Chase,-20776.0,,,2012-02-22,-27.0,-24.0,-24.0,0.1673,28.0,2.0,0.3457,0.06,0.6763400624130557,"Prostate Adenocarcinoma, Acinar Type",2.0,70.0,300.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3b,0.7,5.0,4.0,9.0,559.0,,False,True,False,No Treatment Indicated,True,True,1:DECEASED,43.69267186,1:DEAD WITH TUMOR,43.69267186,1:PROGRESSION,43.69267186,,,,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,3.028798975012003,3.71833970467964,7.887078624132888,4.4228990167454985,7.224365438387903
TCGA-J4-8198,TCGA-J4-8198-01,49,Male,0.0,AFR,ABS - Lahey Clinic,-17935.0,614.0,614.0,2012-06-06,-33.0,-20.0,-44.0,0.0753,26.0,2.0,0.3242,0.02,0.6241543092515653,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,168.0,,t1,t3/t4,m0,t1c,,t3b,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,,False,0:LIVING,20.18608015,0:ALIVE OR DEAD TUMOR FREE,20.18608015,0:CENSORED,20.18608015,0:DiseaseFree,20.18608015,,,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.0,2.387334966125975,4.0530157330181495,8.26352602183687,4.578600636152743,6.126128312133098
TCGA-J4-8200,TCGA-J4-8200-01,47,Male,0.0,EAS_OTHER_OR_MISSING,ABS - Lahey Clinic,-17167.0,1218.0,1218.0,2012-06-06,-27.0,-22.0,-38.0,0.034,18.0,0.0,0.3208,0.04,0.4700036292457356,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,141.0,N0,t2,t2,m0,t2,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,40.04339679,0:ALIVE OR DEAD TUMOR FREE,40.04339679,0:CENSORED,40.04339679,0:DiseaseFree,40.04339679,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.638699448762374,3.364306279535605,7.584833253501125,4.539791596589624,6.994859140125682
TCGA-J4-A67K,TCGA-J4-A67K-01,68,Male,0.0,EUR,ABS - Lahey Clinic,-24908.0,1004.0,1004.0,2013-08-16,,,,0.0084,26.0,0.0,0.2956,0.05,0.6241543092515653,"Prostate Adenocarcinoma, Acinar Type",0.0,40.0,405.0,,t2,t2,m0,t2b,,t2c,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,33.00785745,0:ALIVE OR DEAD TUMOR FREE,33.00785745,0:CENSORED,33.00785745,0:DiseaseFree,33.00785745,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,2.2422366414647388,3.382791736879245,6.6297092357716645,5.264776609971718,7.193806233644532
TCGA-J4-A67L,TCGA-J4-A67L-01,54,Male,0.0,EUR,ABS - Lahey Clinic,-20034.0,770.0,770.0,2013-08-16,,,,0.0606,24.0,1.0,0.3081,0.04,0.6061358033884974,"Prostate Adenocarcinoma, Acinar Type",0.0,95.0,321.0,N0,t2,t3/t4,m0,t2a,n0,t3a,0.01,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,25.31479107,0:ALIVE OR DEAD TUMOR FREE,25.31479107,0:CENSORED,25.31479107,0:DiseaseFree,25.31479107,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,2.7212413999767477,2.6356847502546703,7.2316512845646574,4.82680776776891,4.682809232850721
TCGA-J4-A67M,TCGA-J4-A67M-01,55,Male,0.0,EUR,ABS - Lahey Clinic,-20211.0,941.0,941.0,2013-08-16,,,,0.106,27.0,1.0,0.3138,0.03,0.6592456287118501,"Prostate Adenocarcinoma, Acinar Type",0.0,95.0,245.0,N0,t2,t3/t4,m0,t2a,n0,t3a,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,30.93664727,0:ALIVE OR DEAD TUMOR FREE,30.93664727,0:CENSORED,30.93664727,0:DiseaseFree,30.93664727,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,2.102893242945067,3.1631766661936105,6.984281730975901,4.9847579435323865,5.547428235445572
TCGA-J4-A67N,TCGA-J4-A67N-01,61,Male,0.0,EUR,ABS - Lahey Clinic,-22420.0,937.0,937.0,2013-08-16,,,,0.0976,22.0,2.0,0.311,0.04,0.5500463367269643,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,339.0,N0,t2,t3/t4,m0,t2a,n0,t3a,0.7,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,True,True,0:LIVING,30.80514186,0:ALIVE OR DEAD TUMOR FREE,30.80514186,1:PROGRESSION,14.5313476,,,Biochemical evidence of disease,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,2.459720128795421,3.064486262831029,7.405937066648306,4.446229758178063,5.1441442867716525
TCGA-J4-A67O,TCGA-J4-A67O-01,59,Male,0.0,EUR,ABS - Lahey Clinic,-21714.0,839.0,839.0,2013-08-16,,,,0.0001,14.0,1.0,0.3032,0.01,0.3829922524833785,"Prostate Adenocarcinoma, Acinar Type",0.0,30.0,418.0,N0,t2,t2,m0,t2a,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,27.58325936,0:ALIVE OR DEAD TUMOR FREE,27.58325936,0:CENSORED,27.58325936,0:DiseaseFree,27.58325936,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.7394160934010285,2.136716384488312,6.166757616671681,4.046578366620329,4.857966070618919
TCGA-J4-A67Q,TCGA-J4-A67Q-01,77,Male,0.0,EUR,ABS - Lahey Clinic,-28447.0,975.0,975.0,2013-08-16,,,,0.0002,18.0,0.0,0.3087,0.04,0.4700036292457356,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,340.0,,t2,t2,m0,t2b,,t2c,0.1,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,32.05444324,0:ALIVE OR DEAD TUMOR FREE,32.05444324,0:CENSORED,32.05444324,0:DiseaseFree,32.05444324,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.6628890794062252,2.742717678700741,5.955582493012839,4.05986573796743,4.8379936848917104
TCGA-J4-A67R,TCGA-J4-A67R-01,65,Male,0.0,EUR,ABS - Lahey Clinic,-23807.0,910.0,910.0,2013-08-16,,,,0.0,14.0,0.0,0.3073,0.05,0.3829922524833785,"Prostate Adenocarcinoma, Acinar Type",0.0,25.0,416.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,29.91748036,0:ALIVE OR DEAD TUMOR FREE,29.91748036,0:CENSORED,29.91748036,0:DiseaseFree,29.91748036,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,1.9872844797190627,2.891224740449007,6.756280099205252,4.564920754005049,5.272370379783309
TCGA-J4-A67S,TCGA-J4-A67S-01,63,Male,0.0,EUR,ABS - Lahey Clinic,-23332.0,833.0,833.0,2013-08-16,,,,0.0754,18.0,1.0,0.3055,0.04,0.4700036292457356,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,312.0,N0,t2,t3/t4,m0,t2b,n0,t3a,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,True,True,0:LIVING,27.38600125,0:ALIVE OR DEAD TUMOR FREE,27.38600125,1:PROGRESSION,23.27645724,1:Recurred/Progressed,23.27645724,Biochemical evidence of disease,R1,1.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,2.5915358104149666,3.59932969707355,7.199148168567403,4.727506641171622,5.366661426289032
TCGA-J4-A67T,TCGA-J4-A67T-01,63,Male,0.0,EUR,ABS - Lahey Clinic,-23211.0,183.0,183.0,2013-08-16,-21.0,-20.0,-16.0,0.0056,16.0,0.0,0.3287,0.0,0.4054651081081644,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,378.0,,t1,t2,m0,t1c,,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,,0:LIVING,6.016372423,0:ALIVE OR DEAD TUMOR FREE,6.016372423,0:CENSORED,6.016372423,0:DiseaseFree,6.016372423,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.1061807882919426,3.793386116528643,7.754799334772494,4.327328082629952,6.524276853834636
TCGA-J4-A6G1,TCGA-J4-A6G1-01,68,Male,0.0,EUR,ABS - Lahey Clinic,-24945.0,769.0,769.0,2013-09-12,-35.0,-20.0,-50.0,0.0006,12.0,0.0,0.3098,0.0,0.3600027337988489,"Prostate Adenocarcinoma, Acinar Type",0.0,50.0,212.0,N0,t2,t3/t4,m0,t2b,n0,t3a,0.1,4.0,4.0,8.0,295.0,345.0,True,False,False,Complete Remission/Response,,False,0:LIVING,25.28191472,0:ALIVE OR DEAD TUMOR FREE,25.28191472,0:CENSORED,25.28191472,0:DiseaseFree,25.28191472,,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,4.0,2.574852337802512,3.874924806420686,7.362515476351604,4.224418499768457,5.700889103137879
TCGA-J4-A6G3,TCGA-J4-A6G3-01,57,Male,0.0,EUR,ABS - Lahey Clinic,-20836.0,849.0,849.0,2013-09-12,-27.0,-14.0,-30.0,0.0001,24.0,,0.3194,0.0,0.5690945320786457,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,189.0,N0,t2,t3/t4,m0,t2,n0,t3b,0.4,4.0,4.0,8.0,30.0,417.0,True,True,False,Partial Remission/Response,False,True,0:LIVING,27.91202288,0:ALIVE OR DEAD TUMOR FREE,27.91202288,1:PROGRESSION,20.31758556,,,Biochemical evidence of disease,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,4.0,2.65138469279364,4.12360826237823,7.996021472346068,3.601054647749913,6.787428546415948
TCGA-J4-A6M7,TCGA-J4-A6M7-01,53,Male,0.0,EUR,ABS - Lahey Clinic,-19640.0,512.0,512.0,2013-09-23,-33.0,-20.0,-42.0,0.0036,12.0,0.0,0.3215,0.0,0.3364722366212129,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,207.0,,t2,t2,m0,t2,,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,16.83269224,0:ALIVE OR DEAD TUMOR FREE,16.83269224,0:CENSORED,16.83269224,0:DiseaseFree,16.83269224,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.816435870968101,4.0411290623095,8.047301169990954,4.49756127325582,6.872367072494552
TCGA-J4-A83I,TCGA-J4-A83I-01,63,Male,0.0,EUR,ABS - Lahey Clinic,-23240.0,685.0,685.0,2014-01-20,-33.0,-14.0,-42.0,0.0827,21.0,0.0,0.3164,0.0,0.5306282510621704,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,101.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,22.52030115,0:ALIVE OR DEAD TUMOR FREE,22.52030115,0:CENSORED,22.52030115,0:DiseaseFree,22.52030115,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,3.616369460606924,4.32417694550338,8.143067342726855,4.866225527805852,6.912629508000848
TCGA-J4-A83J,TCGA-J4-A83J-01,68,Male,0.0,EUR,ABS - Lahey Clinic,-24960.0,696.0,696.0,2014-01-20,,,,0.1083,41.0,1.0,0.3343,0.0,0.8614824955200051,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,260.0,N0,t1,t2,m0,t1c,n0,t2c,0.04,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,,False,0:LIVING,22.88194102,0:ALIVE OR DEAD TUMOR FREE,22.88194102,0:CENSORED,22.88194102,0:DiseaseFree,22.88194102,,R1,1.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.5372339341835395,3.9401479530308343,8.080232338154726,3.9496843305930263,6.063362721410658
TCGA-J4-A83K,TCGA-J4-A83K-01,52,Male,0.0,EUR,ABS - Lahey Clinic,-19299.0,328.0,328.0,2014-01-20,-27.0,-20.0,-32.0,0.0005,23.0,0.0,0.3236,0.0,0.5690945320786457,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,100.0,,t1,t2,m0,t1c,,t2c,0.1,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,10.78344347,0:ALIVE OR DEAD TUMOR FREE,10.78344347,0:CENSORED,10.78344347,0:DiseaseFree,10.78344347,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,4.047424964883363,4.626830421961589,7.901779823450838,4.54825781807666,7.100203967443727
TCGA-J4-A83L,TCGA-J4-A83L-01,61,Male,0.0,EUR,ABS - Lahey Clinic,-22338.0,720.0,720.0,2014-01-20,,,,0.0099,14.0,0.0,0.3289,0.0,0.4054651081081644,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,100.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,23.67097347,0:ALIVE OR DEAD TUMOR FREE,23.67097347,0:CENSORED,23.67097347,0:DiseaseFree,23.67097347,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.1259486020433327,3.6107709196795774,7.8405123299857955,3.774976771406596,7.221287434889145
TCGA-J4-A83M,TCGA-J4-A83M-01,64,Male,0.0,EUR,ABS - Lahey Clinic,-23624.0,543.0,543.0,2014-01-20,-29.0,-18.0,-32.0,0.0102,30.0,0.0,0.3224,0.0,0.6931471805599453,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,101.0,N0,t2,t2,m0,t2c,n0,t2c,0.2,4.0,3.0,7.0,668.0,720.0,True,False,False,Complete Remission/Response,,True,0:LIVING,17.85185916,0:ALIVE OR DEAD TUMOR FREE,17.85185916,1:PROGRESSION,17.12857941,1:Recurred/Progressed,17.12857941,Biochemical evidence of disease,R1,1.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,3.5771870997160127,4.296361958740433,8.210945003774466,3.8872620523655055,7.55864877116917
TCGA-J4-A83N,TCGA-J4-A83N-01,57,Male,0.0,EUR,ABS - Lahey Clinic,-20841.0,992.0,992.0,2014-01-20,-21.0,-20.0,-22.0,0.0351,15.0,1.0,0.3325,0.0,0.4054651081081644,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,296.0,,t1,t2,m0,t1c,,t2c,0.1,3.0,4.0,7.0,488.0,561.0,True,False,True,Complete Remission/Response,False,True,0:LIVING,32.61334122,0:ALIVE OR DEAD TUMOR FREE,32.61334122,1:PROGRESSION,14.23546043,0:DiseaseFree,32.61334122,New Primary Tumor,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.538277412047767,3.864404080404781,7.642362227148312,4.339180151925242,7.394153972003023
TCGA-J4-AATV,TCGA-J4-AATV-01,71,Male,0.0,EUR,ABS - Lahey Clinic,-25943.0,553.0,553.0,2014-08-13,,,,0.0002,3.0,0.0,0.3229,0.01,0.1251631426598883,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,115.0,N0,,t2,m0,,n0,t2c,0.0,3.0,3.0,6.0,,0.0,False,False,False,Partial Remission/Response,,False,0:LIVING,18.18062268,0:ALIVE OR DEAD TUMOR FREE,18.18062268,0:CENSORED,18.18062268,,,,R1,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.528246238305167,4.067423604369427,7.684871323165644,3.574707046415546,6.953193055888447
TCGA-J4-AATZ,TCGA-J4-AATZ-01,66,Male,0.0,EAS_OTHER_OR_MISSING,ABS - Lahey Clinic,-24226.0,412.0,412.0,2014-08-14,,,,0.1118,35.0,1.0,0.3366,0.0,0.773189888387328,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,118.0,N0,,t3/t4,m0,,n0,t3a,0.0,4.0,5.0,9.0,142.0,236.0,True,True,False,No Treatment Indicated,True,True,0:LIVING,13.54505704,0:ALIVE OR DEAD TUMOR FREE,13.54505704,1:PROGRESSION,2.597231811,1:Recurred/Progressed,2.597231811,Biochemical evidence of disease,R1,1.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,4.431495932778397,4.048401862828101,8.888823599295863,3.812847305029469,5.654097512813201
TCGA-J4-AAU2,TCGA-J4-AAU2-01,59,Male,0.0,EUR,ABS - Lahey Clinic,-21656.0,825.0,825.0,2014-08-14,,,,0.0006,26.0,0.0,0.3409,0.0,0.6241543092515653,"Prostate Adenocarcinoma, Acinar Type",0.0,95.0,145.0,N0,,t2,m0,,n0,t2c,0.0,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,27.12299043,0:ALIVE OR DEAD TUMOR FREE,27.12299043,0:CENSORED,27.12299043,0:DiseaseFree,27.12299043,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0884469327440183,3.275483892667288,7.506796298668502,4.452529544677926,5.852595673673598
TCGA-J9-A52B,TCGA-J9-A52B-01,62,Male,0.0,EUR,Melbourne Health,-22849.0,422.0,422.0,2013-03-14,-25.0,-22.0,-32.0,0.0615,35.0,5.0,0.2999,0.05,0.7576857015412665,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,120.0,N0,t3/t4,t3/t4,,t3b,n0,t3b,0.01,5.0,4.0,9.0,88.0,198.0,True,True,False,No Treatment Indicated,,True,0:LIVING,13.87382056,0:ALIVE OR DEAD TUMOR FREE,13.87382056,1:PROGRESSION,1.873952066,1:Recurred/Progressed,1.873952066,Biochemical evidence of disease,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,1.9831304246500725,3.474085548443669,7.831673967958594,4.50721744673595,6.050503874112317
TCGA-J9-A52C,TCGA-J9-A52C-01,57,Male,0.0,EUR,Melbourne Health,-20966.0,178.0,178.0,2013-03-14,,,,0.0,488.0,1.0,0.3817,0.23,2.8507065015037334,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,146.0,,t1,t3/t4,,t1c,,t3b,0.03,4.0,5.0,9.0,,0.0,False,False,False,No Treatment Indicated,,False,0:LIVING,5.851990663,0:ALIVE OR DEAD TUMOR FREE,5.851990663,0:CENSORED,5.851990663,,,,R0,0.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,1.5937362077871722,3.2580515183219823,7.053966053853459,4.012488223581147,6.459503751586033
TCGA-J9-A52D,TCGA-J9-A52D-01,71,Male,0.0,EUR,Melbourne Health,-26023.0,212.0,212.0,2014-04-09,,,,,35.0,,0.3015,0.11,0.773189888387328,"Prostate Adenocarcinoma, Other Subtype",0.0,80.0,102.0,,t2,t3/t4,m0,t2b,,t3a,0.059,4.0,5.0,9.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,6.969786633,0:ALIVE OR DEAD TUMOR FREE,6.969786633,0:CENSORED,6.969786633,,,,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,2.292752306171469,3.4295088459761645,7.562897976338434,4.966407394337749,6.637689936523159
TCGA-J9-A52E,TCGA-J9-A52E-01,65,Male,0.0,EUR,Melbourne Health,-23741.0,323.0,323.0,2013-03-15,,,,0.232,21.0,16.0,0.3023,0.0,0.5500463367269643,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,153.0,N0,t2,t3/t4,,t2c,n0,t3b,0.01,4.0,5.0,9.0,117.0,165.0,True,True,False,No Treatment Indicated,False,True,0:LIVING,10.61906171,0:ALIVE OR DEAD TUMOR FREE,10.61906171,0:CENSORED,10.61906171,,,,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,0.932136782309658,3.630382171955665,6.715920818822277,5.312262190677633,5.119339575160023
TCGA-J9-A8CK,TCGA-J9-A8CK-01,66,Male,0.0,EUR,Melbourne Health,-24285.0,321.0,321.0,2015-02-06,-25.0,-18.0,-22.0,0.0525,22.0,0.0,0.3289,0.0,0.5500463367269643,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,158.0,,t3/t4,t3/t4,m0,t3a,,t3a,0.01,4.0,5.0,9.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,10.55330901,0:ALIVE OR DEAD TUMOR FREE,10.55330901,0:CENSORED,10.55330901,,,,R1,1.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,3.4519100313047546,4.412124373727025,7.204671884860139,3.856318450845235,6.727077729016728
TCGA-J9-A8CL,TCGA-J9-A8CL-01,66,Male,0.0,EUR,Melbourne Health,-24145.0,405.0,405.0,2015-01-27,-21.0,-12.0,-30.0,0.2882,41.0,3.0,0.325,0.0,0.8754687373538999,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,101.0,,t3/t4,t3/t4,m0,t3a,,t3b,12.01,4.0,5.0,9.0,,0.0,,False,False,No Treatment Indicated,True,True,0:LIVING,13.31492258,0:ALIVE OR DEAD TUMOR FREE,13.31492258,1:PROGRESSION,4.339678469,,,Biochemical evidence of disease,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.1636436385697166,4.355382813341191,7.485432462686738,3.331676557194749,6.467064234130859
TCGA-J9-A8CM,TCGA-J9-A8CM-01,66,Male,0.0,EUR,Melbourne Health,-24118.0,463.0,463.0,2015-02-01,-27.0,-22.0,-40.0,0.1541,62.0,1.0,0.3135,0.0,1.1420974005014657,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,251.0,N1,t2,t3/t4,m0,t2c,n1,t3b,0.55,5.0,4.0,9.0,,0.0,False,False,False,No Treatment Indicated,True,True,0:LIVING,15.221751,0:ALIVE OR DEAD TUMOR FREE,15.221751,1:PROGRESSION,11.3094651,,,Biochemical evidence of disease,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.507642435770272,4.002999488792416,7.834650546108512,5.371708699967786,6.932591545927053
TCGA-J9-A8CN,TCGA-J9-A8CN-01,53,Male,1.0,EUR,Melbourne Health,-19662.0,1237.0,1237.0,2015-02-01,-17.0,-18.0,-20.0,0.0641,19.0,1.0,0.3236,0.0,0.4906229162443896,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,103.0,,t1,t3/t4,m0,t1c,,t3a,0.03,3.0,3.0,6.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,40.66804747,0:ALIVE OR DEAD TUMOR FREE,40.66804747,0:CENSORED,40.66804747,0:DiseaseFree,40.66804747,,R1,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,2.875367243849589,2.869318694828905,6.422098414644339,4.130683811851551,6.433999309035355
TCGA-J9-A8CP,TCGA-J9-A8CP-01,66,Male,0.0,EUR,Melbourne Health,-24299.0,386.0,386.0,2015-02-01,-27.0,-22.0,-30.0,0.1271,27.0,1.0,0.3121,0.0,0.6418538861723947,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,146.0,,t2,t3/t4,m0,t2a,,t3a,0.01,4.0,3.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,12.69027189,0:ALIVE OR DEAD TUMOR FREE,12.69027189,0:CENSORED,12.69027189,0:DiseaseFree,12.69027189,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,3.4921480171693755,3.698385189898527,7.452554253789933,4.224704032961932,6.1748018749842455
TCGA-KC-A4BL,TCGA-KC-A4BL-01,65,Male,0.0,AFR,Cornell Medical College,-24081.0,934.0,934.0,2015-01-23,-35.0,-24.0,-36.0,0.0,14.0,0.0,0.2964,0.0,0.4054651081081644,"Prostate Adenocarcinoma, Acinar Type",0.0,65.0,300.0,N0,t1,t2,m0,t1c,n0,t2c,3.15,3.0,4.0,7.0,,0.0,,False,False,No Treatment Indicated,True,True,0:LIVING,30.70651281,0:ALIVE OR DEAD TUMOR FREE,30.70651281,1:PROGRESSION,6.345135944,,,Biochemical evidence of disease,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.7141355938563327,4.082566351071412,8.089124166052477,3.7806355612107234,6.794019395672612
TCGA-KC-A4BN,TCGA-KC-A4BN-01,55,Male,0.0,AFR,Cornell Medical College,-20392.0,1815.0,1815.0,2014-07-22,-25.0,-22.0,-30.0,0.0,20.0,0.0,0.3244,0.0,0.5108256239659906,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,125.0,N0,t1,t2,m0,t1c,n0,t2a,0.0,3.0,4.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,,0:LIVING,59.67057895,0:ALIVE OR DEAD TUMOR FREE,59.67057895,0:CENSORED,59.67057895,0:DiseaseFree,59.67057895,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.7232090396410387,3.5968278305006414,8.191676146352428,4.2886021902212965,6.594012515047218
TCGA-KC-A4BO,TCGA-KC-A4BO-01,55,Male,0.0,AFR,Cornell Medical College,-20368.0,607.0,607.0,2015-01-23,,,,0.0002,2.0,,0.323,0.0,0.0645385214500711,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,270.0,N0,t1,t2,m0,t1c,n0,t2c,0.04,3.0,4.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,19.95594569,0:ALIVE OR DEAD TUMOR FREE,19.95594569,0:CENSORED,19.95594569,0:DiseaseFree,19.95594569,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,,,,,
TCGA-KC-A4BR,TCGA-KC-A4BR-01,75,Male,0.0,EUR,Cornell Medical College,-27741.0,1349.0,1349.0,2015-01-23,-23.0,-22.0,-22.0,0.0,8.0,,0.3234,0.0,0.2363887783273882,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,120.0,N1,t2,t3/t4,m0,t2,n1,t3b,0.0,4.0,5.0,9.0,1079.0,1197.0,True,True,False,No Treatment Indicated,True,True,0:LIVING,44.3501989,0:ALIVE OR DEAD TUMOR FREE,44.3501989,1:PROGRESSION,33.59963179,1:Recurred/Progressed,33.59963179,Biochemical evidence of disease,R0,0.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.9022279731938543,3.797708210061545,6.976849340730899,3.3015583827152986,7.69183632317081
TCGA-KC-A4BV,TCGA-KC-A4BV-01,66,Male,0.0,EAS_OTHER_OR_MISSING,Cornell Medical College,-24138.0,1328.0,1328.0,2014-07-22,-37.0,-24.0,-52.0,0.1314,34.0,2.0,0.3105,0.0,0.7576857015412665,"Prostate Adenocarcinoma, Acinar Type",0.0,75.0,225.0,N0,t2,t3/t4,m0,t2,n0,t3a,0.53,4.0,5.0,9.0,,0.0,False,False,False,No Treatment Indicated,True,True,0:LIVING,43.65979551,0:ALIVE OR DEAD TUMOR FREE,43.65979551,1:PROGRESSION,43.65979551,1:Recurred/Progressed,43.65979551,Biochemical evidence of disease,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,3.063779029770571,3.97820478380896,8.521996881029198,4.4088137426749565,5.145828237475548
TCGA-KC-A7F3,TCGA-KC-A7F3-01,67,Male,0.0,EUR,Cornell Medical College,-24676.0,665.0,665.0,2015-01-23,-17.0,-22.0,-4.0,0.0563,23.0,0.0,0.3208,0.0,0.5690945320786457,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,700.0,N0,t1,t2,m0,t1c,n0,t2c,0.0,3.0,4.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,21.86277411,0:ALIVE OR DEAD TUMOR FREE,21.86277411,0:CENSORED,21.86277411,0:DiseaseFree,21.86277411,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.6488680529243287,4.138298426418839,7.62610835948202,5.625553973309956,6.804244624910476
TCGA-KC-A7F5,TCGA-KC-A7F5-01,54,Male,0.0,EUR,Cornell Medical College,-20015.0,91.0,91.0,2015-01-25,,,,,30.0,,0.3311,0.0,0.6931471805599453,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,1230.0,N0,t2,t2,m0,t2c,n0,t2c,0.0,4.0,3.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,2.991748036,0:ALIVE OR DEAD TUMOR FREE,2.991748036,0:CENSORED,2.991748036,0:DiseaseFree,2.991748036,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,3.2348998000678204,4.250825177848784,7.856474707035755,5.810774690220393,5.637801495545571
TCGA-KC-A7F6,TCGA-KC-A7F6-01,63,Male,0.0,EUR,Cornell Medical College,-23367.0,263.0,263.0,2015-01-25,-29.0,-22.0,-16.0,0.0466,22.0,2.0,0.3256,0.0,0.5500463367269643,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,550.0,N0,t1,t2,m0,t1c,n0,t2c,0.0,3.0,4.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,8.646480587,0:ALIVE OR DEAD TUMOR FREE,8.646480587,0:CENSORED,8.646480587,0:DiseaseFree,8.646480587,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.9063518888950752,4.642487866188056,7.548991400723216,3.8619851305855377,7.193178382038329
TCGA-KC-A7FA,TCGA-KC-A7FA-01,63,Male,1.0,EUR,Cornell Medical College,-23208.0,598.0,598.0,2015-01-25,-11.0,-22.0,-22.0,0.074,36.0,3.0,0.3437,0.0,0.8183103236610101,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,630.0,N0,t2,t3/t4,m0,t2c,n0,t3a,0.0,3.0,4.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,19.66005852,0:ALIVE OR DEAD TUMOR FREE,19.66005852,0:CENSORED,19.66005852,0:DiseaseFree,19.66005852,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.6970509567880807,4.231647444918946,6.406926066400599,4.254359722107218,5.88356950000064
TCGA-KC-A7FD,TCGA-KC-A7FD-01,62,Male,0.0,EUR,Cornell Medical College,-22745.0,270.0,270.0,2015-01-25,-15.0,-20.0,2.0,0.0153,38.0,1.0,0.3307,0.0,0.8183103236610101,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,360.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.0,3.0,4.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,8.876615051,0:ALIVE OR DEAD TUMOR FREE,8.876615051,0:CENSORED,8.876615051,0:DiseaseFree,8.876615051,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,4.567600204766564,4.19001427068544,8.516582135159965,5.117495577954242,6.465894493897394
TCGA-KC-A7FE,TCGA-KC-A7FE-01,62,Male,0.0,EUR,Cornell Medical College,-22718.0,352.0,352.0,2015-01-25,-37.0,-26.0,-26.0,0.0,7.0,,0.3344,0.0,0.2097205307117988,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,350.0,N0,t1,t2,m0,t1c,n0,t2c,0.0,3.0,4.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,11.57247592,0:ALIVE OR DEAD TUMOR FREE,11.57247592,0:CENSORED,11.57247592,0:DiseaseFree,11.57247592,,R1,1.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.4278877121851625,3.443686209670219,7.336724342344625,4.042548037802283,5.8906996042329
TCGA-KK-A59V,TCGA-KK-A59V-01,64,Male,0.0,EUR,MD Anderson Cancer Center,-23483.0,3440.0,3440.0,2014-03-27,,,,0.0273,761.0,1.0,0.5438,7.58,3.27965729725353,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,108.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3b,0.1,4.0,5.0,9.0,,0.0,False,False,False,Complete Remission/Response,False,,0:LIVING,113.094651,0:ALIVE OR DEAD TUMOR FREE,113.094651,0:CENSORED,113.094651,0:DiseaseFree,113.094651,,R0,0.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,0.8768017739782707,3.56346323668308,5.977985068720672,4.944642962274664,3.9786258108882873
TCGA-KK-A59X,TCGA-KK-A59X-01,55,Male,0.0,AFR,MD Anderson Cancer Center,-20416.0,2535.0,2535.0,2013-05-28,11.0,-6.0,8.0,0.1551,45.0,1.0,0.3164,0.06,0.9162907318741552,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,140.0,N1,t3/t4,t3/t4,m0,t3a,n1,t3b,,5.0,4.0,9.0,298.0,2455.0,True,True,True,No Treatment Indicated,False,True,0:LIVING,83.34155242,0:ALIVE OR DEAD TUMOR FREE,83.34155242,1:PROGRESSION,73.41289411,,,Locoregional Recurrence,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,2.0202710529837384,3.75944349172384,7.488039345052086,5.001063595440027,4.154542705187375
TCGA-KK-A59Y,TCGA-KK-A59Y-01,56,Male,0.0,EUR,MD Anderson Cancer Center,-20768.0,1968.0,1968.0,2013-05-28,-17.0,-22.0,-30.0,0.1105,23.0,2.0,0.3093,0.0,0.5690945320786457,"Prostate Adenocarcinoma, Acinar Type",5.0,70.0,100.0,N1,t3/t4,t3/t4,m0,t3a,n1,t3a,0.1,4.0,5.0,9.0,71.0,1072.0,True,True,False,Complete Remission/Response,False,False,0:LIVING,64.70066082,0:ALIVE OR DEAD TUMOR FREE,64.70066082,0:CENSORED,64.70066082,0:DiseaseFree,64.70066082,,RX,0.0,0.0,1.0,0.0,1.0,0.0,3.0,5.0,2.77856605128561,3.699473899015116,8.085845798671599,5.719175224655202,4.818170559251088
TCGA-KK-A59Z,TCGA-KK-A59Z-01,66,Male,0.0,AFR,MD Anderson Cancer Center,-24306.0,2628.0,2628.0,2013-05-28,-23.0,-22.0,-22.0,0.3999,48.0,14.0,0.31,0.0,0.9808292531367264,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,120.0,N0,t2,t2,m0,t2b,n0,t2c,0.1,4.0,3.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,,0:LIVING,86.39905316,0:ALIVE OR DEAD TUMOR FREE,86.39905316,0:CENSORED,86.39905316,,,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,1.5558652254870076,3.0530765723047906,6.317115903648544,3.7173309573364928,5.608489922371531
TCGA-KK-A5A1,TCGA-KK-A5A1-01,72,Male,0.0,AFR,MD Anderson Cancer Center,-26415.0,2364.0,2364.0,2013-05-28,,,,,92.0,,0.327,0.0,1.410986973710262,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,108.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3b,0.1,4.0,5.0,9.0,,0.0,False,False,False,No Treatment Indicated,,,1:DECEASED,81.17171319,,81.17171319,1:PROGRESSION,6.673899464,,,Locoregional Recurrence,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,2.298247734166577,3.3607013810798327,6.7794343988361,4.487769303864421,6.70398937146176
TCGA-KK-A6DY,TCGA-KK-A6DY-01,50,Male,0.0,AFR,MD Anderson Cancer Center,-18420.0,4295.0,4295.0,2014-03-27,-33.0,-20.0,-36.0,0.0995,27.0,6.0,0.3423,0.0,0.6418538861723947,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,120.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,No Treatment Indicated,True,,0:LIVING,141.203932,0:ALIVE OR DEAD TUMOR FREE,141.203932,0:CENSORED,141.203932,,,,R1,1.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.7209788451443524,4.437886870119232,8.150193574692713,4.377193174554341,7.18773014338737
TCGA-KK-A6E0,TCGA-KK-A6E0-01,59,Male,0.0,EAS_OTHER_OR_MISSING,MD Anderson Cancer Center,-21700.0,1483.0,1483.0,2014-03-27,-9.0,-18.0,-2.0,0.1489,20.0,1.0,0.3138,0.0,0.5306282510621704,"Prostate Adenocarcinoma, Acinar Type",5.0,80.0,140.0,N0,t2,t3/t4,m0,t2b,n0,t3a,0.3,4.0,5.0,9.0,424.0,605.0,True,True,False,Complete Remission/Response,True,False,0:LIVING,48.75563008,0:ALIVE OR DEAD TUMOR FREE,48.75563008,1:PROGRESSION,30.93664727,1:Recurred/Progressed,30.93664727,Biochemical evidence of disease,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,2.430097897817976,3.676966918665335,7.4055652723440355,5.931796501750706,5.889278833705537
TCGA-KK-A6E1,TCGA-KK-A6E1-01,57,Male,0.0,EUR,MD Anderson Cancer Center,-21063.0,2198.0,2198.0,2014-03-28,-7.0,-14.0,-22.0,0.2188,22.0,7.0,0.342,0.07,0.5500463367269643,"Prostate Adenocarcinoma, Acinar Type",10.0,90.0,450.0,N1,t2,t3/t4,m0,t2c,n1,t3b,0.1,4.0,5.0,9.0,107.0,778.0,True,True,False,Complete Remission/Response,False,,0:LIVING,72.26222178,0:ALIVE OR DEAD TUMOR FREE,72.26222178,0:CENSORED,72.26222178,0:DiseaseFree,72.26222178,,RX,0.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.1290521672699576,4.402578936963313,8.47223836512123,5.3649995748700725,5.640505248683442
TCGA-KK-A6E2,TCGA-KK-A6E2-01,54,Male,0.0,AFR,MD Anderson Cancer Center,-19974.0,5024.0,5024.0,2014-03-27,-33.0,-18.0,-48.0,0.0154,35.0,0.0,0.3365,0.02,0.7884573603642703,"Prostate Adenocarcinoma, Acinar Type",0.0,100.0,105.0,N0,t2,t2,m0,t2a,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,,0:LIVING,165.1707927,0:ALIVE OR DEAD TUMOR FREE,165.1707927,0:CENSORED,165.1707927,0:DiseaseFree,165.1707927,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.1389291199469334,3.342611632961442,8.335365341807655,5.228518578714668,7.583507801470027
TCGA-KK-A6E3,TCGA-KK-A6E3-01,56,Male,0.0,AFR,MD Anderson Cancer Center,-20547.0,2056.0,2056.0,2014-03-27,,,,0.0003,31.0,0.0,0.3074,0.0,0.7259370035442264,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,150.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,67.59377979,0:ALIVE OR DEAD TUMOR FREE,67.59377979,0:CENSORED,67.59377979,,,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.585419281830912,2.2928406335380065,6.496922466008071,3.6289718500970944,4.488720652895283
TCGA-KK-A6E4,TCGA-KK-A6E4-01,69,Male,0.0,AFR,MD Anderson Cancer Center,-25338.0,2753.0,2753.0,2014-03-27,,,,0.1139,29.0,0.0,0.3064,0.0,0.6763400624130557,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,120.0,N0,t1,t2,m0,t1c,n0,t2b,0.1,3.0,4.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,,1:DECEASED,115.1329848,0:ALIVE OR DEAD TUMOR FREE,115.1329848,0:CENSORED,115.1329848,0:DiseaseFree,115.1329848,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.7006838458762474,3.330916878114617,6.882919335683776,5.420479033525097,7.038763191757983
TCGA-KK-A6E5,TCGA-KK-A6E5-01,63,Male,0.0,AFR,MD Anderson Cancer Center,-23144.0,2073.0,2073.0,2014-03-27,-21.0,-28.0,-20.0,0.0884,19.0,1.0,0.3389,0.0,0.5108256239659906,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,150.0,N0,t1,t3/t4,m0,t1c,n0,t3b,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,68.15267778,0:ALIVE OR DEAD TUMOR FREE,68.15267778,0:CENSORED,68.15267778,0:DiseaseFree,68.15267778,,R0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.0,2.115898866655386,3.209219396110764,7.548599226992734,4.632308936155821,6.45495067297589
TCGA-KK-A6E6,TCGA-KK-A6E6-01,69,Male,0.0,EUR,MD Anderson Cancer Center,-25320.0,3447.0,3447.0,2014-03-27,-17.0,-16.0,-16.0,0.0436,33.0,9.0,0.3151,0.0,0.7576857015412665,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,180.0,N0,t2,t3/t4,m0,t2b,n0,t3a,0.1,4.0,5.0,9.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,113.3247855,0:ALIVE OR DEAD TUMOR FREE,113.3247855,0:CENSORED,113.3247855,,,,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,2.739826505306519,2.8993883446299864,7.210609982286565,4.4988635636189525,5.9977304795637245
TCGA-KK-A6E7,TCGA-KK-A6E7-01,46,Male,0.0,EAS_OTHER_OR_MISSING,MD Anderson Cancer Center,-17074.0,2760.0,2760.0,2014-03-27,,,,0.0965,24.0,6.0,0.3293,0.0,0.5877866649021191,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,150.0,N1,t1,t3/t4,m0,t1c,n1,t3a,0.1,5.0,4.0,9.0,,0.0,False,False,False,Partial Remission/Response,True,True,0:LIVING,90.73873163,0:ALIVE OR DEAD TUMOR FREE,90.73873163,1:PROGRESSION,30.41062564,,,Biochemical evidence of disease,R1,1.0,0.0,1.0,0.0,1.0,0.0,3.0,5.0,1.3817817223280793,3.120866148926725,8.931243374605431,1.4065910899649297,2.500445158552971
TCGA-KK-A6E8,TCGA-KK-A6E8-01,68,Male,0.0,EUR,MD Anderson Cancer Center,-25026.0,1770.0,1770.0,2014-03-27,,,,0.2482,37.0,7.0,0.3175,0.0,0.8183103236610101,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,240.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,4.0,5.0,9.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,58.19114311,0:ALIVE OR DEAD TUMOR FREE,58.19114311,0:CENSORED,58.19114311,,,,RX,0.0,0.0,0.0,0.0,0.0,0.0,3.0,5.0,1.678748009963357,2.856149102318409,6.810989281087723,5.531184928670972,5.527079721509892
TCGA-KK-A7AP,TCGA-KK-A7AP-01,55,Male,1.0,EAS_OTHER_OR_MISSING,MD Anderson Cancer Center,-20403.0,196.0,196.0,2014-06-06,-17.0,-26.0,-16.0,0.1799,32.0,4.0,0.3362,0.03,0.7259370035442264,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,140.0,N1,t2,t3/t4,m0,t2b,n1,t3b,,4.0,5.0,9.0,,0.0,,False,False,No Treatment Indicated,,,0:LIVING,6.443765,0:ALIVE OR DEAD TUMOR FREE,6.443765,0:CENSORED,6.443765,,,,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.874295328273675,4.731661163771682,8.462310036779932,5.40317226676856,7.219847105293252
TCGA-KK-A7AQ,TCGA-KK-A7AQ-01,62,Male,0.0,EUR,MD Anderson Cancer Center,-22731.0,1610.0,1610.0,2014-08-19,,,,0.1193,33.0,1.0,0.3307,0.0,0.7419373447293773,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,120.0,N0,t2,t2,m0,t2a,n0,t2c,0.1,4.0,3.0,7.0,1219.0,,False,True,False,Complete Remission/Response,False,False,0:LIVING,52.93092678,0:ALIVE OR DEAD TUMOR FREE,52.93092678,1:PROGRESSION,40.01052043,1:Recurred/Progressed,40.01052043,Biochemical evidence of disease,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,2.297631642895129,3.5472277070956784,7.190610909779552,5.008509298683096,4.62924003395155
TCGA-KK-A7AU,TCGA-KK-A7AU-01,63,Male,0.0,EUR,MD Anderson Cancer Center,-23118.0,1775.0,1775.0,2014-08-28,-19.0,-20.0,-28.0,0.1196,18.0,2.0,0.3338,0.0,0.4700036292457356,"Prostate Adenocarcinoma, Acinar Type",1.0,70.0,120.0,N1,t2,t3/t4,m0,t2b,n1,t3b,0.0,4.0,5.0,9.0,207.0,1406.0,True,True,False,Progressive Disease,False,False,0:LIVING,58.35552487,0:ALIVE OR DEAD TUMOR FREE,58.35552487,1:PROGRESSION,6.805404872,,,Biochemical evidence of disease,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.496551828158504,4.924674758244381,8.04995851673045,4.939052578590133,6.093564401481364
TCGA-KK-A7AV,TCGA-KK-A7AV-01,58,Male,0.0,AFR,MD Anderson Cancer Center,-21192.0,822.0,822.0,2014-08-28,-31.0,-22.0,-34.0,0.0418,14.0,2.0,0.3364,0.05,0.4054651081081644,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,160.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,27.02436138,0:ALIVE OR DEAD TUMOR FREE,27.02436138,0:CENSORED,27.02436138,0:DiseaseFree,27.02436138,,RX,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.9056012120282046,4.5478076205263225,7.633543099165548,4.562773604596222,6.20101234915241
TCGA-KK-A7AW,TCGA-KK-A7AW-01,57,Male,0.0,AFR,MD Anderson Cancer Center,-20869.0,1054.0,1054.0,2014-08-19,,,,0.0705,25.0,1.0,0.3206,0.0,0.6061358033884974,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,84.0,N1,t2,t3/t4,m0,t2a,n1,t3a,0.8,4.0,3.0,7.0,,0.0,,False,False,No Treatment Indicated,False,,0:LIVING,34.65167505,0:ALIVE OR DEAD TUMOR FREE,34.65167505,0:CENSORED,34.65167505,,,,R0,0.0,0.0,1.0,0.0,1.0,1.0,2.0,3.0,0.4896456880402872,1.8701476824663603,6.596836773462738,5.210229093021324,4.953805333595902
TCGA-KK-A7AY,TCGA-KK-A7AY-01,60,Male,0.0,EUR,MD Anderson Cancer Center,-22220.0,1754.0,1754.0,2014-08-28,,,,0.0642,42.0,0.0,0.3325,0.0,0.8754687373538999,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,72.0,N0,t2,t2,m0,t2a,n0,t2c,0.2,4.0,3.0,7.0,1161.0,1211.0,True,False,False,Complete Remission/Response,False,False,0:LIVING,57.66512148,0:ALIVE OR DEAD TUMOR FREE,57.66512148,1:PROGRESSION,36.95301969,1:Recurred/Progressed,36.95301969,Biochemical evidence of disease,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,2.6507645591169022,2.93973434711047,7.415057223490272,5.4052708317583775,5.93718429308651
TCGA-KK-A7AZ,TCGA-KK-A7AZ-01,56,Male,0.0,EUR,MD Anderson Cancer Center,-20507.0,1519.0,1519.0,2014-08-19,,,,0.1127,33.0,4.0,0.3182,0.0,0.7419373447293773,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,100.0,N0,t2,t3/t4,,t2b,n0,t3a,,4.0,3.0,7.0,,0.0,,False,False,No Treatment Indicated,,,0:LIVING,49.93917875,0:ALIVE OR DEAD TUMOR FREE,49.93917875,0:CENSORED,49.93917875,,,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,2.829585751823088,4.691444831191138,7.06672103863322,5.070676979473933,6.988280221077036
TCGA-KK-A7B0,TCGA-KK-A7B0-01,67,Male,0.0,EUR,MD Anderson Cancer Center,-24756.0,1329.0,1329.0,2014-08-28,,,,0.1451,27.0,2.0,0.3268,0.0,0.6418538861723947,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,180.0,N0,t2,t3/t4,m0,t2b,n0,t3b,0.1,4.0,5.0,9.0,640.0,696.0,True,True,False,Stable Disease,,False,0:LIVING,43.69267186,0:ALIVE OR DEAD TUMOR FREE,43.69267186,1:PROGRESSION,19.92306934,,,Biochemical evidence of disease,R0,0.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,1.7372541043243297,2.2817575885202954,6.509729090667746,5.009190388012466,5.750140179594887
TCGA-KK-A7B1,TCGA-KK-A7B1-01,65,Male,0.0,EUR,MD Anderson Cancer Center,-23803.0,1063.0,1063.0,2014-06-06,-27.0,-22.0,-22.0,0.0261,18.0,0.0,0.3404,0.0,0.4906229162443896,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,144.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,,,0:LIVING,34.94756222,0:ALIVE OR DEAD TUMOR FREE,34.94756222,0:CENSORED,34.94756222,0:DiseaseFree,34.94756222,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,3.350412380173853,4.291574090919157,7.578805906600527,4.256852154504361,6.230172265062604
TCGA-KK-A7B2,TCGA-KK-A7B2-01,68,Male,0.0,EUR,MD Anderson Cancer Center,-24845.0,1099.0,1099.0,2014-06-06,,,,0.0,17.0,0.0,0.3301,0.0,0.4274440146095482,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,182.0,N1,t1,t3/t4,m0,t1c,n1,t3a,0.3,4.0,5.0,9.0,,0.0,False,False,False,Stable Disease,True,True,0:LIVING,36.13111089,0:ALIVE OR DEAD TUMOR FREE,36.13111089,1:PROGRESSION,22.75043561,,,Biochemical evidence of disease,R0,0.0,0.0,1.0,0.0,1.0,0.0,3.0,5.0,2.480420242213839,3.198981255998624,7.199520215910149,3.977408157359908,5.792899590168542
TCGA-KK-A7B3,TCGA-KK-A7B3-01,62,Male,1.0,EUR,MD Anderson Cancer Center,-22830.0,899.0,899.0,2014-08-28,-21.0,-18.0,-14.0,0.0843,29.0,1.0,0.3256,0.01,0.6592456287118501,"Prostate Adenocarcinoma, Acinar Type",1.0,80.0,234.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3b,0.1,4.0,5.0,9.0,,0.0,False,False,False,Complete Remission/Response,False,True,0:LIVING,29.55584048,0:ALIVE OR DEAD TUMOR FREE,29.55584048,1:PROGRESSION,9.6656475,1:Recurred/Progressed,9.6656475,Biochemical evidence of disease,R0,0.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,3.0583338147550645,5.328850822189949,7.653110189449974,4.806726182232949,5.273400260595233
TCGA-KK-A7B4,TCGA-KK-A7B4-01,64,Male,1.0,EUR,MD Anderson Cancer Center,-23644.0,987.0,987.0,2014-08-28,-15.0,-18.0,-18.0,0.204,26.0,4.0,0.3133,0.09,0.6241543092515653,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,224.0,N1,t3/t4,t3/t4,m0,t3b,n1,t3b,0.6,4.0,5.0,9.0,119.0,439.0,False,True,False,Stable Disease,True,True,0:LIVING,32.44895946,0:ALIVE OR DEAD TUMOR FREE,32.44895946,1:PROGRESSION,20.94223625,,,Biochemical evidence of disease,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,2.7737221026252934,4.302786955208793,8.22105199241308,4.278735645660858,6.817464654658038
TCGA-KK-A8I4,TCGA-KK-A8I4-01,64,Male,0.0,EUR,MD Anderson Cancer Center,-23706.0,2259.0,2259.0,2014-08-28,-23.0,-22.0,-38.0,0.1893,20.0,11.0,0.3235,0.01,0.5306282510621704,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,192.0,N1,t2,t3/t4,m0,t2c,n1,t3b,0.2,4.0,3.0,7.0,1204.0,1984.0,False,True,False,Progressive Disease,True,True,0:LIVING,74.26767926,0:ALIVE OR DEAD TUMOR FREE,74.26767926,1:PROGRESSION,38.20232107,,,Distant Metastasis,R0,0.0,1.0,0.0,0.0,1.0,1.0,2.0,3.0,3.6946462232810062,3.788748344349753,7.242614890341971,3.494095544940634,6.21139384956997
TCGA-KK-A8I5,TCGA-KK-A8I5-01,55,Male,0.0,AFR,MD Anderson Cancer Center,-20337.0,3096.0,3096.0,2014-08-18,-13.0,-16.0,-20.0,0.1006,32.0,0.0,0.3281,0.0,0.7259370035442264,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,80.0,N0,t2,t2,m0,t2a,n0,t2b,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,,0:LIVING,101.7851859,0:ALIVE OR DEAD TUMOR FREE,101.7851859,0:CENSORED,101.7851859,0:DiseaseFree,101.7851859,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.76009317445814,4.12720403886236,7.706900710209461,4.4532014817778975,5.401405198542686
TCGA-KK-A8I6,TCGA-KK-A8I6-01,58,Male,0.0,EUR,MD Anderson Cancer Center,-21499.0,668.0,668.0,2014-08-18,-21.0,-16.0,-28.0,0.061,23.0,0.0,0.3292,0.0,0.5690945320786457,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,192.0,N0,t2,t3/t4,m0,t2b,n0,t3a,0.2,4.0,3.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,21.96140316,0:ALIVE OR DEAD TUMOR FREE,21.96140316,0:CENSORED,21.96140316,0:DiseaseFree,21.96140316,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,3.6553174783216944,4.243090180931072,8.250620086454887,4.532747085172079,6.980668564055838
TCGA-KK-A8I7,TCGA-KK-A8I7-01,55,Male,0.0,EUR,MD Anderson Cancer Center,-20256.0,2002.0,2002.0,2014-08-18,,,,0.0233,15.0,2.0,0.317,0.0,0.4054651081081644,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,70.0,N0,t2,t3/t4,m0,t2c,n0,t3b,0.1,4.0,5.0,9.0,709.0,1757.0,True,True,False,Progressive Disease,False,True,0:LIVING,65.81845678,0:ALIVE OR DEAD TUMOR FREE,65.81845678,1:PROGRESSION,35.76947102,,,Biochemical evidence of disease,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,3.128260402118226,3.372631772913622,7.304040044742042,3.939160742684463,6.238358878091544
TCGA-KK-A8I8,TCGA-KK-A8I8-01,69,Male,0.0,EUR,MD Anderson Cancer Center,-25546.0,967.0,967.0,2014-08-18,-21.0,-16.0,-24.0,0.1017,16.0,2.0,0.3249,0.0,0.4274440146095482,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,196.0,N0,t2,t3/t4,m0,t2a,n0,t3b,0.1,4.0,5.0,9.0,296.0,340.0,True,False,False,Complete Remission/Response,False,False,0:LIVING,31.79143242,0:ALIVE OR DEAD TUMOR FREE,31.79143242,0:CENSORED,31.79143242,0:DiseaseFree,31.79143242,,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,3.720190893832597,4.269422202612502,8.009611427140436,5.348901621242481,7.151214467641843
TCGA-KK-A8I9,TCGA-KK-A8I9-01,61,Male,0.0,EAS_OTHER_OR_MISSING,MD Anderson Cancer Center,-22295.0,1001.0,1001.0,2014-08-18,-13.0,-26.0,0.0,0.0643,37.0,0.0,0.3312,0.0,0.7884573603642703,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,180.0,N0,t2,t3/t4,m0,t2b,n0,t3a,0.1,4.0,4.0,8.0,151.0,427.0,True,True,False,Complete Remission/Response,False,True,0:LIVING,32.90922839,0:ALIVE OR DEAD TUMOR FREE,32.90922839,1:PROGRESSION,30.90377092,1:Recurred/Progressed,30.90377092,Biochemical evidence of disease,RX,0.0,0.0,1.0,0.0,0.0,0.0,3.0,4.0,3.137946100927408,4.396686973928868,7.401579272391014,4.834372444018075,6.424507287343065
TCGA-KK-A8IA,TCGA-KK-A8IA-01,69,Male,0.0,EUR,MD Anderson Cancer Center,-25284.0,1931.0,1931.0,2014-08-18,-21.0,-12.0,-28.0,0.2758,31.0,2.0,0.3211,0.0,0.7096764823472214,"Prostate Adenocarcinoma, Acinar Type",1.0,90.0,240.0,N1,t3/t4,t3/t4,m0,t3b,n1,t3b,0.1,4.0,5.0,9.0,210.0,,False,True,False,No Treatment Indicated,,,0:LIVING,63.48423579,0:ALIVE OR DEAD TUMOR FREE,63.48423579,0:CENSORED,63.48423579,,,,RX,0.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.2105135518004686,4.501789425931135,8.126612075461447,4.883439979354553,5.67229238159593
TCGA-KK-A8IB,TCGA-KK-A8IB-01,65,Male,1.0,EUR,MD Anderson Cancer Center,-24041.0,83.0,83.0,2014-08-19,-3.0,-10.0,-2.0,0.2666,39.0,7.0,0.3276,0.0,0.8329091229351039,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,300.0,N0,t2,t3/t4,m0,t2a,n0,t3a,,4.0,5.0,9.0,,0.0,,False,False,No Treatment Indicated,,,0:LIVING,2.728737219,0:ALIVE OR DEAD TUMOR FREE,2.728737219,0:CENSORED,2.728737219,,,,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,2.7380976654934197,3.384022168694394,6.926035010922459,4.739961483707463,6.467171861309694
TCGA-KK-A8IC,TCGA-KK-A8IC-01,54,Male,0.0,EUR,MD Anderson Cancer Center,-19902.0,2051.0,2051.0,2014-08-28,-27.0,-22.0,-40.0,0.1252,14.0,5.0,0.3236,0.0,0.4054651081081644,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,224.0,N0,t1,t3/t4,m0,t1c,n0,t3b,0.9,4.0,5.0,9.0,1088.0,1139.0,True,True,False,Progressive Disease,True,True,0:LIVING,67.42939803,0:ALIVE OR DEAD TUMOR FREE,67.42939803,1:PROGRESSION,34.84893316,,,Biochemical evidence of disease,R0,0.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,3.9015523779362113,3.612611995371814,8.209171135177241,3.1773916306649888,6.069214513095533
TCGA-KK-A8ID,TCGA-KK-A8ID-01,70,Male,0.0,EAS_OTHER_OR_MISSING,MD Anderson Cancer Center,-25851.0,2107.0,2107.0,2014-08-18,-23.0,-20.0,-28.0,0.2165,49.0,2.0,0.324,0.0,0.9682504706782838,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,192.0,N1,t2,t3/t4,m0,t2b,n1,t3b,0.1,5.0,4.0,9.0,97.0,1455.0,False,True,False,Complete Remission/Response,False,False,0:LIVING,69.27047375,0:ALIVE OR DEAD TUMOR FREE,69.27047375,0:CENSORED,69.27047375,0:DiseaseFree,69.27047375,,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.4664705096374298,4.576389108774474,8.473820998290728,4.951014220722286,5.9832102477965545
TCGA-KK-A8IF,TCGA-KK-A8IF-01,57,Male,0.0,AFR,MD Anderson Cancer Center,-20888.0,804.0,804.0,2014-08-18,-13.0,-22.0,-24.0,0.2874,24.0,9.0,0.3243,0.02,0.6061358033884974,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,110.0,N0,t2,t3/t4,m0,t2a,n0,t3a,0.7,4.0,3.0,7.0,,0.0,,False,False,No Treatment Indicated,True,True,0:LIVING,26.43258704,0:ALIVE OR DEAD TUMOR FREE,26.43258704,1:PROGRESSION,21.30387612,,,Biochemical evidence of disease,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,3.2214749878453306,3.5570056426190138,7.165808455009019,6.150315957503784,6.780975380839006
TCGA-KK-A8IG,TCGA-KK-A8IG-01,55,Male,0.0,EUR,MD Anderson Cancer Center,-20266.0,2505.0,2505.0,2014-08-19,-19.0,-22.0,-32.0,0.2051,30.0,6.0,0.3341,0.0,0.6931471805599453,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,100.0,N0,t2,t3/t4,m0,t2a,n0,t3a,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,82.35526186,0:ALIVE OR DEAD TUMOR FREE,82.35526186,0:CENSORED,82.35526186,0:DiseaseFree,82.35526186,,R1,1.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,3.120053283525982,3.565121885522595,7.470226915916888,4.198824144173834,6.14188642299604
TCGA-KK-A8IH,TCGA-KK-A8IH-01,50,Male,0.0,EAS_OTHER_OR_MISSING,MD Anderson Cancer Center,-18560.0,2013.0,2013.0,2014-08-19,-25.0,-12.0,-36.0,0.0842,20.0,1.0,0.3267,0.0,0.5108256239659906,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,150.0,N0,t2,t3/t4,m0,t2b,n0,t3a,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,66.18009666,0:ALIVE OR DEAD TUMOR FREE,66.18009666,0:CENSORED,66.18009666,0:DiseaseFree,66.18009666,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,3.372520338849408,4.684184754807231,7.970170328592671,4.596869563849486,6.436531662451071
TCGA-KK-A8II,TCGA-KK-A8II-01,61,Male,0.0,EUR,MD Anderson Cancer Center,-22460.0,,,2014-08-28,-27.0,-10.0,-36.0,0.0532,30.0,1.0,0.3449,0.04,0.6931471805599453,"Prostate Adenocarcinoma, Other Subtype",0.0,80.0,100.0,N0,t2,t3/t4,m0,t2c,n0,t3a,39.8,4.0,5.0,9.0,904.0,3467.0,True,True,True,No Treatment Indicated,True,True,1:DECEASED,113.9823125,1:DEAD WITH TUMOR,113.9823125,1:PROGRESSION,20.58059638,,,Biochemical evidence of disease,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,3.5183966537541638,4.629024324774113,8.268459190620037,4.116647545115124,6.279031065347565
TCGA-KK-A8IJ,TCGA-KK-A8IJ-01,59,Male,0.0,EUR,MD Anderson Cancer Center,-21793.0,1559.0,1559.0,2014-08-19,-21.0,-20.0,-22.0,0.036,25.0,1.0,0.322,0.0,0.6061358033884974,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,84.0,N1,t3/t4,t3/t4,m0,t3a,n1,t3b,0.1,4.0,3.0,7.0,,0.0,,False,False,No Treatment Indicated,,True,0:LIVING,51.25423283,0:ALIVE OR DEAD TUMOR FREE,51.25423283,1:PROGRESSION,10.09304008,,,New Primary Tumor,R0,0.0,1.0,0.0,0.0,1.0,1.0,2.0,3.0,3.467318612706136,3.188638294561388,8.316312308912137,3.844797391073077,5.684675694989593
TCGA-KK-A8IK,TCGA-KK-A8IK-01,56,Male,0.0,EUR,MD Anderson Cancer Center,-20594.0,2052.0,2052.0,2014-08-28,-11.0,0.0,-8.0,0.4633,28.0,14.0,0.3476,0.14,0.6592456287118501,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,56.0,N0,t1,t2,m0,t1c,n0,t2c,0.0,4.0,5.0,9.0,,0.0,False,False,False,Complete Remission/Response,False,,0:LIVING,67.46227439,0:ALIVE OR DEAD TUMOR FREE,67.46227439,0:CENSORED,67.46227439,0:DiseaseFree,67.46227439,,R0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,5.0,3.150592169341025,3.964795988666903,6.741545186442821,5.54541242915416,5.3523877770854815
TCGA-KK-A8IL,TCGA-KK-A8IL-01,65,Male,0.0,AFR,MD Anderson Cancer Center,-23849.0,,,2014-08-19,-21.0,-24.0,-10.0,0.0166,27.0,0.0,0.3313,0.0,0.6418538861723947,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,90.0,N1,t1,t3/t4,m0,t1c,n1,t3b,0.1,4.0,5.0,9.0,,0.0,,False,False,No Treatment Indicated,,,1:DECEASED,20.64634908,,20.64634908,0:CENSORED,20.64634908,,,,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.333080194006724,4.1879577294935775,7.245585980551652,4.052876662156593,6.496516676522542
TCGA-KK-A8IM,TCGA-KK-A8IM-01,55,Male,0.0,EUR,MD Anderson Cancer Center,-20425.0,1915.0,1915.0,2014-08-18,,,,0.0571,25.0,1.0,0.3305,0.0,0.6061358033884974,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,80.0,N0,t2,t2,m0,t2a,n0,t2c,0.1,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,62.95821416,0:ALIVE OR DEAD TUMOR FREE,62.95821416,0:CENSORED,62.95821416,0:DiseaseFree,62.95821416,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,3.4062781483095828,4.259174546190836,8.320359664303675,4.113825496208103,6.177112527727509
TCGA-M7-A71Y,TCGA-M7-A71Y-01,55,Male,0.0,EUR,University of North Carolina,-20357.0,493.0,493.0,2013-12-10,-27.0,-22.0,-24.0,0.0,13.0,3.0,0.3205,0.0,0.3829922524833785,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,280.0,,t1,t2,,t1c,,t2c,,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,16.20804156,0:ALIVE OR DEAD TUMOR FREE,16.20804156,0:CENSORED,16.20804156,0:DiseaseFree,16.20804156,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.9454391541957388,3.73611776175452,7.449860942079042,4.327004652720688,4.733988769968665
TCGA-M7-A71Z,TCGA-M7-A71Z-01,62,Male,0.0,EUR,University of North Carolina,-22785.0,643.0,643.0,2013-12-10,,,,0.0483,25.0,1.0,0.3313,0.0,0.5877866649021191,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,296.0,N0,t2,t3/t4,,t2a,n0,t3a,,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,21.13949436,0:ALIVE OR DEAD TUMOR FREE,21.13949436,0:CENSORED,21.13949436,0:DiseaseFree,21.13949436,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,3.115965431586807,4.22254956348778,6.805737424338145,4.54491189996519,6.879842972601197
TCGA-M7-A720,TCGA-M7-A720-01,53,Male,0.0,EUR,University of North Carolina,-19642.0,384.0,384.0,2013-12-10,-31.0,-18.0,-42.0,0.0,6.0,0.0,0.312,0.0,0.1823215567939546,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,295.0,,t1,t2,,t1c,,t2c,,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,12.62451918,0:ALIVE OR DEAD TUMOR FREE,12.62451918,0:CENSORED,12.62451918,0:DiseaseFree,12.62451918,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.1298599795764868,3.778755266843221,8.353389901339678,3.79464459986288,4.573247266986508
TCGA-M7-A721,TCGA-M7-A721-01,70,Male,0.0,EUR,University of North Carolina,-25585.0,400.0,400.0,2013-12-10,-17.0,-22.0,-32.0,0.0558,29.0,0.0,0.3164,0.04,0.6763400624130557,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,263.0,,t1,t2,m0,t1c,,t2c,,3.0,4.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,,0:LIVING,13.15054082,0:ALIVE OR DEAD TUMOR FREE,13.15054082,0:CENSORED,13.15054082,0:DiseaseFree,13.15054082,,R1,1.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.276154189638599,3.6742459488229193,8.487407964347316,4.556165745429019,6.122117729380523
TCGA-M7-A722,TCGA-M7-A722-01,65,Male,0.0,EUR,University of North Carolina,-23880.0,1060.0,1060.0,2014-03-27,,,,0.0523,32.0,0.0,0.3239,0.0,0.7259370035442264,"Prostate Adenocarcinoma, Acinar Type",5.0,50.0,349.0,N0,t2,t3/t4,m0,t2a,n0,t3a,,4.0,4.0,8.0,,0.0,False,False,False,Partial Remission/Response,True,True,0:LIVING,34.84893316,0:ALIVE OR DEAD TUMOR FREE,34.84893316,1:PROGRESSION,18.37788079,,,Biochemical evidence of disease,R1,1.0,0.0,1.0,0.0,0.0,0.0,3.0,4.0,0.3149864854685155,2.323370069061269,6.546241627709332,5.14115890793091,5.789351055060947
TCGA-M7-A723,TCGA-M7-A723-01,54,Male,0.0,EUR,University of North Carolina,-20064.0,763.0,763.0,2013-12-10,,,,0.0001,3.0,,0.2994,0.07,0.0953101798043249,"Prostate Adenocarcinoma, Acinar Type",5.0,50.0,395.0,N1,t1,t3/t4,m0,t1c,n1,t3b,0.1,4.0,3.0,7.0,74.0,189.0,True,True,False,Complete Remission/Response,False,False,0:LIVING,25.08465661,0:ALIVE OR DEAD TUMOR FREE,25.08465661,0:CENSORED,25.08465661,0:DiseaseFree,25.08465661,,R1,1.0,1.0,0.0,0.0,1.0,1.0,2.0,3.0,2.555570777896172,2.2088917750261534,6.077486561361361,4.050449456487348,4.353132707312395
TCGA-M7-A724,TCGA-M7-A724-01,64,Male,0.0,EUR,University of North Carolina,-23595.0,889.0,889.0,2013-12-10,,,,0.1325,27.0,2.0,0.3212,0.0,0.6418538861723947,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,308.0,N0,t1,t3/t4,m0,t1c,n0,t3a,,4.0,4.0,8.0,179.0,279.0,True,True,False,Progressive Disease,True,True,0:LIVING,29.22707696,0:ALIVE OR DEAD TUMOR FREE,29.22707696,0:CENSORED,29.22707696,,,,R1,1.0,0.0,1.0,0.0,0.0,0.0,3.0,4.0,2.4868945377893583,4.325220892465629,7.350640448675731,6.631412816108066,8.518991023412065
TCGA-M7-A725,TCGA-M7-A725-01,56,Male,0.0,EUR,University of North Carolina,-20474.0,573.0,573.0,2013-12-10,-13.0,-4.0,-14.0,0.1838,27.0,5.0,0.3095,0.11,0.6418538861723947,"Prostate Adenocarcinoma, Acinar Type",5.0,70.0,239.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3b,,4.0,3.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,18.83814972,0:ALIVE OR DEAD TUMOR FREE,18.83814972,0:CENSORED,18.83814972,0:DiseaseFree,18.83814972,,R1,1.0,1.0,0.0,0.0,0.0,1.0,2.0,3.0,3.420980865687691,4.059095652222201,8.417848718315005,4.060151170946765,4.384491944414584
TCGA-MG-AAMC,TCGA-MG-AAMC-01,59,Male,0.0,EAS_OTHER_OR_MISSING,BLN - Baylor,-21846.0,173.0,173.0,2014-07-28,,,,0.0697,22.0,3.0,0.3368,0.05,0.5500463367269643,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,200.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.01,4.0,5.0,9.0,,0.0,False,False,False,Complete Remission/Response,False,,0:LIVING,5.687608903,0:ALIVE OR DEAD TUMOR FREE,5.687608903,0:CENSORED,5.687608903,0:DiseaseFree,5.687608903,,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,2.3572704756795595,3.4518309253395043,6.436148510584727,4.873754150968987,3.573338167745836
TCGA-QU-A6IL,TCGA-QU-A6IL-01,64,Male,0.0,EAS_OTHER_OR_MISSING,Harvard Beth Israel,-23710.0,97.0,97.0,2013-08-21,,,,0.1072,20.0,2.0,0.3107,0.01,0.5108256239659906,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,144.0,N0,t2,t2,m0,t2a,n0,t2c,0.2,3.0,4.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,3.189006148,0:ALIVE OR DEAD TUMOR FREE,3.189006148,0:CENSORED,3.189006148,0:DiseaseFree,3.189006148,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.7857597744270111,2.555619856668128,6.127168951030249,4.868983016743325,5.092004417944179
TCGA-QU-A6IM,TCGA-QU-A6IM-01,59,Male,1.0,EUR,Harvard Beth Israel,-21792.0,1247.0,1247.0,2013-08-21,,,,0.0852,62.0,1.0,0.3139,0.03,1.1096621247448044,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,88.0,N0,t2,t2,m0,t2b,n0,t2a,0.1,3.0,4.0,7.0,,0.0,False,False,False,No Treatment Indicated,,False,0:LIVING,40.99681099,0:ALIVE OR DEAD TUMOR FREE,40.99681099,0:CENSORED,40.99681099,0:DiseaseFree,40.99681099,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.7308355623222009,2.274470408227373,5.810445674575316,4.593784005260661,3.890378593531995
TCGA-QU-A6IN,TCGA-QU-A6IN-01,61,Male,0.0,EUR,Harvard Beth Israel,-22286.0,4264.0,4264.0,2013-08-21,,,,0.0354,20.0,0.0,0.3265,0.0,0.5108256239659906,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,132.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,140.1847651,0:ALIVE OR DEAD TUMOR FREE,140.1847651,0:CENSORED,140.1847651,0:DiseaseFree,140.1847651,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,1.558561531800457,3.4564907715833795,6.80690916348229,5.033246783747944,5.83357323422371
TCGA-QU-A6IO,TCGA-QU-A6IO-01,53,Male,0.0,AFR,Harvard Beth Israel,-19564.0,3716.0,3716.0,2013-08-21,,,,0.0565,26.0,2.0,0.3272,0.0,0.6241543092515653,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,30.0,N0,t1,t2,m0,t1c,n0,t2c,0.1,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,122.1685242,0:ALIVE OR DEAD TUMOR FREE,122.1685242,0:CENSORED,122.1685242,0:DiseaseFree,122.1685242,,R1,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.8567865462880808,2.2431206551458933,6.556978062520373,4.6301841107849935,4.832895076243724
TCGA-QU-A6IP,TCGA-QU-A6IP-01,66,Male,0.0,EUR,Harvard Beth Israel,-24212.0,2620.0,2620.0,2013-08-21,-31.0,-26.0,-30.0,0.0021,14.0,0.0,0.2956,0.0,0.3600027337988489,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,110.0,N0,t2,t2,m0,t2a,n0,t2a,0.0,3.0,3.0,6.0,,0.0,False,False,False,No Treatment Indicated,,False,0:LIVING,86.13604235,0:ALIVE OR DEAD TUMOR FREE,86.13604235,0:CENSORED,86.13604235,0:DiseaseFree,86.13604235,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.2261077255163704,3.8062931200667354,7.473190264372002,4.327342455609822,5.798952565331475
TCGA-SU-A7E7,TCGA-SU-A7E7-01,60,Male,0.0,EUR,Global Bioclinical-Moldova,-22185.0,551.0,551.0,2014-01-24,-33.0,-20.0,-40.0,0.0287,21.0,0.0,0.325,0.0,0.5500463367269643,"Prostate Adenocarcinoma, Acinar Type",5.0,60.0,250.0,N0,t2,t2,m0,t2b,n0,t2b,0.01,5.0,3.0,8.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,18.11486997,0:ALIVE OR DEAD TUMOR FREE,18.11486997,0:CENSORED,18.11486997,0:DiseaseFree,18.11486997,,R0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,4.0,3.643833106469404,4.376373741582169,8.330661919724536,4.467644673485825,6.883179681005576
TCGA-TK-A8OK,TCGA-TK-A8OK-01,73,Male,0.0,EUR,Global BioClinical - Georgia,-26976.0,27.0,27.0,2014-11-14,-31.0,-26.0,-36.0,0.1019,37.0,2.0,0.3346,0.0,0.803495237579557,"Prostate Adenocarcinoma, Acinar Type",10.0,90.0,100.0,,,,m0,,,,,3.0,4.0,7.0,,0.0,False,False,False,No Treatment Indicated,,,0:LIVING,0.887661505,0:ALIVE OR DEAD TUMOR FREE,0.887661505,0:CENSORED,0.887661505,,,,,1.0,0.0,0.0,,0.0,0.0,1.0,2.0,3.250552347788337,3.721416409989807,6.965905465955979,3.227987458734593,5.698646332795144
TCGA-TP-A8TT,TCGA-TP-A8TT-01,64,Male,0.0,EUR,Maine Medical Center,-23476.0,526.0,526.0,2014-03-28,,,,0.0741,24.0,0.0,0.3272,0.0,0.5877866649021191,"Prostate Adenocarcinoma, Acinar Type",0.0,50.0,500.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.024,4.0,3.0,7.0,306.0,362.0,True,False,False,No Treatment Indicated,,,0:LIVING,17.29296117,0:ALIVE OR DEAD TUMOR FREE,17.29296117,0:CENSORED,17.29296117,,,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,3.783833780238975,4.345297012807056,7.538667745843592,3.92351052224124,5.423645396584236
TCGA-TP-A8TV,TCGA-TP-A8TV-01,62,Male,0.0,EUR,Maine Medical Center,-22872.0,610.0,610.0,2014-03-28,,,,0.1572,34.0,1.0,0.34,0.0,0.7576857015412665,"Prostate Adenocarcinoma, Acinar Type",0.0,35.0,100.0,N0,t1,t2,m0,t1c,n0,t2c,0.019,4.0,3.0,7.0,258.0,,True,False,False,Complete Remission/Response,False,False,0:LIVING,20.05457474,0:ALIVE OR DEAD TUMOR FREE,20.05457474,0:CENSORED,20.05457474,0:DiseaseFree,20.05457474,,R1,1.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,3.13702801180121,4.396570532821856,7.917520667922028,5.493608909412357,5.731533552314192
TCGA-V1-A8MF,TCGA-V1-A8MF-01,65,Male,0.0,AFR,University of California San Francisco,-24090.0,1449.0,1449.0,2014-07-23,-23.0,-26.0,-12.0,0.0886,28.0,2.0,0.3376,0.0,0.6763400624130557,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,350.0,N0,,,,,,,,,,,,0.0,False,False,False,,,False,0:LIVING,47.63783411,0:ALIVE OR DEAD TUMOR FREE,47.63783411,0:CENSORED,47.63783411,0:DiseaseFree,47.63783411,,R1,1.0,1.0,0.0,,0.0,,,4.0,2.5456966030058017,3.0484280206429437,6.834081643593093,3.925771606616772,6.455172666916546
TCGA-V1-A8MG,TCGA-V1-A8MG-01,53,Male,0.0,AFR,University of California San Francisco,-19710.0,857.0,857.0,2014-07-23,-29.0,-22.0,-24.0,0.1514,23.0,5.0,0.321,0.0,0.5690945320786457,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,300.0,,,,,,,,,,,,,0.0,False,False,False,,,False,0:LIVING,28.1750337,0:ALIVE OR DEAD TUMOR FREE,28.1750337,0:CENSORED,28.1750337,0:DiseaseFree,28.1750337,,R1,1.0,0.0,0.0,,0.0,,,3.0,3.1768493240650133,4.496986359462861,7.565667237467904,4.19599320162785,6.319272897510048
TCGA-V1-A8MJ,TCGA-V1-A8MJ-01,58,Male,0.0,AFR,University of California San Francisco,-21535.0,1791.0,1791.0,2014-07-15,-25.0,-24.0,-30.0,0.0001,16.0,3.0,0.3186,0.0,0.4489502202606691,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,100.0,N1,,,,,,,,,,,,0.0,False,False,False,,,True,0:LIVING,58.8815465,0:ALIVE OR DEAD TUMOR FREE,58.8815465,0:CENSORED,58.8815465,,,,R0,0.0,0.0,0.0,,0.0,,,3.0,3.7905843919112328,3.974180527250165,7.783100389377347,2.654550108647,5.626696112116375
TCGA-V1-A8MK,TCGA-V1-A8MK-01,41,Male,0.0,AFR,University of California San Francisco,-15330.0,508.0,508.0,2014-07-15,,,,0.0,8.0,,0.3185,0.0,0.262364264467491,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,100.0,N0,,,,,,,,,,,,0.0,False,False,False,,,False,0:LIVING,16.70118684,0:ALIVE OR DEAD TUMOR FREE,16.70118684,0:CENSORED,16.70118684,0:DiseaseFree,16.70118684,,R0,0.0,0.0,0.0,,0.0,,,3.0,3.2926786959015484,3.626240533427181,7.543907227952631,3.9692057593979206,5.484312172383953
TCGA-V1-A8ML,TCGA-V1-A8ML-01,63,Male,0.0,AFR,University of California San Francisco,-23360.0,448.0,448.0,2014-07-15,-25.0,-28.0,-32.0,0.0045,10.0,1.0,0.3314,0.0,0.287682072201781,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,100.0,N0,,,,,,,,,,,,0.0,False,False,False,,,False,0:LIVING,14.72860571,0:ALIVE OR DEAD TUMOR FREE,14.72860571,0:CENSORED,14.72860571,0:DiseaseFree,14.72860571,,R0,0.0,0.0,1.0,,0.0,,,3.0,3.364572432295856,3.692282117809934,6.86896943988332,4.449000033940462,5.994287806885795
TCGA-V1-A8MM,TCGA-V1-A8MM-01,60,Male,0.0,AFR,University of California San Francisco,-22265.0,1195.0,1195.0,2014-07-15,,,,0.1216,17.0,1.0,0.3341,0.0,0.4489502202606691,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,200.0,N0,,,,,,,,,,,,0.0,False,False,False,,,True,0:LIVING,39.28724069,0:ALIVE OR DEAD TUMOR FREE,39.28724069,1:PROGRESSION,32.54758852,1:Recurred/Progressed,32.54758852,Biochemical evidence of disease,R0,0.0,0.0,0.0,,0.0,,,3.0,2.799190944236534,4.130864991836488,6.996622623067207,5.77361398135738,5.726419815949728
TCGA-V1-A8MU,TCGA-V1-A8MU-01,56,Male,0.0,AFR,University of California San Francisco,-20805.0,1876.0,1876.0,2014-07-15,-27.0,-26.0,-26.0,0.0528,22.0,0.0,0.3168,0.0,0.5500463367269643,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,150.0,N1,,,,,,,,,,,259.0,,False,True,False,,,True,0:LIVING,61.67603643,0:ALIVE OR DEAD TUMOR FREE,61.67603643,0:CENSORED,61.67603643,,,,R1,1.0,0.0,0.0,,0.0,,,3.0,3.43648169189106,4.454379909536572,7.248755876091613,4.120285577521498,5.570065163548509
TCGA-V1-A8WL,TCGA-V1-A8WL-01,64,Male,0.0,AFR,University of California San Francisco,-23725.0,1948.0,1948.0,2014-07-23,-27.0,-22.0,-28.0,0.0359,25.0,1.0,0.3343,0.02,0.6061358033884974,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,150.0,N0,,,,,,,,,,,,0.0,False,False,False,,,False,0:LIVING,64.04313377,0:ALIVE OR DEAD TUMOR FREE,64.04313377,0:CENSORED,64.04313377,0:DiseaseFree,64.04313377,,R0,0.0,0.0,0.0,,0.0,,,2.0,3.4977145449155245,4.034611908959077,7.117303359298448,4.394898224156726,5.570654184736515
TCGA-V1-A8WN,TCGA-V1-A8WN-01,47,Male,0.0,AFR,University of California San Francisco,-17520.0,924.0,924.0,2014-07-15,-39.0,-20.0,-42.0,0.0118,12.0,0.0,0.332,0.0,0.287682072201781,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,100.0,,,,,,,,,,,,,0.0,False,False,False,,,False,0:LIVING,30.37774929,0:ALIVE OR DEAD TUMOR FREE,30.37774929,0:CENSORED,30.37774929,0:DiseaseFree,30.37774929,,R0,0.0,0.0,0.0,,0.0,,,2.0,3.587773016687537,4.093357346294737,8.401486264957688,3.926948247949772,6.016585460434449
TCGA-V1-A8WS,TCGA-V1-A8WS-01,56,Male,0.0,EUR,University of California San Francisco,-20805.0,474.0,474.0,2014-07-23,-31.0,-22.0,-18.0,0.0417,23.0,0.0,0.3298,0.0,0.5690945320786457,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,100.0,,,,,,,,,,,,,0.0,False,False,False,,,True,0:LIVING,15.58339087,0:ALIVE OR DEAD TUMOR FREE,15.58339087,0:CENSORED,15.58339087,,,,R0,0.0,0.0,0.0,,0.0,,,2.0,3.4150149569927177,4.114833409849322,7.655363994144443,4.308200670415923,5.885442583095451
TCGA-V1-A8WV,TCGA-V1-A8WV-01,52,Male,0.0,EAS_OTHER_OR_MISSING,University of California San Francisco,-19345.0,686.0,686.0,2014-07-15,-23.0,-10.0,-14.0,0.5379,39.0,21.0,0.3198,0.02,0.8329091229351039,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,150.0,N1,,,,,,,,,,,250.0,615.0,False,True,False,,,False,0:LIVING,22.5531775,0:ALIVE OR DEAD TUMOR FREE,22.5531775,0:CENSORED,22.5531775,0:DiseaseFree,22.5531775,,R0,0.0,0.0,0.0,,0.0,,,2.0,3.0464212112487106,4.253232938538032,6.762443167153397,4.548516772194237,4.91395689465663
TCGA-V1-A8WW,TCGA-V1-A8WW-01,59,Male,0.0,EUR,University of California San Francisco,-21900.0,1078.0,1078.0,2014-07-15,-3.0,-6.0,-6.0,0.2146,32.0,2.0,0.3368,0.0,0.7259370035442264,"Prostate Adenocarcinoma, Acinar Type",5.0,70.0,150.0,N1,,,,,,,,,,,112.0,,False,True,False,,,True,0:LIVING,35.4407075,0:ALIVE OR DEAD TUMOR FREE,35.4407075,0:CENSORED,35.4407075,0:DiseaseFree,35.4407075,,R0,0.0,0.0,0.0,,0.0,,,4.0,3.709941245936307,3.8634231101645575,7.615717906239635,3.4059379173263187,4.810972577555023
TCGA-V1-A8X3,TCGA-V1-A8X3-01,51,Male,0.0,EUR,University of California San Francisco,-18980.0,202.0,202.0,2014-07-23,-35.0,-20.0,-38.0,0.0612,22.0,1.0,0.3208,0.0,0.5500463367269643,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,250.0,N0,,,,,,,,,,,,0.0,False,False,False,,,False,0:LIVING,6.641023112,0:ALIVE OR DEAD TUMOR FREE,6.641023112,0:CENSORED,6.641023112,0:DiseaseFree,6.641023112,,R1,1.0,0.0,0.0,,0.0,,,3.0,3.5017193765800974,4.151607199679046,8.443348885941694,4.918500729509373,6.702537036756244
TCGA-V1-A9O5,TCGA-V1-A9O5-01,64,Male,0.0,EUR,University of California San Francisco,-23725.0,1932.0,1932.0,2014-07-23,,,,0.259,37.0,5.0,0.3292,0.0,0.803495237579557,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,150.0,N1,,,,,,,,,,,118.0,210.0,True,True,False,,,True,0:LIVING,63.51711214,0:ALIVE OR DEAD TUMOR FREE,63.51711214,1:PROGRESSION,4.076667653,1:Recurred/Progressed,4.076667653,Biochemical evidence of disease,R1,1.0,1.0,0.0,,0.0,,,4.0,3.5966728103488896,4.202911335044157,8.627914661935648,3.403444980216229,5.820638508876027
TCGA-V1-A9O7,TCGA-V1-A9O7-01,60,Male,0.0,EUR,University of California San Francisco,-22265.0,2499.0,2499.0,2014-07-23,,,,0.1288,23.0,5.0,0.3298,0.04,0.5500463367269643,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,300.0,N0,,,,,,,,,,,943.0,,True,False,False,,,True,0:LIVING,82.15800375,0:ALIVE OR DEAD TUMOR FREE,82.15800375,1:PROGRESSION,26.92573232,,,Biochemical evidence of disease,R1,1.0,1.0,0.0,,0.0,,,5.0,3.8456004442542486,4.086758294606462,7.340299661812197,4.03000936012721,7.256850267926881
TCGA-V1-A9O9,TCGA-V1-A9O9-01,56,Male,0.0,EUR,University of California San Francisco,-20805.0,2870.0,2870.0,2014-07-23,,,,0.0731,26.0,1.0,0.3216,0.0,0.6241543092515653,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,100.0,N0,,,,,,,,,,,,0.0,False,False,False,,,False,0:LIVING,94.35513036,0:ALIVE OR DEAD TUMOR FREE,94.35513036,0:CENSORED,94.35513036,0:DiseaseFree,94.35513036,,R0,0.0,0.0,0.0,,0.0,,,2.0,3.843802993502192,4.704639609888507,7.96341343240212,4.571294548283165,5.862620001724582
TCGA-V1-A9OA,TCGA-V1-A9OA-01,61,Male,0.0,EUR,University of California San Francisco,-22630.0,636.0,636.0,2014-07-23,,,,0.1664,17.0,3.0,0.3348,0.0,0.4489502202606691,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,100.0,N1,,,,,,,,,,,,0.0,True,False,False,,,False,0:LIVING,20.9093599,0:ALIVE OR DEAD TUMOR FREE,20.9093599,0:CENSORED,20.9093599,0:DiseaseFree,20.9093599,,R0,0.0,0.0,0.0,,0.0,,,3.0,3.109026176498367,3.5259435722872503,7.576694452896303,3.6949693140644095,6.159128611676023
TCGA-V1-A9OF,TCGA-V1-A9OF-01,49,Male,0.0,EUR,University of California San Francisco,-18250.0,1184.0,1184.0,2014-07-23,,,,0.0223,13.0,0.0,0.3231,0.04,0.3600027337988489,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,100.0,,,,,,,,,,,,,0.0,False,False,False,,,False,0:LIVING,38.92560082,0:ALIVE OR DEAD TUMOR FREE,38.92560082,0:CENSORED,38.92560082,0:DiseaseFree,38.92560082,,R1,1.0,0.0,0.0,,0.0,,,3.0,3.456819288469739,4.063917053692312,7.877791480263539,4.555288542552128,6.079503984076674
TCGA-V1-A9OH,TCGA-V1-A9OH-01,63,Male,0.0,EUR,University of California San Francisco,-23360.0,2403.0,2403.0,2014-07-23,,,,0.0905,51.0,0.0,0.318,0.0,0.9932517730102834,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,100.0,,,,,,,,,,,,,0.0,False,False,False,,,,0:LIVING,79.00187395,0:ALIVE OR DEAD TUMOR FREE,79.00187395,0:CENSORED,79.00187395,0:DiseaseFree,79.00187395,,R0,0.0,0.0,1.0,,0.0,,,3.0,3.2000020660218675,3.134943749342822,7.848805691089168,5.08683046278937,5.962801171764858
TCGA-V1-A9OL,TCGA-V1-A9OL-01,65,Male,0.0,EAS_OTHER_OR_MISSING,University of California San Francisco,-24090.0,1913.0,1913.0,2014-07-11,,,,0.2705,28.0,3.0,0.3249,0.0,0.6592456287118501,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,150.0,N0,,,,,,,,,,,,0.0,False,False,False,,,True,0:LIVING,62.89246145,0:ALIVE OR DEAD TUMOR FREE,62.89246145,1:PROGRESSION,3.452016964,1:Recurred/Progressed,3.452016964,Biochemical evidence of disease,R0,0.0,0.0,0.0,,0.0,,,3.0,3.769634232436105,5.021293159954422,8.647101126309671,4.625673779670295,6.287825020780786
TCGA-V1-A9OQ,TCGA-V1-A9OQ-01,67,Male,0.0,EAS_OTHER_OR_MISSING,University of California San Francisco,-24820.0,371.0,371.0,2014-07-11,,,,0.0474,45.0,0.0,0.3344,0.0,0.9295359584925968,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,200.0,,,,,,,,,,,,,0.0,False,False,False,,,False,0:LIVING,12.19712661,0:ALIVE OR DEAD TUMOR FREE,12.19712661,0:CENSORED,12.19712661,0:DiseaseFree,12.19712661,,R1,1.0,0.0,0.0,,0.0,,,4.0,2.7661286749911334,2.947329519847386,6.277802539770946,5.718191726120237,5.551217604211136
TCGA-V1-A9OT,TCGA-V1-A9OT-01,61,Male,0.0,EUR,University of California San Francisco,-22630.0,476.0,476.0,2014-07-23,,,,0.05,21.0,0.0,0.325,0.02,0.5306282510621704,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,100.0,,,,,,,,,,,,,0.0,False,False,False,,,True,0:LIVING,15.64914357,0:ALIVE OR DEAD TUMOR FREE,15.64914357,1:PROGRESSION,9.599894796,,,Biochemical evidence of disease,R1,1.0,1.0,0.0,,0.0,,,4.0,1.1417597473138994,3.904647867007828,5.385831346781704,4.025135131730313,4.16871423268119
TCGA-V1-A9OX,TCGA-V1-A9OX-01,56,Male,0.0,EUR,University of California San Francisco,-20805.0,1134.0,1134.0,2014-07-23,,,,0.1368,20.0,3.0,0.3313,0.0,0.5108256239659906,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,100.0,N0,,,,,,,,,,,,0.0,False,False,False,,,False,0:LIVING,37.28178321,0:ALIVE OR DEAD TUMOR FREE,37.28178321,0:CENSORED,37.28178321,,,,R0,0.0,0.0,0.0,,0.0,,,2.0,2.740754901366097,4.114367024952,6.900660348981035,4.317586269424583,4.037496438161036
TCGA-V1-A9OY,TCGA-V1-A9OY-01,57,Male,0.0,EUR,University of California San Francisco,-21170.0,1067.0,1067.0,2014-07-23,,,,0.0229,16.0,0.0,0.3267,0.0,0.4274440146095482,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,100.0,N1,,,,,,,,,,,,0.0,False,False,False,,,False,0:LIVING,35.07906763,0:ALIVE OR DEAD TUMOR FREE,35.07906763,0:CENSORED,35.07906763,0:DiseaseFree,35.07906763,,R1,1.0,0.0,0.0,,0.0,,,4.0,3.83220140590282,4.6422163566065855,7.899990663122271,4.898561484129129,5.461079939391473
TCGA-V1-A9Z7,TCGA-V1-A9Z7-01,54,Male,0.0,EUR,University of California San Francisco,-20075.0,874.0,874.0,2014-07-23,,,,0.1225,25.0,4.0,0.3332,0.0,0.6061358033884974,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,300.0,N0,,,,,,,,,,,,0.0,False,False,False,,,,0:LIVING,28.73393168,0:ALIVE OR DEAD TUMOR FREE,28.73393168,0:CENSORED,28.73393168,0:DiseaseFree,28.73393168,,R0,0.0,0.0,0.0,,0.0,,,2.0,3.4559912826022536,3.6011259806018283,7.497327342927001,4.629263351930892,7.787692341450673
TCGA-V1-A9Z8,TCGA-V1-A9Z8-01,59,Male,0.0,EUR,University of California San Francisco,-21900.0,827.0,827.0,2014-07-23,,,,0.0943,26.0,1.0,0.3284,0.0,0.6241543092515653,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,200.0,N0,,,,,,,,,,,,0.0,False,False,False,,,,0:LIVING,27.18874314,0:ALIVE OR DEAD TUMOR FREE,27.18874314,0:CENSORED,27.18874314,0:DiseaseFree,27.18874314,,R1,1.0,1.0,0.0,,0.0,,,4.0,3.1684173991813047,2.958805563639465,7.107029761591539,3.8917885628144737,4.823621998132874
TCGA-V1-A9Z9,TCGA-V1-A9Z9-01,63,Male,0.0,EUR,University of California San Francisco,-23360.0,540.0,540.0,2014-07-23,,,,0.0623,28.0,0.0,0.322,0.0,0.6592456287118501,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,100.0,N0,,,,,,,,,,,,0.0,False,False,False,,,False,0:LIVING,17.7532301,0:ALIVE OR DEAD TUMOR FREE,17.7532301,0:CENSORED,17.7532301,0:DiseaseFree,17.7532301,,R0,0.0,0.0,1.0,,0.0,,,3.0,3.6403432820058654,3.925106949581157,7.720714874674002,4.069839625068634,5.224283430597332
TCGA-V1-A9ZG,TCGA-V1-A9ZG-01,64,Male,0.0,EAS_OTHER_OR_MISSING,University of California San Francisco,-23725.0,1517.0,1517.0,2014-07-23,,,,0.0269,24.0,1.0,0.3293,0.0,0.5877866649021191,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,150.0,N0,,,,,,,,,,,,0.0,False,False,False,,,False,0:LIVING,49.87342605,0:ALIVE OR DEAD TUMOR FREE,49.87342605,0:CENSORED,49.87342605,0:DiseaseFree,49.87342605,,R0,0.0,0.0,0.0,,0.0,,,2.0,3.95315347005995,3.696060603000928,7.856872430291094,4.0512415745522565,5.903633644697464
TCGA-V1-A9ZI,TCGA-V1-A9ZI-01,68,Male,0.0,EUR,University of California San Francisco,-25185.0,1640.0,1640.0,2014-07-23,,,,0.204,27.0,7.0,0.3176,0.0,0.6418538861723947,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,100.0,N0,,,,,,,,,,,,0.0,False,False,False,,,True,0:LIVING,53.91721735,0:ALIVE OR DEAD TUMOR FREE,53.91721735,0:CENSORED,53.91721735,,,,R0,0.0,0.0,1.0,,0.0,,,4.0,3.0608774728993344,4.01075298934011,6.581459716402383,4.549120817772215,6.037700686822019
TCGA-V1-A9ZK,TCGA-V1-A9ZK-01,68,Male,0.0,EUR,University of California San Francisco,-25185.0,1383.0,1383.0,2014-10-23,,,,0.0276,22.0,1.0,0.3281,0.0,0.5500463367269643,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,100.0,N0,,,,,,,,,,,,0.0,False,False,False,,,False,0:LIVING,45.46799487,0:ALIVE OR DEAD TUMOR FREE,45.46799487,0:CENSORED,45.46799487,0:DiseaseFree,45.46799487,,R0,0.0,0.0,1.0,,0.0,,,4.0,3.650408435976749,3.609790414596626,8.362083212900146,4.468700604518855,5.155417335792714
TCGA-V1-A9ZR,TCGA-V1-A9ZR-01,68,Male,0.0,EUR,University of California San Francisco,-25185.0,1361.0,1361.0,2014-07-23,,,,0.0727,33.0,0.0,0.3482,0.0,0.7576857015412665,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,150.0,N0,,,,,,,,,,,,0.0,False,False,False,,,,0:LIVING,44.74471513,0:ALIVE OR DEAD TUMOR FREE,44.74471513,0:CENSORED,44.74471513,0:DiseaseFree,44.74471513,,R1,1.0,0.0,0.0,,0.0,,,4.0,3.179288100036805,4.481066396743702,7.406138663310939,4.447671758797479,8.32255868529247
TCGA-VN-A88I,TCGA-VN-A88I-01,59,Male,0.0,EUR,NCI Urologic Oncology Branch,-21576.0,269.0,269.0,2014-01-10,-31.0,-24.0,-22.0,0.0007,12.0,0.0,0.3228,0.0,0.3829922524833785,"Prostate Adenocarcinoma, Acinar Type",0.0,100.0,50.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.16,4.0,4.0,8.0,,0.0,,False,False,Partial Remission/Response,True,,0:LIVING,8.843738699,0:ALIVE OR DEAD TUMOR FREE,8.843738699,0:CENSORED,8.843738699,,,,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,4.0,3.509645175721828,4.261989576484376,6.825672435560926,3.5685307580164207,5.576250019732357
TCGA-VN-A88K,TCGA-VN-A88K-01,58,Male,0.0,EUR,NCI Urologic Oncology Branch,-21524.0,776.0,776.0,2014-01-10,-19.0,-24.0,-26.0,0.1365,22.0,3.0,0.3381,0.03,0.5500463367269643,"Prostate Adenocarcinoma, Acinar Type",0.0,100.0,108.0,N1,t1,t3/t4,m0,t1c,n1,t3a,0.0,4.0,4.0,8.0,130.0,,False,True,False,No Treatment Indicated,,False,0:LIVING,25.51204918,0:ALIVE OR DEAD TUMOR FREE,25.51204918,0:CENSORED,25.51204918,0:DiseaseFree,25.51204918,,R0,0.0,0.0,1.0,0.0,1.0,0.0,3.0,4.0,3.6719273848147367,4.63931900022497,7.596274004092554,4.839511194287121,7.400410697670845
TCGA-VN-A88L,TCGA-VN-A88L-01,54,Male,0.0,EUR,NCI Urologic Oncology Branch,-20026.0,746.0,746.0,2014-01-10,-21.0,-22.0,-28.0,0.0429,15.0,0.0,0.3338,0.0,0.4054651081081644,"Prostate Adenocarcinoma, Acinar Type",0.0,100.0,120.0,N0,t1,t2,m0,t1c,n0,t2c,0.0,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,24.52575862,0:ALIVE OR DEAD TUMOR FREE,24.52575862,0:CENSORED,24.52575862,0:DiseaseFree,24.52575862,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.000342599390144,4.099564527163197,7.318599748148473,3.993275822202105,5.945485975333672
TCGA-VN-A88M,TCGA-VN-A88M-01,55,Male,0.0,AFR,NCI Urologic Oncology Branch,-20157.0,189.0,189.0,2014-01-10,,,,0.056,16.0,0.0,0.3158,0.0,0.4274440146095482,"Prostate Adenocarcinoma, Acinar Type",0.0,100.0,120.0,N0,t1,t2,m0,t1c,n0,t2c,,3.0,4.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,,0:LIVING,6.213630536,0:ALIVE OR DEAD TUMOR FREE,6.213630536,0:CENSORED,6.213630536,0:DiseaseFree,6.213630536,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.3608699038142857,3.879460722538024,6.447146058550911,4.842787800285773,4.524558952836954
TCGA-VN-A88N,TCGA-VN-A88N-01,62,Male,0.0,EUR,NCI Urologic Oncology Branch,-22695.0,766.0,766.0,2014-01-10,-23.0,-22.0,-34.0,0.0175,22.0,0.0,0.3258,0.0,0.5500463367269643,"Prostate Adenocarcinoma, Acinar Type",0.0,100.0,80.0,N0,t1,t2,m0,t1c,n0,t2c,0.0,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,25.18328566,0:ALIVE OR DEAD TUMOR FREE,25.18328566,0:CENSORED,25.18328566,0:DiseaseFree,25.18328566,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,3.4735791277893022,4.21298948010725,8.024522477435395,4.376255649313362,4.066364783484402
TCGA-VN-A88O,TCGA-VN-A88O-01,49,Male,0.0,EAS_OTHER_OR_MISSING,NCI Urologic Oncology Branch,-17945.0,481.0,481.0,2014-01-10,-19.0,-20.0,-22.0,0.0666,29.0,2.0,0.3181,0.0,0.6763400624130557,"Prostate Adenocarcinoma, Acinar Type",0.0,100.0,140.0,N0,t1,t2,m0,t1c,n0,t2c,0.0,3.0,4.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,,0:LIVING,15.81352533,0:ALIVE OR DEAD TUMOR FREE,15.81352533,0:CENSORED,15.81352533,0:DiseaseFree,15.81352533,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.468492086793681,4.020955500359669,7.966776517561227,4.24807177573468,5.681092201899808
TCGA-VN-A88P,TCGA-VN-A88P-01,60,Male,0.0,EUR,NCI Urologic Oncology Branch,-21916.0,1260.0,1260.0,2014-01-10,-15.0,-24.0,-22.0,0.1159,34.0,2.0,0.3267,0.0,0.7576857015412665,"Prostate Adenocarcinoma, Acinar Type",0.0,75.0,80.0,N0,t1,t2,m0,t1c,n0,t2c,0.0,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,41.42420357,0:ALIVE OR DEAD TUMOR FREE,41.42420357,0:CENSORED,41.42420357,0:DiseaseFree,41.42420357,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.5205856818443984,3.599246371383754,6.683991138176004,4.353570306836968,6.093942517425876
TCGA-VN-A88Q,TCGA-VN-A88Q-01,60,Male,0.0,EUR,NCI Urologic Oncology Branch,-22087.0,1366.0,1366.0,2014-01-10,-31.0,-22.0,-36.0,0.0606,30.0,2.0,0.3317,0.0,0.7259370035442264,"Prostate Adenocarcinoma, Other Subtype",0.0,75.0,80.0,N0,t2,t2,m0,t2a,n0,t2c,0.0,4.0,4.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,44.90909689,0:ALIVE OR DEAD TUMOR FREE,44.90909689,0:CENSORED,44.90909689,0:DiseaseFree,44.90909689,,R0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,4.0,3.750756554465928,4.454702328163688,8.11000089530489,4.496724378313657,6.222159252671507
TCGA-VN-A88R,TCGA-VN-A88R-01,53,Male,0.0,AFR,NCI Urologic Oncology Branch,-19513.0,784.0,784.0,2014-01-10,-9.0,-24.0,-16.0,0.1203,22.0,1.0,0.3327,0.0,0.5500463367269643,"Prostate Adenocarcinoma, Acinar Type",0.0,75.0,80.0,N0,t1,t2,m0,t1c,n0,t2c,0.15,4.0,4.0,8.0,652.0,666.0,False,True,False,Partial Remission/Response,,True,0:LIVING,25.77506,0:ALIVE OR DEAD TUMOR FREE,25.77506,1:PROGRESSION,16.83269224,,,Biochemical evidence of disease,R0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,4.0,2.848517785722192,3.854983046473475,5.805607172335272,4.418446344298279,4.74748944818707
TCGA-VN-A943,TCGA-VN-A943-01,71,Male,0.0,EUR,NCI Urologic Oncology Branch,-26162.0,496.0,496.0,2014-03-05,,,,0.0399,22.0,0.0,0.3218,0.0,0.5500463367269643,"Prostate Adenocarcinoma, Acinar Type",0.0,100.0,80.0,N0,t1,t2,m0,t1c,n0,t2c,0.01,4.0,4.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,16.30667061,0:ALIVE OR DEAD TUMOR FREE,16.30667061,0:CENSORED,16.30667061,0:DiseaseFree,16.30667061,,R0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,4.0,3.7854877790157975,4.084761625660294,8.023482141927632,5.112591718065918,5.725637557902382
TCGA-VP-A872,TCGA-VP-A872-01,60,Male,0.0,EUR,Washington University,-22098.0,3631.0,3631.0,2014-03-26,-9.0,-12.0,-12.0,0.1414,26.0,4.0,0.3341,0.02,0.6241543092515653,"Prostate Adenocarcinoma, Other Subtype",0.0,70.0,150.0,N0,t2,t3/t4,m0,t2,n0,t3a,0.01,5.0,3.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,119.3740343,0:ALIVE OR DEAD TUMOR FREE,119.3740343,0:CENSORED,119.3740343,0:DiseaseFree,119.3740343,,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,4.0,3.7339074484614696,3.917212135855828,7.756722431372654,3.4443755303071035,4.536575160799756
TCGA-VP-A875,TCGA-VP-A875-01,67,Male,0.0,AFR,Washington University,-24742.0,2309.0,2309.0,2014-03-26,-29.0,-24.0,-36.0,0.1832,28.0,0.0,0.3324,0.0,0.6592456287118501,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,600.0,N0,t2,t3/t4,m0,t2a,n0,t3a,0.01,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,,False,0:LIVING,75.91149686,0:ALIVE OR DEAD TUMOR FREE,75.91149686,0:CENSORED,75.91149686,0:DiseaseFree,75.91149686,,R0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.7842945780317625,4.949450890081317,8.184108180474954,5.27178794786572,7.747203425506125
TCGA-VP-A876,TCGA-VP-A876-01,46,Male,0.0,EUR,Washington University,-16934.0,3333.0,3333.0,2014-03-26,-29.0,-14.0,-30.0,0.0688,20.0,2.0,0.3195,0.0,0.5108256239659906,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,90.0,N0,t1,t2,,t1c,n0,t2c,0.1,3.0,5.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,109.5768814,0:ALIVE OR DEAD TUMOR FREE,109.5768814,0:CENSORED,109.5768814,0:DiseaseFree,109.5768814,,R0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,4.0,3.3063643273540517,3.812138790338512,7.732421168401441,5.072144397631673,7.808531140588889
TCGA-VP-A878,TCGA-VP-A878-01,58,Male,0.0,EUR,Washington University,-21402.0,3130.0,3130.0,2014-03-27,-33.0,-26.0,-28.0,0.0735,27.0,0.0,0.3197,0.0,0.6418538861723947,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,350.0,N1,t1,t2,,t1c,n1,t2c,0.1,4.0,5.0,9.0,115.0,784.0,False,True,False,Partial Remission/Response,,True,0:LIVING,102.9029819,0:ALIVE OR DEAD TUMOR FREE,102.9029819,1:PROGRESSION,3.2218825,,,Biochemical evidence of disease,R1,1.0,0.0,0.0,0.0,1.0,0.0,3.0,5.0,3.506754256425383,4.0860449089646425,8.166963437066194,4.611845166004898,6.462873583307199
TCGA-VP-A879,TCGA-VP-A879-01,70,Male,0.0,EUR,Washington University,-25799.0,,,2014-04-07,-33.0,-24.0,-40.0,0.0079,40.0,0.0,0.3134,0.0,0.8472978602443463,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,140.0,N0,t1,t2,m0,t1c,n0,t2b,0.01,4.0,5.0,9.0,,0.0,False,False,False,No Treatment Indicated,,False,1:DECEASED,23.93398429,0:ALIVE OR DEAD TUMOR FREE,23.93398429,0:CENSORED,23.93398429,0:DiseaseFree,23.93398429,,R0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,5.0,4.391774592534143,4.320867324151291,8.235919444637007,3.6773503771951774,5.264311226891969
TCGA-VP-A87B,TCGA-VP-A87B-01,63,Male,0.0,EUR,Washington University,-23271.0,2722.0,2722.0,2014-03-28,-23.0,-22.0,-22.0,0.1284,36.0,2.0,0.3227,0.0,0.7884573603642703,"Prostate Adenocarcinoma, Acinar Type",0.0,65.0,200.0,N0,t1,t2,m0,t1c,n0,t2b,3.37,4.0,4.0,8.0,2540.0,2679.0,True,True,False,Progressive Disease,False,True,0:LIVING,89.48943025,0:ALIVE OR DEAD TUMOR FREE,89.48943025,1:PROGRESSION,81.3032186,0:DiseaseFree,89.48943025,New Primary Tumor,R0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,4.0,2.9866111692481114,3.546931491156736,8.038711621262282,4.446262847741545,6.18196520575692
TCGA-VP-A87C,TCGA-VP-A87C-01,67,Male,0.0,AFR,Washington University,-24608.0,1690.0,1690.0,2014-03-28,-35.0,-24.0,-44.0,0.0648,20.0,3.0,0.3158,0.0,0.5108256239659906,"Prostate Adenocarcinoma, Acinar Type",0.0,75.0,190.0,N0,t1,t2,m0,t1c,n0,t2c,0.5,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,55.56103495,0:ALIVE OR DEAD TUMOR FREE,55.56103495,0:CENSORED,55.56103495,0:DiseaseFree,55.56103495,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,3.825297185396853,3.874285490498035,7.566649264980747,3.706961473289234,6.154929470686972
TCGA-VP-A87D,TCGA-VP-A87D-01,54,Male,0.0,EUR,Washington University,-19818.0,1853.0,1853.0,2014-03-28,-37.0,-24.0,-44.0,0.0953,48.0,2.0,0.3234,0.0,0.9932517730102834,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,110.0,N1,t1,t3/t4,m0,t1c,n1,t3a,0.2,4.0,5.0,9.0,248.0,837.0,False,True,True,Complete Remission/Response,False,False,0:LIVING,60.91988033,0:ALIVE OR DEAD TUMOR FREE,60.91988033,1:PROGRESSION,39.25436434,1:Recurred/Progressed,39.25436434,Biochemical evidence of disease,R0,0.0,0.0,1.0,0.0,1.0,0.0,3.0,5.0,3.527020275829424,4.15261340467436,8.54454566213087,4.700284342616318,6.997766603270153
TCGA-VP-A87E,TCGA-VP-A87E-01,59,Male,0.0,AFR,Washington University,-21811.0,2037.0,2037.0,2014-03-28,-21.0,-22.0,-14.0,0.0,19.0,0.0,0.3287,0.0,0.5108256239659906,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,240.0,N0,t1,t2,m0,t1c,n0,t2c,0.11,3.0,3.0,6.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,66.96912911,0:ALIVE OR DEAD TUMOR FREE,66.96912911,0:CENSORED,66.96912911,0:DiseaseFree,66.96912911,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.6467617351704806,3.4762390961052785,7.72267025519337,3.750188427127541,6.938764493344655
TCGA-VP-A87H,TCGA-VP-A87H-01,76,Male,0.0,EUR,Washington University,-28060.0,663.0,663.0,2014-03-28,-17.0,-22.0,-10.0,0.3105,27.0,11.0,0.3177,0.0,0.6418538861723947,"Prostate Adenocarcinoma, Acinar Type",0.0,75.0,90.0,N0,t2,t3/t4,m0,t2,n0,t3b,0.01,4.0,5.0,9.0,,0.0,False,False,False,Complete Remission/Response,True,False,0:LIVING,21.7970214,0:ALIVE OR DEAD TUMOR FREE,21.7970214,0:CENSORED,21.7970214,0:DiseaseFree,21.7970214,,R2,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,3.27484309556596,3.5291462820302604,8.307861541951944,4.150364704611994,6.80605720115885
TCGA-VP-A87J,TCGA-VP-A87J-01,56,Male,0.0,AFR,Washington University,-20792.0,1774.0,1774.0,2014-03-31,-23.0,-20.0,-26.0,0.0632,28.0,3.0,0.3196,0.04,0.6592456287118501,"Prostate Adenocarcinoma, Acinar Type",0.0,75.0,160.0,N1,t2,t3/t4,m0,t2a,n1,t3a,0.13,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,True,False,0:LIVING,58.32264852,0:ALIVE OR DEAD TUMOR FREE,58.32264852,0:CENSORED,58.32264852,0:DiseaseFree,58.32264852,,R2,1.0,0.0,1.0,0.0,1.0,0.0,1.0,2.0,3.638977411297002,3.498570012544256,8.767899728420133,3.853327023605444,4.480161699348165
TCGA-VP-A87K,TCGA-VP-A87K-01,63,Male,0.0,EUR,Washington University,-23030.0,1306.0,1306.0,2014-03-31,-21.0,-22.0,-22.0,0.1171,29.0,4.0,0.3178,0.02,0.6763400624130557,"Prostate Adenocarcinoma, Other Subtype",0.0,80.0,110.0,N0,t1,t3/t4,m0,t1c,n0,t3b,0.3,4.0,4.0,8.0,699.0,752.0,True,False,False,Complete Remission/Response,True,True,0:LIVING,42.93651576,0:ALIVE OR DEAD TUMOR FREE,42.93651576,1:PROGRESSION,17.52309564,1:Recurred/Progressed,17.52309564,Biochemical evidence of disease,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,4.0,4.212779424773205,4.706569230170883,8.433315027845174,4.803035835669149,6.481491085706706
TCGA-VP-AA1N,TCGA-VP-AA1N-01,70,Male,0.0,EUR,Washington University,-25781.0,1365.0,1365.0,2014-03-31,,,,0.1897,30.0,16.0,0.3318,0.0,0.6931471805599453,"Prostate Adenocarcinoma, Acinar Type",0.0,55.0,920.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.01,5.0,4.0,9.0,321.0,321.0,True,False,False,Complete Remission/Response,False,False,0:LIVING,44.87622054,0:ALIVE OR DEAD TUMOR FREE,44.87622054,0:CENSORED,44.87622054,0:DiseaseFree,44.87622054,,R1,1.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,3.429923884804793,3.3172317002226057,7.689875703946946,4.146573766847959,6.163704011893871
TCGA-WW-A8ZI,TCGA-WW-A8ZI-01,70,Male,0.0,EUR,Wake Forest University,-25593.0,449.0,449.0,2014-03-26,-33.0,-22.0,-36.0,0.0819,26.0,2.0,0.3274,0.0,0.6241543092515653,"Prostate Adenocarcinoma, Acinar Type",0.0,100.0,126.0,N0,t2,t2,m0,t2c,n0,t2c,0.0,4.0,4.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,14.76148207,0:ALIVE OR DEAD TUMOR FREE,14.76148207,0:CENSORED,14.76148207,0:DiseaseFree,14.76148207,,R0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,4.0,2.313478057653328,4.39215940466837,7.536126743193536,3.15390259314058,5.717917651664659
TCGA-X4-A8KQ,TCGA-X4-A8KQ-01,65,Male,0.0,EUR,Institute for Medical Research,-23999.0,1383.0,1383.0,2014-03-07,,,,0.1748,37.0,5.0,0.332,0.0,0.803495237579557,"Prostate Adenocarcinoma, Acinar Type",0.0,34.0,270.0,N0,t1,t3/t4,m0,t1c,n0,t3b,0.25,4.0,5.0,9.0,963.0,1131.0,True,True,False,Progressive Disease,False,True,0:LIVING,45.46799487,0:ALIVE OR DEAD TUMOR FREE,45.46799487,0:CENSORED,45.46799487,,,,RX,0.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,2.0865460143190804,3.272351715740585,6.073027561345609,3.3401064592075627,4.881478642572761
TCGA-X4-A8KS,TCGA-X4-A8KS-01,61,Male,0.0,AFR,Institute for Medical Research,-22571.0,979.0,979.0,2014-03-07,,,,0.0004,23.0,2.0,0.3343,0.0,0.5690945320786457,"Prostate Adenocarcinoma, Acinar Type",0.0,40.0,420.0,,t2,t2,m0,t2c,,t2c,0.01,3.0,4.0,7.0,,0.0,False,False,False,Partial Remission/Response,False,False,0:LIVING,32.18594865,0:ALIVE OR DEAD TUMOR FREE,32.18594865,0:CENSORED,32.18594865,,,,RX,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.6151337575144284,2.5923972351979403,4.7827387952533815,3.43550858670081,2.7914181871640373
TCGA-XA-A8JR,TCGA-XA-A8JR-01,68,Male,0.0,EUR,University of Minnesota,-25090.0,376.0,376.0,2013-10-09,-31.0,-20.0,-32.0,0.0302,20.0,0.0,0.3025,0.0,0.5306282510621704,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,110.0,N0,,t2,m0,,n0,t2c,0.0,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,12.36150837,0:ALIVE OR DEAD TUMOR FREE,12.36150837,0:CENSORED,12.36150837,0:DiseaseFree,12.36150837,,R2,1.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,3.331905815688509,4.193803277369882,7.233688694406432,3.9915445208686777,5.886240407737865
TCGA-XJ-A83F,TCGA-XJ-A83F-01,67,Male,0.0,EUR,University of Kansas,,1127.0,1127.0,2014-03-06,,,,0.0835,29.0,3.0,0.3173,0.0,0.6763400624130557,"Prostate Adenocarcinoma, Acinar Type",1.0,75.0,57.0,N0,,t3/t4,,,n0,t3a,0.01,3.0,4.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,37.05164875,0:ALIVE OR DEAD TUMOR FREE,37.05164875,0:CENSORED,37.05164875,0:DiseaseFree,37.05164875,,RX,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.321047782389803,4.27876537616561,7.128749121002996,5.041181641853,6.060797511132996
TCGA-XJ-A83G,TCGA-XJ-A83G-01,51,Male,0.0,AFR,University of Kansas,,1461.0,1461.0,2014-03-06,-13.0,-20.0,-6.0,0.092,19.0,0.0,0.3336,0.0,0.5108256239659906,"Prostate Adenocarcinoma, Acinar Type",5.0,75.0,64.0,N0,t1,t3/t4,,t1c,n0,t3b,0.01,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,48.03235033,0:ALIVE OR DEAD TUMOR FREE,48.03235033,0:CENSORED,48.03235033,0:DiseaseFree,48.03235033,,,0.0,1.0,0.0,0.0,0.0,1.0,2.0,3.0,3.140140588324437,3.750756554465928,7.673023512067636,5.121471353198279,5.247118618182784
TCGA-XJ-A83H,TCGA-XJ-A83H-01,57,Male,0.0,EUR,University of Kansas,,0.0,0.0,2014-03-06,-23.0,-22.0,-30.0,0.051,32.0,2.0,0.3136,0.0,0.7419373447293773,"Prostate Adenocarcinoma, Acinar Type",2.0,70.0,170.0,,t2,t2,m0,t2a,,t2c,0.03,3.0,4.0,7.0,,0.0,False,False,False,No Treatment Indicated,,,0:LIVING,42.08173061,0:ALIVE OR DEAD TUMOR FREE,42.08173061,0:CENSORED,42.08173061,,,,R0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0632095414725846,3.4253653063077567,8.084424149342876,4.256987981599969,6.788431233094304
TCGA-XJ-A9DI,TCGA-XJ-A9DI-01,62,Male,0.0,EUR,University of Kansas,,1461.0,1461.0,2014-05-21,-31.0,-22.0,-44.0,0.0003,17.0,0.0,0.3393,0.0,0.4489502202606691,"Prostate Adenocarcinoma, Acinar Type",1.0,75.0,13.0,N0,t2,t3/t4,m0,t2b,n0,t3b,0.1,5.0,4.0,9.0,151.0,1461.0,True,True,False,Complete Remission/Response,False,False,0:LIVING,48.03235033,0:ALIVE OR DEAD TUMOR FREE,48.03235033,0:CENSORED,48.03235033,0:DiseaseFree,48.03235033,,R0,0.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,3.5087582288651955,4.575221554234233,8.096999712842454,4.0075812451457296,5.384322704613901
TCGA-XJ-A9DK,TCGA-XJ-A9DK-01,63,Male,0.0,EUR,University of Kansas,,275.0,275.0,2014-05-21,-31.0,-14.0,-32.0,0.0,4.0,0.0,0.3301,0.0,0.1251631426598883,"Prostate Adenocarcinoma, Acinar Type",5.0,60.0,152.0,,t1,t2,m0,t1c,,t2c,0.1,4.0,4.0,8.0,,0.0,,False,False,No Treatment Indicated,,,0:LIVING,9.040996811,0:ALIVE OR DEAD TUMOR FREE,9.040996811,0:CENSORED,9.040996811,0:DiseaseFree,9.040996811,,R0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,4.0,3.2720829267493405,4.286437628276274,8.015039763477427,4.08448102096164,4.919506941022522
TCGA-XJ-A9DQ,TCGA-XJ-A9DQ-01,48,Male,0.0,EUR,University of Kansas,,91.0,91.0,2014-05-21,,,,0.0007,9.0,0.0,0.3259,0.0,0.262364264467491,"Prostate Adenocarcinoma, Acinar Type",1.0,60.0,86.0,,t1,t2,m0,t1c,,t2a,,3.0,3.0,6.0,,0.0,,False,False,No Treatment Indicated,,,0:LIVING,2.991748036,0:ALIVE OR DEAD TUMOR FREE,2.991748036,0:CENSORED,2.991748036,,,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.83497408834344,4.1600085376147895,7.300658228273605,4.258903290678847,4.612057559563064
TCGA-XJ-A9DX,TCGA-XJ-A9DX-01,51,Male,0.0,EUR,University of Kansas,,973.0,973.0,2014-05-21,,,,0.3074,61.0,6.0,0.3309,0.03,1.1096621247448044,"Prostate Adenocarcinoma, Acinar Type",1.0,75.0,69.0,N1,t1,t3/t4,m1c,t1c,n1,t3b,0.05,5.0,4.0,9.0,151.0,274.0,True,True,False,Partial Remission/Response,False,True,0:LIVING,31.98869054,0:ALIVE OR DEAD TUMOR FREE,31.98869054,0:CENSORED,31.98869054,,,,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,2.2389396793574927,4.669673111404663,7.552216431364479,4.14107305330262,4.59053016431982
TCGA-XK-AAIR,TCGA-XK-AAIR-01,75,Male,0.0,EUR,Mayo Clinic Arizona,-27703.0,972.0,972.0,2014-05-08,,,,0.0691,25.0,2.0,0.3372,0.0,0.6061358033884974,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,224.0,N0,t1,t2,m0,t1c,n0,t2c,0.09,4.0,4.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,31.95581418,0:ALIVE OR DEAD TUMOR FREE,31.95581418,0:CENSORED,31.95581418,0:DiseaseFree,31.95581418,,R0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,4.0,3.718306821867008,3.7897709773100576,8.45303023341068,4.00421372342396,5.102868054251107
TCGA-XK-AAIV,TCGA-XK-AAIV-01,63,Male,0.0,EUR,Mayo Clinic Arizona,-23325.0,1133.0,1133.0,2014-05-08,,,,0.2581,43.0,19.0,0.3378,0.0,0.8892620593492495,"Prostate Adenocarcinoma, Acinar Type",10.0,90.0,278.0,N1,t1,t3/t4,m0,t1c,n1,t3b,0.32,5.0,5.0,10.0,97.0,232.0,True,True,False,Complete Remission/Response,True,False,0:LIVING,37.24890686,0:ALIVE OR DEAD TUMOR FREE,37.24890686,0:CENSORED,37.24890686,0:DiseaseFree,37.24890686,,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.8923910259134034,3.3335239174022493,7.925359199241673,4.728981669948702,6.274326897929914
TCGA-XK-AAJA,TCGA-XK-AAJA-01,62,Male,0.0,EAS_OTHER_OR_MISSING,Mayo Clinic Arizona,-22771.0,930.0,930.0,2014-05-12,,,,0.1428,40.0,0.0,0.3349,0.05,0.8472978602443463,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,181.0,N0,t2,t3/t4,m0,t2a,n0,t3a,0.09,4.0,3.0,7.0,,0.0,False,False,False,No Treatment Indicated,,False,0:LIVING,30.5750074,0:ALIVE OR DEAD TUMOR FREE,30.5750074,0:CENSORED,30.5750074,0:DiseaseFree,30.5750074,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,2.94341502893787,5.421984006639041,7.664892380192001,4.679952944481175,5.444299323546172
TCGA-XK-AAJP,TCGA-XK-AAJP-01,66,Male,0.0,EUR,Mayo Clinic Arizona,-24320.0,1259.0,1259.0,2014-05-13,,,,0.1054,30.0,1.0,0.3238,0.03,0.7096764823472214,"Prostate Adenocarcinoma, Acinar Type",0.0,95.0,195.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.09,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,41.39132722,0:ALIVE OR DEAD TUMOR FREE,41.39132722,0:CENSORED,41.39132722,0:DiseaseFree,41.39132722,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,3.2775236061210373,4.208392399790676,7.711019206918912,5.162544402413325,5.540393105810509
TCGA-XK-AAJR,TCGA-XK-AAJR-01,61,Male,0.0,EUR,Mayo Clinic Arizona,-22643.0,1124.0,1124.0,2014-05-13,,,,0.0989,24.0,2.0,0.3205,0.0,0.5877866649021191,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,310.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.09,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,36.95301969,0:ALIVE OR DEAD TUMOR FREE,36.95301969,1:PROGRESSION,4.306802117,1:Recurred/Progressed,4.306802117,Biochemical evidence of disease,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,3.539791596589624,4.202370701959185,8.386380728875402,4.529858418640512,5.0184071774841525
TCGA-XK-AAJT,TCGA-XK-AAJT-01,75,Male,0.0,EUR,Mayo Clinic Arizona,-27428.0,1434.0,1434.0,2014-05-13,,,,0.2114,28.0,5.0,0.3264,0.0,0.6418538861723947,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,207.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.09,4.0,3.0,7.0,,0.0,False,False,False,Partial Remission/Response,True,False,0:LIVING,47.14468883,0:ALIVE OR DEAD TUMOR FREE,47.14468883,0:CENSORED,47.14468883,,,,R1,1.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,2.805189254839489,3.0978298808731517,6.678224056331773,3.1810707379434926,4.707718035482914
TCGA-XK-AAJU,TCGA-XK-AAJU-01,65,Male,0.0,EUR,Mayo Clinic Arizona,-23958.0,1576.0,1576.0,2014-05-13,,,,0.0,1.0,0.0,0.3238,0.03,0.0327898225004103,"Prostate Adenocarcinoma, Acinar Type",0.0,50.0,267.0,N0,t1,t2,m0,t1c,n0,t2c,0.09,4.0,3.0,7.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,51.81313082,0:ALIVE OR DEAD TUMOR FREE,51.81313082,0:CENSORED,51.81313082,0:DiseaseFree,51.81313082,,R0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,3.5026233886821627,4.198667015237449,7.919981190742275,3.5628773756251,5.168686156451816
TCGA-XQ-A8TA,TCGA-XQ-A8TA-01,59,Male,0.0,EUR,University of Sao Paulo,-21889.0,,,2015-01-26,11.0,20.0,22.0,0.3508,106.0,5.0,0.3286,0.2,1.5114575040003673,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,100.0,,t3/t4,,m1b,t3a,,,323.0,5.0,5.0,10.0,,0.0,False,False,False,No Treatment Indicated,True,False,1:DECEASED,4.799947398,1:DEAD WITH TUMOR,4.799947398,1:PROGRESSION,4.799947398,,,,,0.0,0.0,1.0,,0.0,0.0,3.0,5.0,3.768014897429407,5.67646206416847,7.6161988788697,5.176302823732618,8.200934886462614
TCGA-XQ-A8TB,TCGA-XQ-A8TB-01,67,Male,0.0,EAS_OTHER_OR_MISSING,University of Sao Paulo,-24623.0,770.0,770.0,2015-01-26,-31.0,-20.0,-42.0,0.0652,24.0,1.0,0.3204,0.0,0.5877866649021191,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,100.0,N0,t2,t3/t4,m0,t2a,n0,t3b,0.0,4.0,5.0,9.0,,0.0,True,False,False,Complete Remission/Response,False,False,0:LIVING,25.31479107,0:ALIVE OR DEAD TUMOR FREE,25.31479107,0:CENSORED,25.31479107,0:DiseaseFree,25.31479107,,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,3.871212824257514,4.255379874051316,8.005229859173017,4.03804981917952,7.1452810671505
TCGA-Y6-A8TL,TCGA-Y6-A8TL-01,65,Male,0.0,EUR,University of Arizona,-23776.0,992.0,992.0,2014-04-17,-23.0,-20.0,-28.0,0.0468,26.0,0.0,0.3388,0.0,0.6418538861723947,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,100.0,N0,t2,t3/t4,,t2a,n0,t3a,0.0,3.0,3.0,6.0,,0.0,False,False,False,No Treatment Indicated,False,False,0:LIVING,32.61334122,0:ALIVE OR DEAD TUMOR FREE,32.61334122,0:CENSORED,32.61334122,,,,R0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,2.9411438806406016,3.858279452882846,7.554813679715153,5.586170252142557,6.393572364993056
TCGA-Y6-A9XI,TCGA-Y6-A9XI-01,72,Male,0.0,EUR,University of Arizona,-26471.0,526.0,526.0,2014-11-13,,,,0.0769,40.0,1.0,0.3279,0.0,0.8472978602443463,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,100.0,N0,,,,,n0,,0.06,4.0,4.0,8.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,17.29296117,0:ALIVE OR DEAD TUMOR FREE,17.29296117,0:CENSORED,17.29296117,0:DiseaseFree,17.29296117,,R1,1.0,0.0,0.0,,0.0,0.0,3.0,4.0,3.596505846939519,4.726166378085065,8.313378286274734,4.257282229778289,4.595103784740845
TCGA-YJ-A8SW,TCGA-YJ-A8SW-01,67,Male,0.0,EUR,Stanford University,,148.0,148.0,2014-05-13,-23.0,-16.0,-20.0,0.3677,54.0,6.0,0.3258,0.1,1.029619417181158,"Prostate Adenocarcinoma, Other Subtype",0.0,70.0,100.0,N0,t1,t3/t4,,t1c,n0,t3b,0.38,5.0,4.0,9.0,,0.0,,False,False,No Treatment Indicated,,,0:LIVING,4.865700102,0:ALIVE OR DEAD TUMOR FREE,4.865700102,0:CENSORED,4.865700102,,,,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,3.17229548475702,4.112216373546053,8.16230924638991,4.195701928588242,6.4944444128060095
TCGA-YL-A8HJ,TCGA-YL-A8HJ-01,58,Male,0.0,EUR,PROCURE Biobank,-21416.0,1611.0,1611.0,2014-03-13,-33.0,-22.0,-40.0,0.0091,30.0,0.0,0.3259,0.0,0.6931471805599453,"Prostate Adenocarcinoma, Other Subtype",0.0,95.0,100.0,,,t3/t4,m0,,,t3b,0.03,4.0,5.0,9.0,209.0,1036.0,True,True,False,Complete Remission/Response,False,False,0:LIVING,52.96380314,0:ALIVE OR DEAD TUMOR FREE,52.96380314,0:CENSORED,52.96380314,0:DiseaseFree,52.96380314,,R0,0.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.604664415163704,3.6936876663255935,7.431071314218852,3.7063647795091255,6.3710674262617335
TCGA-YL-A8HK,TCGA-YL-A8HK-01,59,Male,0.0,EUR,PROCURE Biobank,-21850.0,1491.0,1491.0,2014-03-13,-33.0,-20.0,-24.0,0.1384,16.0,3.0,0.3218,0.0,0.4274440146095482,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,100.0,N0,,t3/t4,m0,,n0,t3b,1.0,4.0,5.0,9.0,179.0,284.0,True,True,False,Complete Remission/Response,True,True,0:LIVING,49.01864089,0:ALIVE OR DEAD TUMOR FREE,49.01864089,1:PROGRESSION,45.23786041,1:Recurred/Progressed,45.23786041,Biochemical evidence of disease,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,3.872621942009325,4.733636343660015,8.003035480810153,4.177535148296273,5.844307811257887
TCGA-YL-A8HL,TCGA-YL-A8HL-01,58,Male,0.0,EUR,PROCURE Biobank,-21249.0,1565.0,1565.0,2014-03-13,-27.0,-18.0,-30.0,0.0677,17.0,1.0,0.3202,0.0,0.4489502202606691,"Prostate Adenocarcinoma, Acinar Type",0.0,100.0,100.0,N1,,t3/t4,m0,,n1,t3b,0.03,4.0,5.0,9.0,132.0,1228.0,True,True,False,Stable Disease,,False,0:LIVING,51.45149094,0:ALIVE OR DEAD TUMOR FREE,51.45149094,0:CENSORED,51.45149094,,,,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.967721964967356,4.464478770155844,8.666959634083298,3.2378390155307786,5.278025647868058
TCGA-YL-A8HM,TCGA-YL-A8HM-01,66,Male,0.0,EUR,PROCURE Biobank,-24121.0,1482.0,1482.0,2014-03-13,-11.0,-2.0,-26.0,0.2811,34.0,7.0,0.3376,0.02,0.7576857015412665,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,100.0,N0,,t3/t4,m0,,n0,t3b,0.03,4.0,5.0,9.0,216.0,752.0,True,True,False,Complete Remission/Response,False,True,0:LIVING,48.72275372,0:ALIVE OR DEAD TUMOR FREE,48.72275372,1:PROGRESSION,48.42686656,1:Recurred/Progressed,48.42686656,Biochemical evidence of disease,R0,0.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,2.9426271015338563,3.332536088761395,7.66096140813042,5.413495922735008,7.272020388796217
TCGA-YL-A8HO,TCGA-YL-A8HO-01,67,Male,0.0,AFR,PROCURE Biobank,-24509.0,2304.0,2304.0,2014-03-14,-23.0,-26.0,-26.0,0.2893,28.0,9.0,0.3212,0.0,0.6592456287118501,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,100.0,N0,,t3/t4,m0,,n0,t3a,0.01,4.0,3.0,7.0,1650.0,1687.0,True,False,False,Stable Disease,,True,0:LIVING,75.7471151,0:ALIVE OR DEAD TUMOR FREE,75.7471151,1:PROGRESSION,35.11194398,,,Biochemical evidence of disease,R1,1.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,3.146427135768754,3.226215645318576,7.019321622567739,3.9001422603598166,5.227571663187147
TCGA-YL-A8S8,TCGA-YL-A8S8-01,68,Male,0.0,EUR,PROCURE Biobank,-25119.0,1890.0,1890.0,2014-04-25,-19.0,-14.0,-18.0,0.3664,38.0,8.0,0.3138,0.0,0.8183103236610101,"Prostate Adenocarcinoma, Acinar Type",0.0,95.0,100.0,N0,,t3/t4,m0,,n0,t3a,1.36,4.0,5.0,9.0,870.0,926.0,True,False,False,Stable Disease,True,True,0:LIVING,62.13630536,0:ALIVE OR DEAD TUMOR FREE,62.13630536,1:PROGRESSION,22.32304304,,,Biochemical evidence of disease,R1,1.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,2.894061059259358,3.9532931799006494,7.85268492821042,4.253255634138867,6.554748460172067
TCGA-YL-A8S9,TCGA-YL-A8S9-01,63,Male,0.0,EUR,PROCURE Biobank,-23204.0,1842.0,1842.0,2014-04-25,-25.0,-26.0,-34.0,0.1121,28.0,4.0,0.3464,0.12,0.6592456287118501,"Prostate Adenocarcinoma, Acinar Type",0.0,100.0,100.0,N0,,t3/t4,m0,,n0,t3a,0.03,4.0,5.0,9.0,1077.0,1128.0,True,False,False,Stable Disease,,True,0:LIVING,60.55824046,0:ALIVE OR DEAD TUMOR FREE,60.55824046,1:PROGRESSION,33.07361015,,,Locoregional Recurrence,R1,1.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,3.170614124462233,3.5411059105359506,8.055217350046279,5.248166677270227,6.738662467584238
TCGA-YL-A8SA,TCGA-YL-A8SA-01,69,Male,0.0,EUR,PROCURE Biobank,-25340.0,512.0,512.0,2014-04-25,-27.0,-20.0,-42.0,0.0816,24.0,1.0,0.3196,0.0,0.6061358033884974,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,100.0,N0,t2,t3/t4,m0,t2b,n0,t3b,0.06,4.0,4.0,8.0,279.0,327.0,True,False,False,Stable Disease,,,0:LIVING,16.83269224,0:ALIVE OR DEAD TUMOR FREE,16.83269224,0:CENSORED,16.83269224,,,,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,4.0,3.770776199092398,4.662045951095695,8.468106738412748,4.307151617753038,3.86079399365606
TCGA-YL-A8SB,TCGA-YL-A8SB-01,62,Male,0.0,EUR,PROCURE Biobank,-22991.0,1719.0,1719.0,2014-04-25,-31.0,-24.0,-32.0,0.0844,26.0,4.0,0.3172,0.0,0.6241543092515653,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,100.0,N0,,t3/t4,m0,,n0,t3a,0.23,4.0,5.0,9.0,270.0,1630.0,True,True,False,Stable Disease,,True,0:LIVING,56.51444916,0:ALIVE OR DEAD TUMOR FREE,56.51444916,1:PROGRESSION,45.50087122,,,Biochemical evidence of disease,R1,1.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,2.712815854437372,3.457003225255764,7.3735994943265055,4.0198264326851945,5.733603807660083
TCGA-YL-A8SC,TCGA-YL-A8SC-01,66,Male,0.0,EUR,PROCURE Biobank,-24206.0,1261.0,1261.0,2014-04-27,-25.0,-18.0,-26.0,0.1463,38.0,6.0,0.3322,0.0,0.8183103236610101,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,100.0,N0,,t3/t4,m0,,n0,t3a,0.65,4.0,5.0,9.0,166.0,195.0,False,True,False,Partial Remission/Response,True,True,0:LIVING,41.45707992,0:ALIVE OR DEAD TUMOR FREE,41.45707992,1:PROGRESSION,4.99720551,,,Biochemical evidence of disease,R1,1.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,3.104705674139329,4.628073654196136,8.518860448288592,4.318331304370666,6.256167164736494
TCGA-YL-A8SF,TCGA-YL-A8SF-01,62,Male,0.0,EUR,PROCURE Biobank,-22844.0,1373.0,1373.0,2014-04-25,-33.0,-22.0,-44.0,0.1365,13.0,3.0,0.3283,0.0,0.3600027337988489,"Prostate Adenocarcinoma, Acinar Type",0.0,100.0,100.0,N0,,t3/t4,m0,,n0,t3b,0.01,4.0,4.0,8.0,,0.0,False,False,False,Stable Disease,,False,0:LIVING,45.13923135,0:ALIVE OR DEAD TUMOR FREE,45.13923135,0:CENSORED,45.13923135,,,,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,4.0,3.21494852314081,4.116439617845473,7.685668286354502,3.7699092329579273,7.1515574798280745
TCGA-YL-A8SH,TCGA-YL-A8SH-01,69,Male,0.0,EUR,PROCURE Biobank,-25395.0,,,2014-04-25,-29.0,-24.0,-32.0,0.0699,32.0,0.0,0.3319,0.0,0.7259370035442264,"Prostate Adenocarcinoma, Acinar Type",,,,N0,,t3/t4,m0,,n0,t3a,0.06,4.0,3.0,7.0,,0.0,False,False,False,No Treatment Indicated,False,False,1:DECEASED,28.76680804,0:ALIVE OR DEAD TUMOR FREE,28.76680804,0:CENSORED,28.76680804,0:DiseaseFree,28.76680804,,R0,0.0,0.0,1.0,0.0,0.0,1.0,2.0,3.0,2.887369295278882,3.825052902335867,7.54348969689861,3.839032418508365,5.952957853550741
TCGA-YL-A8SI,TCGA-YL-A8SI-01,69,Male,0.0,EUR,PROCURE Biobank,-25292.0,1614.0,1614.0,2014-04-25,,,,0.0146,21.0,0.0,0.3157,0.0,0.5306282510621704,"Prostate Adenocarcinoma, Acinar Type",0.0,95.0,100.0,N0,,t3/t4,m0,,n0,t3a,0.48,4.0,5.0,9.0,1471.0,1517.0,True,True,False,Complete Remission/Response,True,True,0:LIVING,53.06243219,0:ALIVE OR DEAD TUMOR FREE,53.06243219,1:PROGRESSION,46.78304895,1:Recurred/Progressed,46.78304895,Biochemical evidence of disease,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,3.4876278335434314,3.765269520690589,7.308408205025517,5.053267764790324,6.608996958198594
TCGA-YL-A8SJ,TCGA-YL-A8SJ-01,60,Male,0.0,EUR,PROCURE Biobank,-21916.0,1395.0,1395.0,2014-04-25,-37.0,-20.0,-46.0,0.0629,26.0,2.0,0.3334,0.0,0.6241543092515653,"Prostate Adenocarcinoma, Acinar Type",,,,N0,,t3/t4,m0,,n0,t3b,0.24,4.0,5.0,9.0,904.0,932.0,True,False,False,Complete Remission/Response,True,True,0:LIVING,45.8625111,0:ALIVE OR DEAD TUMOR FREE,45.8625111,1:PROGRESSION,24.72301673,1:Recurred/Progressed,24.72301673,Biochemical evidence of disease,R0,0.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,3.5585860205768785,4.049709172933222,7.53077462115476,4.097324251633336,6.749884172636659
TCGA-YL-A8SK,TCGA-YL-A8SK-01,67,Male,0.0,EUR,PROCURE Biobank,-24759.0,1408.0,1408.0,2014-04-25,-41.0,-22.0,-46.0,0.1851,31.0,3.0,0.3263,0.0,0.7096764823472214,"Prostate Adenocarcinoma, Acinar Type",,,,N1,,t3/t4,m0,,n1,t3b,0.03,4.0,5.0,9.0,163.0,940.0,True,True,False,Stable Disease,,False,0:LIVING,46.28990367,0:ALIVE OR DEAD TUMOR FREE,46.28990367,0:CENSORED,46.28990367,,,,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.2383130154000983,4.232054390506359,7.839400963944316,3.481027635631913,6.225874514087956
TCGA-YL-A8SL,TCGA-YL-A8SL-01,74,Male,0.0,EUR,PROCURE Biobank,-27033.0,987.0,987.0,2014-04-25,-15.0,-22.0,-12.0,0.2142,39.0,13.0,0.3229,0.0,0.8329091229351039,"Prostate Adenocarcinoma, Acinar Type",,,,N1,,t3/t4,m0,,n1,t3b,0.0,4.0,4.0,8.0,266.0,296.0,False,True,False,Complete Remission/Response,False,False,0:LIVING,32.44895946,0:ALIVE OR DEAD TUMOR FREE,32.44895946,0:CENSORED,32.44895946,0:DiseaseFree,32.44895946,,R0,0.0,1.0,0.0,0.0,1.0,0.0,3.0,4.0,4.190520046905134,4.97640946394518,7.466226587703014,4.186025074517679,6.992431959039073
TCGA-YL-A8SO,TCGA-YL-A8SO-01,64,Male,0.0,EUR,PROCURE Biobank,-23584.0,3479.0,3479.0,2014-04-27,-11.0,-14.0,-2.0,0.2187,31.0,4.0,0.3093,0.0,0.7096764823472214,"Prostate Adenocarcinoma, Acinar Type",,,,,t1,t3/t4,m0,t1a,,t3a,0.0,4.0,5.0,9.0,1387.0,1862.0,False,True,False,Stable Disease,,False,0:LIVING,114.3768288,0:ALIVE OR DEAD TUMOR FREE,114.3768288,0:CENSORED,114.3768288,,,,R1,1.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,2.801365627622766,4.543205087967604,7.296206841245653,6.015513180190378,6.37093844005437
TCGA-YL-A8SP,TCGA-YL-A8SP-01,58,Male,0.0,EUR,PROCURE Biobank,-21455.0,2366.0,2366.0,2014-04-30,-27.0,-20.0,-32.0,0.0768,20.0,2.0,0.3147,0.05,0.5108256239659906,"Prostate Adenocarcinoma, Acinar Type",,,,,t2,t3/t4,m0,t2a,,t3b,0.38,4.0,5.0,9.0,359.0,2170.0,False,True,False,Stable Disease,True,False,0:LIVING,77.78544893,0:ALIVE OR DEAD TUMOR FREE,77.78544893,1:PROGRESSION,66.93625275,,,Biochemical evidence of disease,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.4497198312701527,4.706254253573203,7.646510469513844,5.41063620815056,8.259171720875436
TCGA-YL-A8SQ,TCGA-YL-A8SQ-01,61,Male,0.0,EUR,PROCURE Biobank,-22482.0,2083.0,2083.0,2014-04-30,-31.0,-22.0,-32.0,0.4599,34.0,20.0,0.323,0.0,0.7576857015412665,"Prostate Adenocarcinoma, Acinar Type",,,,N0,,t3/t4,m0,,n0,t3b,1.1,4.0,5.0,9.0,481.0,,False,True,False,Stable Disease,True,True,0:LIVING,68.4814413,0:ALIVE OR DEAD TUMOR FREE,68.4814413,1:PROGRESSION,10.81631982,,,Biochemical evidence of disease,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,3.2499003781629083,4.3042846903180125,7.682293073813836,4.397111561873789,6.506614635658092
TCGA-YL-A8SR,TCGA-YL-A8SR-01,64,Male,0.0,EUR,PROCURE Biobank,-23488.0,273.0,273.0,2014-04-25,-17.0,-26.0,-26.0,0.2351,25.0,4.0,0.3195,0.02,0.6061358033884974,"Prostate Adenocarcinoma, Acinar Type",,,,N0,t1,t3/t4,m0,t1c,n0,t3a,0.06,4.0,5.0,9.0,,0.0,False,False,False,No Treatment Indicated,,,0:LIVING,8.975244107,0:ALIVE OR DEAD TUMOR FREE,8.975244107,0:CENSORED,8.975244107,,,,R1,1.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,3.669389662012837,4.3528150116028055,7.876973011669732,4.188274311321204,5.3795516533654935
TCGA-YL-A9WH,TCGA-YL-A9WH-01,67,Male,0.0,EUR,PROCURE Biobank,-24755.0,427.0,427.0,2014-04-10,11.0,14.0,16.0,0.5475,51.0,20.0,0.3165,0.0,0.9932517730102834,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,100.0,N1,,t3/t4,m0,,n1,t3b,0.03,4.0,5.0,9.0,203.0,650.0,True,True,False,Stable Disease,,False,0:LIVING,14.03820232,0:ALIVE OR DEAD TUMOR FREE,14.03820232,0:CENSORED,14.03820232,,,,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.630650093796575,4.2222867915826745,7.943669371940343,3.567362908889674,6.665425460995004
TCGA-YL-A9WI,TCGA-YL-A9WI-01,63,Male,0.0,EUR,PROCURE Biobank,-23184.0,1623.0,1623.0,2014-04-10,-11.0,-12.0,-14.0,0.376,37.0,11.0,0.3211,0.0,0.803495237579557,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,100.0,N1,,t3/t4,m0,,n1,t3a,0.03,4.0,5.0,9.0,,0.0,False,False,False,Stable Disease,,False,0:LIVING,53.35831936,0:ALIVE OR DEAD TUMOR FREE,53.35831936,0:CENSORED,53.35831936,,,,R0,0.0,0.0,1.0,0.0,1.0,0.0,3.0,5.0,3.2443238720333243,3.838336650530712,7.579957746944804,5.668573016475889,7.7635437003752035
TCGA-YL-A9WJ,TCGA-YL-A9WJ-01,47,Male,0.0,EUR,PROCURE Biobank,-17322.0,,,2014-04-14,-27.0,-22.0,-20.0,0.0872,22.0,2.0,0.3418,0.0,0.5500463367269643,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,100.0,N1,t3/t4,t3/t4,m0,t4,n1,t3b,3.1,4.0,4.0,8.0,838.0,876.0,True,False,False,No Treatment Indicated,True,True,1:DECEASED,60.98563303,1:DEAD WITH TUMOR,60.98563303,1:PROGRESSION,48.52549561,,,Distant Metastasis,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,4.0,3.461266608488791,3.977353201387015,8.166097789487052,4.042197803219813,7.006082546197954
TCGA-YL-A9WK,TCGA-YL-A9WK-01,63,Male,0.0,AFR,PROCURE Biobank,-23272.0,2136.0,2136.0,2014-04-13,,,,0.2269,27.0,7.0,0.3473,0.0,0.6418538861723947,"Prostate Adenocarcinoma, Acinar Type",0.0,95.0,100.0,N0,t2,t3/t4,m0,t2b,n0,t3b,15.6,4.0,5.0,9.0,360.0,1527.0,False,True,False,Stable Disease,True,True,0:LIVING,70.22388796,0:ALIVE OR DEAD TUMOR FREE,70.22388796,1:PROGRESSION,33.17223921,,,Biochemical evidence of disease,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,3.8380239498455606,4.584301113914692,7.104498115195887,4.171358968628516,6.084576687786025
TCGA-YL-A9WL,TCGA-YL-A9WL-01,59,Male,0.0,EUR,PROCURE Biobank,-21626.0,740.0,740.0,2014-04-12,,,,0.1404,25.0,1.0,0.3378,0.04,0.6241543092515653,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,100.0,N0,t2,t3/t4,m0,t2a,n0,t3a,6.4,4.0,5.0,9.0,271.0,417.0,True,True,False,Complete Remission/Response,True,True,0:LIVING,24.32850051,0:ALIVE OR DEAD TUMOR FREE,24.32850051,1:PROGRESSION,24.32850051,1:Recurred/Progressed,24.32850051,Biochemical evidence of disease,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,4.094987629665034,4.847891706206076,7.736797645671285,4.956126368593931,6.22259013429596
TCGA-YL-A9WX,TCGA-YL-A9WX-01,68,Male,0.0,EUR,PROCURE Biobank,-25008.0,1518.0,1518.0,2014-04-12,,,,0.0056,5.0,2.0,0.3366,0.02,0.1541506801129724,"Prostate Adenocarcinoma, Acinar Type",0.0,90.0,100.0,N1,t3/t4,t3/t4,m0,t3a,n1,t3b,0.76,4.0,5.0,9.0,,0.0,False,False,False,Complete Remission/Response,True,True,0:LIVING,49.9063024,0:ALIVE OR DEAD TUMOR FREE,49.9063024,1:PROGRESSION,49.51178617,,,Biochemical evidence of disease,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.512239530586865,4.248694215991378,8.081285827934858,4.218920626729427,5.609568822651029
TCGA-YL-A9WY,TCGA-YL-A9WY-01,57,Male,0.0,EUR,PROCURE Biobank,-21164.0,1098.0,1098.0,2014-04-13,,,,0.1806,29.0,12.0,0.3309,0.0,0.6763400624130557,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,100.0,N1,t3/t4,t3/t4,m0,t3a,n1,t3b,1.8,5.0,4.0,9.0,236.0,,False,True,False,Stable Disease,True,True,0:LIVING,36.09823454,0:ALIVE OR DEAD TUMOR FREE,36.09823454,1:PROGRESSION,25.15040931,,,Biochemical evidence of disease,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,4.01435529297707,4.541855525044516,7.684324339084501,4.098419557765545,5.375324465822405
TCGA-ZG-A8QW,TCGA-ZG-A8QW-01,72,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-26632.0,94.0,94.0,2014-05-21,-11.0,-12.0,-12.0,0.0114,28.0,1.0,0.3219,0.0,0.6592456287118501,"Prostate Adenocarcinoma, Acinar Type",5.0,60.0,366.0,N1,t3/t4,t3/t4,m0,t3a,n1,t3b,,4.0,5.0,9.0,,0.0,False,False,False,Progressive Disease,,False,0:LIVING,3.090377092,0:ALIVE OR DEAD TUMOR FREE,3.090377092,0:CENSORED,3.090377092,,,,R0,0.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.1224739411756444,3.828133944794661,7.477379433383606,3.927886974755231,6.392454815764045
TCGA-ZG-A8QX,TCGA-ZG-A8QX-01,56,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-20683.0,442.0,442.0,2014-05-21,-17.0,-26.0,-16.0,0.0474,27.0,0.0,0.3199,0.0,0.6418538861723947,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,346.0,N0,t1,t2,m0,t1c,n0,t2c,,3.0,3.0,6.0,,0.0,False,False,False,Stable Disease,,False,0:LIVING,14.5313476,0:ALIVE OR DEAD TUMOR FREE,14.5313476,0:CENSORED,14.5313476,,,,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.299464474710217,3.0755155172456745,7.197322863693544,4.043125739043447,4.808271772508429
TCGA-ZG-A8QY,TCGA-ZG-A8QY-01,67,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-24731.0,404.0,404.0,2014-05-21,-31.0,-24.0,-30.0,0.1223,51.0,0.0,0.3152,0.0,0.9932517730102834,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,422.0,N1,t2,t3/t4,m0,t2c,n1,t3b,,5.0,4.0,9.0,,0.0,False,False,False,Stable Disease,,False,0:LIVING,13.28204622,0:ALIVE OR DEAD TUMOR FREE,13.28204622,0:CENSORED,13.28204622,,,,RX,0.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,2.9814873677982616,3.608726462716353,8.049629678733368,4.092892420266,4.962400951689934
TCGA-ZG-A8QZ,TCGA-ZG-A8QZ-01,65,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-23980.0,308.0,308.0,2014-05-21,-33.0,-18.0,-50.0,0.0672,26.0,2.0,0.3215,0.0,0.6241543092515653,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,261.0,N1,t2,t3/t4,m0,t2a,n1,t3b,0.01,4.0,5.0,9.0,89.0,159.0,True,True,False,Stable Disease,False,False,0:LIVING,10.12591643,0:ALIVE OR DEAD TUMOR FREE,10.12591643,0:CENSORED,10.12591643,,,,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.169588333319963,3.755752859606722,7.918603886550107,4.341181654649368,6.422246458596406
TCGA-ZG-A9KY,TCGA-ZG-A9KY-01,73,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-27000.0,130.0,130.0,2014-07-17,,,,0.2727,55.0,5.0,0.3332,0.02,1.041453874710514,"Prostate Adenocarcinoma, Acinar Type",2.0,90.0,186.0,N1,t1,t3/t4,m0,t1c,n1,t4,,5.0,4.0,9.0,,0.0,False,False,False,Stable Disease,,False,0:LIVING,4.273925765,0:ALIVE OR DEAD TUMOR FREE,4.273925765,0:CENSORED,4.273925765,,,,R1,1.0,0.0,0.0,1.0,1.0,0.0,3.0,5.0,3.304277388065675,4.346914352288677,8.05745622924572,3.368489000645104,6.559400035792183
TCGA-ZG-A9L0,TCGA-ZG-A9L0-01,71,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-26055.0,355.0,355.0,2014-07-17,,,,0.4797,35.0,4.0,0.3249,0.0,0.7884573603642703,"Prostate Adenocarcinoma, Acinar Type",2.0,80.0,718.0,N1,,t3/t4,m0,,n1,t3b,,5.0,4.0,9.0,,0.0,False,False,False,Stable Disease,False,False,0:LIVING,11.67110497,0:ALIVE OR DEAD TUMOR FREE,11.67110497,0:CENSORED,11.67110497,,,,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,2.7592836888473307,3.935110818576768,7.140959594706745,4.877376168548641,6.0357162744442565
TCGA-ZG-A9L1,TCGA-ZG-A9L1-01,66,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-24214.0,1302.0,1302.0,2014-07-17,,,,0.3262,24.0,12.0,0.3181,0.0,0.5690945320786457,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,963.0,N1,t1,t3/t4,m0,t1c,n1,t3b,0.07,4.0,5.0,9.0,148.0,199.0,True,False,False,Progressive Disease,True,False,0:LIVING,42.80501036,0:ALIVE OR DEAD TUMOR FREE,42.80501036,0:CENSORED,42.80501036,,,,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.906390374617695,3.8384072509836415,8.136776357474782,3.646093516761183,6.205488308889009
TCGA-ZG-A9L2,TCGA-ZG-A9L2-01,70,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-25573.0,1154.0,1154.0,2014-07-17,,,,0.0641,25.0,3.0,0.3309,0.0,0.6061358033884974,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,693.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3b,0.01,4.0,5.0,9.0,,0.0,False,False,False,Stable Disease,True,False,0:LIVING,37.93931025,0:ALIVE OR DEAD TUMOR FREE,37.93931025,1:PROGRESSION,5.917743367,,,Biochemical evidence of disease,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,3.788330734736344,2.694523652674208,7.593883329320729,5.021848349304653,5.424683634269228
TCGA-ZG-A9L4,TCGA-ZG-A9L4-01,61,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-22388.0,1108.0,1108.0,2014-07-17,,,,0.0498,24.0,2.0,0.3332,0.0,0.5877866649021191,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,271.0,N0,t1,t3/t4,m0,t1c,n0,t3b,0.03,5.0,4.0,9.0,,0.0,False,False,False,Stable Disease,,False,0:LIVING,36.42699806,0:ALIVE OR DEAD TUMOR FREE,36.42699806,0:CENSORED,36.42699806,,,,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,4.174789893047815,3.376568225425708,7.9701686026128495,3.472942603600464,6.661648427501561
TCGA-ZG-A9L5,TCGA-ZG-A9L5-01,58,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-21293.0,908.0,908.0,2014-07-17,,,,0.4144,42.0,16.0,0.3366,0.02,0.8754687373538999,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,714.0,N1,t2,t3/t4,m0,t2a,n1,t4,,5.0,4.0,9.0,,0.0,False,False,False,Progressive Disease,True,False,0:LIVING,29.85172765,0:ALIVE OR DEAD TUMOR FREE,29.85172765,0:CENSORED,29.85172765,,,,R1,1.0,0.0,0.0,1.0,1.0,0.0,3.0,5.0,3.1721354396018366,3.586224306922192,6.788214565573674,4.332321253873716,6.00863030514344
TCGA-ZG-A9L6,TCGA-ZG-A9L6-01,64,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-23681.0,687.0,687.0,2014-07-17,,,,0.0789,27.0,1.0,0.3341,0.0,0.6418538861723947,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,769.0,N0,t1,t3/t4,m0,t1c,n0,t3b,0.36,5.0,4.0,9.0,,0.0,False,False,False,Partial Remission/Response,True,False,0:LIVING,22.58605385,0:ALIVE OR DEAD TUMOR FREE,22.58605385,1:PROGRESSION,21.82989776,,,Biochemical evidence of disease,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,3.32972638767445,3.478402378037273,6.872150336422474,3.070337802148401,4.715421178466618
TCGA-ZG-A9L9,TCGA-ZG-A9L9-01,60,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-22108.0,617.0,617.0,2014-07-17,,,,0.324,33.0,12.0,0.3215,0.0,0.7419373447293773,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,378.0,N1,t2,t3/t4,m0,t2b,n1,t3b,,4.0,5.0,9.0,829.0,851.0,True,False,False,Progressive Disease,True,False,0:LIVING,20.28470921,0:ALIVE OR DEAD TUMOR FREE,20.28470921,1:PROGRESSION,1.676693954,,,Biochemical evidence of disease,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,2.8770374506986984,2.40433094306401,6.308521062193259,4.905244985085586,4.770866037738776
TCGA-ZG-A9LB,TCGA-ZG-A9LB-01,72,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-26447.0,583.0,583.0,2014-07-17,,,,0.3329,52.0,19.0,0.3235,0.0,1.0055218654801463,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,488.0,N0,t2,t3/t4,m0,t2a,n0,t3b,0.02,5.0,4.0,9.0,,0.0,False,False,False,Partial Remission/Response,True,False,0:LIVING,19.16691324,0:ALIVE OR DEAD TUMOR FREE,19.16691324,0:CENSORED,19.16691324,,,,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,2.2048293391035023,3.5016302179412047,6.266153114746019,5.57139770824079,7.31326036574917
TCGA-ZG-A9LM,TCGA-ZG-A9LM-01,72,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-26377.0,378.0,378.0,2014-07-18,,,,0.3341,30.0,11.0,0.3418,0.02,0.6931471805599453,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,159.0,N1,t2,t3/t4,m0,t2b,n1,t3a,0.0,4.0,5.0,9.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,12.42726107,0:ALIVE OR DEAD TUMOR FREE,12.42726107,0:CENSORED,12.42726107,0:DiseaseFree,12.42726107,,R0,0.0,0.0,1.0,0.0,1.0,0.0,3.0,5.0,2.74504366879086,2.956075243723553,6.367898699169052,3.47534433714261,4.192896400577129
TCGA-ZG-A9LN,TCGA-ZG-A9LN-01,57,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-21050.0,115.0,115.0,2014-07-18,,,,0.1039,31.0,1.0,0.3322,0.0,0.7259370035442264,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,148.0,N1,t1,t3/t4,m0,t1c,n1,t3b,7.42,5.0,4.0,9.0,73.0,,False,True,False,Partial Remission/Response,True,False,0:LIVING,3.780780485,0:ALIVE OR DEAD TUMOR FREE,3.780780485,0:CENSORED,3.780780485,,,,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,2.6754772306094066,3.467005525012587,6.475091369872333,3.789750114493765,5.783608564140677
TCGA-ZG-A9LS,TCGA-ZG-A9LS-01,64,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-23540.0,516.0,516.0,2014-07-18,,,,0.1958,18.0,7.0,0.3278,0.0,0.4700036292457356,"Prostate Adenocarcinoma, Acinar Type",2.0,70.0,266.0,N1,t2,t3/t4,m0,t2a,n1,t3b,0.03,5.0,4.0,9.0,160.0,211.0,True,False,False,Complete Remission/Response,True,False,0:LIVING,16.96419765,0:ALIVE OR DEAD TUMOR FREE,16.96419765,0:CENSORED,16.96419765,0:DiseaseFree,16.96419765,,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.5818814636913343,3.5128083992044696,7.055626254925812,4.506322657655852,6.398988181313424
TCGA-ZG-A9LU,TCGA-ZG-A9LU-01,67,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-24742.0,579.0,579.0,2014-07-18,,,,0.0198,18.0,13.0,0.32,0.0,0.4700036292457356,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,569.0,N0,t2,t3/t4,m0,t2b,n0,t3a,0.7,5.0,4.0,9.0,206.0,267.0,True,False,False,Partial Remission/Response,True,False,0:LIVING,19.03540783,0:ALIVE OR DEAD TUMOR FREE,19.03540783,0:CENSORED,19.03540783,,,,R1,1.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,2.873675417355985,3.919235190027174,7.010703764118208,3.684325040478929,4.647429644221862
TCGA-ZG-A9LY,TCGA-ZG-A9LY-01,60,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-21942.0,370.0,370.0,2014-07-18,,,,0.1869,33.0,4.0,0.3084,0.0,0.7259370035442264,"Prostate Adenocarcinoma, Acinar Type",0.0,80.0,258.0,N1,t2,t3/t4,m0,t2b,n1,t3b,0.01,4.0,5.0,9.0,208.0,258.0,True,False,False,Complete Remission/Response,False,False,0:LIVING,12.16425026,0:ALIVE OR DEAD TUMOR FREE,12.16425026,0:CENSORED,12.16425026,0:DiseaseFree,12.16425026,,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.052328940286731,3.335569005556749,8.050196387564267,4.520604538343609,5.462971711141227
TCGA-ZG-A9LZ,TCGA-ZG-A9LZ-01,66,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-24132.0,692.0,692.0,2014-07-18,,,,0.3111,30.0,3.0,0.306,0.04,0.6931471805599453,"Prostate Adenocarcinoma, Acinar Type",0.0,60.0,293.0,N0,t3/t4,t3/t4,m0,t3a,n0,t3b,2.19,4.0,5.0,9.0,105.0,156.0,True,False,False,Partial Remission/Response,True,False,0:LIVING,22.75043561,0:ALIVE OR DEAD TUMOR FREE,22.75043561,0:CENSORED,22.75043561,,,,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,3.37300779934775,3.3921800167078064,7.249821704930645,4.862669589268398,6.922911406258192
TCGA-ZG-A9M4,TCGA-ZG-A9M4-01,65,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-24030.0,547.0,547.0,2014-07-18,,,,0.3097,32.0,20.0,0.325,0.06,0.7419373447293773,"Prostate Adenocarcinoma, Acinar Type",2.0,60.0,289.0,N1,t2,t3/t4,m0,t2a,n1,t3b,0.95,5.0,4.0,9.0,,0.0,False,False,False,Partial Remission/Response,True,False,0:LIVING,17.98336457,0:ALIVE OR DEAD TUMOR FREE,17.98336457,0:CENSORED,17.98336457,,,,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.612376091283237,3.405910695381115,8.17962898099381,3.2011633404150674,4.081228830218227
TCGA-ZG-A9MC,TCGA-ZG-A9MC-01,69,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-25477.0,455.0,455.0,2014-07-18,,,,0.0134,28.0,2.0,0.3238,0.05,0.6592456287118501,"Prostate Adenocarcinoma, Acinar Type",1.0,60.0,319.0,N1,t2,t3/t4,m0,t2a,n1,t3b,31.85,5.0,4.0,9.0,140.0,184.0,True,False,False,Partial Remission/Response,True,False,0:LIVING,14.95874018,0:ALIVE OR DEAD TUMOR FREE,14.95874018,0:CENSORED,14.95874018,,,,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.945017695561417,3.22203170248449,8.078270382312631,3.0769010875572635,6.169452040550529
TCGA-ZG-A9N3,TCGA-ZG-A9N3-01,73,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-26902.0,349.0,349.0,2014-07-18,,,,0.5503,48.0,18.0,0.3385,0.15,0.9555114450274363,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,325.0,N1,t1,t3/t4,m0,t1c,n1,t3b,0.1,5.0,4.0,9.0,140.0,,False,True,False,Partial Remission/Response,True,False,0:LIVING,11.47384686,0:ALIVE OR DEAD TUMOR FREE,11.47384686,0:CENSORED,11.47384686,,,,R1,1.0,1.0,0.0,0.0,1.0,0.0,3.0,5.0,3.0735460609151546,3.1489178395525697,6.881359947510511,4.508194100441154,5.523053787011941
TCGA-ZG-A9ND,TCGA-ZG-A9ND-01,55,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-20428.0,410.0,410.0,2014-07-18,,,,0.167,25.0,2.0,0.3249,0.0,0.6061358033884974,"Prostate Adenocarcinoma, Acinar Type",0.0,85.0,111.0,N0,t1,t3/t4,m0,t1c,n0,t3a,0.08,5.0,4.0,9.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,13.47930434,0:ALIVE OR DEAD TUMOR FREE,13.47930434,0:CENSORED,13.47930434,0:DiseaseFree,13.47930434,,R0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0,3.983139547518919,3.795517612578692,7.925812544225951,4.766960824267833,5.097791964826549
TCGA-ZG-A9NI,TCGA-ZG-A9NI-01,73,Male,0.0,EUR,University Medical Center Hamburg-Eppendorf,-26697.0,132.0,132.0,2014-07-18,,,,0.2181,83.0,7.0,0.3079,0.0,1.3261904371386808,"Prostate Adenocarcinoma, Acinar Type",0.0,70.0,501.0,N0,t2,t3/t4,m0,t2a,n0,t3b,0.03,5.0,4.0,9.0,,0.0,False,False,False,Complete Remission/Response,False,False,0:LIVING,4.339678469,0:ALIVE OR DEAD TUMOR FREE,4.339678469,0:CENSORED,4.339678469,0:DiseaseFree,4.339678469,,R1,1.0,1.0,0.0,0.0,0.0,0.0,3.0,5.0,3.0926810407128373,2.756809814294497,7.245135286320892,4.427921225121404,5.510012465448515
